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A B S T R A C T
Background
This is an updated version of the original Cochrane review published in 2010, Issue 9. Non-invasive brain stimulation techniques aim
to induce an electrical stimulation of the brain in an attempt to reduce chronic pain by directly altering brain activity. They include
repetitive transcranial magnetic stimulation (rTMS), cranial electrotherapy stimulation (CES), transcranial direct current stimulation
(tDCS) and reduced impedance non-invasive cortical electrostimulation (RINCE).
Objectives
To evaluate the efficacy of non-invasive brain stimulation techniques in chronic pain.
Search methods
We searched CENTRAL (2013, Issue 6), MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS and clinical trials registers. The
original search for the review was run in November 2009 and searched all databases from their inception. To identify studies for
inclusion in this update we searched from 2009 to July 2013.
Selection criteria
Randomised and quasi-randomised studies of rTMS, CES, tDCS or RINCE if they employed a sham stimulation control group,
recruited patients over the age of 18 with pain of three months duration or more and measured pain as a primary outcome.
Data collection and analysis
Two authors independently extracted and verified data. Where possible we entered data into meta-analyses. We excluded studies judged
as being at high risk of bias from the analysis. We used the GRADE system to summarise the quality of evidence for core comparisons.
Main results
We included an additional 23 trials (involving 773 participants randomised) in this update, making a total of 56 trials in the review
(involving 1710 participants randomised). This update included a total of 30 rTMS studies, 11 CES, 14 tDCS and one study of
RINCE(the original review included 19 rTMS, eight CES and six tDCS studies). We judged only three studies as being at low risk of
bias across all criteria.
1Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Meta-analysis of studies of rTMS (involving 528 participants) demonstrated significant heterogeneity. Pre-specified subgroup analyses
suggest that low-frequency stimulation is ineffective (low-quality evidence) and that rTMS applied to the dorsolateral prefrontal cortex
is ineffective (very low-quality evidence). We found a short-term effect on pain of active high-frequency stimulation of the motor cortex
in single-dose studies (low-quality evidence, standardised mean difference (SMD) 0.39 (95% confidence interval (CI) -0.27 to -0.51
P < 0.01)). This equates to a 12% (95% CI 8% to 15%) reduction in pain, which does not exceed the pre-established criteria for
a minimal clinically important difference (≥ 15%). Evidence for multiple-dose studies was heterogenous but did not demonstrate a
significant effect (very low-quality evidence).
For CES (six studies, 270 participants) no statistically significant difference was found between active stimulation and sham (low-
quality evidence).
Analysis of tDCS studies (11 studies, 193 people) demonstrated significant heterogeneity and did not find a significant difference
between active and sham stimulation (very low-quality evidence). Pre-specified subgroup analysis of tDCS applied to the motor cortex
(n = 183) did not demonstrate a statistically significant effect and this lack of effect was consistent for subgroups of single or multiple-
dose studies.
One small study (n = 91) at unclear risk of bias suggested a positive effect of RINCE over sham stimulation on pain (very low-quality
evidence).
Non-invasive brain stimulation appears to be frequently associated with minor and transient side effects, though there were two reported
incidences of seizure related to active rTMS in the included studies.
Authors’ conclusions
Single doses of high-frequency rTMS of the motor cortex may have small short-term effects on chronic pain. It is likely that multiple
sources of bias may exaggerate this observed effect. The effects do not meet the predetermined threshold of minimal clinical significance
and multiple-dose studies do not consistently demonstrate effectiveness. The available evidence suggests that low-frequency rTMS,
rTMS applied to the pre-frontal cortex, CES and tDCS are not effective in the treatment of chronic pain. While the broad conclusions
for rTMS and CES have not changed substantially, the addition of this new evidence and the application of the GRADE system has
modified some of our interpretation and the conclusion regarding the effectiveness of tDCS has changed. We recommend that previous
readers should re-read this update. There is a need for larger, rigorously designed studies, particularly of longer courses of stimulation.
It is likely that future evidence may substantially impact upon the presented results.
P L A I N L A N G U A G E S U M M A R Y
Stimulating the brain without surgery in the management of chronic pain
Various devices are available that can electrically stimulate the brain without the need for surgery or any invasive treatment in order to
manage chronic pain. There are four main treatment types: repetitive transcranial magnetic stimulation (rTMS) in which the brain is
stimulated by a coil applied to the scalp, cranial electrotherapy stimulation (CES) in which electrodes are clipped to the ears or applied
to the scalp, transcranial direct current stimulation (tDCS) and reduced impedance non-invasive cortical electrostimulation (RINCE)
in which electrodes are applied to the scalp. These have been used to try to reduce pain by aiming to alter the activity of the brain, but
the efficacy of these treatments is uncertain.
This review update included 56 studies: 30 of rTMS, 11 of CES, 14 of tDCS and one of RINCE. We judged only three studies as
having a low risk of bias. Low or very low-quality evidence suggests that low-frequency rTMS and rTMS applied to pre-frontal areas of
the brain are not effective but that a single dose of high-frequency stimulation of the motor cortex area of the brain provides short-term
pain relief. This effect appears to be small and may be exaggerated by a number of sources of bias. Studies that gave a course of multiple
treatments of rTMS produced conflicting results with no overall effect seen when we pooled the results of these studies. Most studies
of rTMS are small and there is substantial variation between studies in terms of the treatment methods used. Low-quality evidence
does not suggest that CES or tDCS are effective treatments for chronic pain. A single small study of RINCE provided very low-quality
evidence of a short-term effect on pain. For all forms of stimulation the evidence is not conclusive and uncertainty remains.
The reporting of side effects varied across the studies. Of the studies that clearly reported side effects, short-lived and minor side effects
such as headache, nausea and skin irritation were usually reported both after real and sham stimulation. There were two reports of
seizure following real rTMS.
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While the broad conclusions for rTMS and CES have not changed substantially, the addition of this new evidence and the application
of the GRADE system has modified some of our interpretation. Previous readers should re-read this update.
More studies of rigorous design and adequate size are required to evaluate accurately all forms of non-invasive brain stimulation for the
treatment of chronic pain.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Repetitive transcranial magnetic stimulation (rTMS) compared with sham for chronic pain
Intervention: active rTMS
Comparison: sham rTMS
Outcomes: pain (VAS or NRS)
Comparison No of participants
(studies)
Effect size
(SMD, 95% CIs)
Relative effect
(average % improve-
ment (reduction) in pain
(95% CIs) in relation
to post-treatment score
from sham group)*
*statistically significant
outcomes with low het-
erogeneity only
Quality of the evidence
(GRADE)
Pain: short-term follow-
up
Subgroup analysis: low-
frequency rTMS
81
(6)
Ineffective
0.15 (-0.01 to 0.31) P =
0.07
⊕⊕©© low
Pain: short-term follow-
up
subgroup analysis: high-
frequency rTMS
447
(20)
Effective
-0.27 (-0.35 to -0.20) P
<0.01
⊕⊕©© low
Pain: short-term follow-
up
Subgroup analysis: mo-
tor cortex studies only,
low-frequency studies
excluded, single-dose
studies
233
(12)
Effective
-0.39 (-0.51 to -0.27)
P <0.01
12% (8% to 15%) ⊕⊕©© low
Pain: short-term follow-
up
Subgroup analysis: mo-
tor cortex studies only,
low-frequency studies
excluded, multiple-dose
studies
157
(5)
Ineffective
-0.07 (-0.41 to 0.26)
P = 0.68
⊕©©© very low
Pain: short-term follow-
up
Subgroup analysis: pre-
frontal cortex studies
only
68
(5)
Ineffective
-0.47 (-1.48 to 0.11)
P = 0.36
⊕©©© very low
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Pain: medium-term fol-
low-up
rTMS all studies
184
(8)
Ineffective
-0.18 (-0.43 to 0.06)
P = 0.15
⊕©©© very low
Pain: long-term follow-
up
rTMS all studies
59
(3)
Ineffective
-0.12 (-0.46 to 0.21)
P = 0.47
⊕⊕©© low
CES compared with sham for chronic pain
Intervention: active CES
Comparison: sham CES
Outcomes: pain (VAS or NRS)
Pain: short-term follow-
up
CES all studies
270
(5)
Ineffective
-0.24 (-0.48 to 0.01)
P = 0.06
⊕⊕©© low
tDCS compared with sham for chronic pain
Intervention: active tDCS
Comparison: sham tDCS
Outcomes: pain (VAS or NRS)
Pain: short-term follow-
up
tDCS all studies
183
(10)
Ineffective
-0.18 (-0.56 to 0.09)
P = 0.19
⊕©©© very low
Pain: short-term follow-
up
Subgroup analysis: mo-
tor cortex studies only
(single and multiple-
dose studies)
172
(10)
Ineffective
-0.23 (-0.48 to 0.01)
P = 0.06
⊕⊕©© low
Pain: short-term follow-
up
Subgroup analysis: mo-
tor cortex studies only
(multiple-dose studies
only)
119
(7)
Ineffective
-0.35 (-0.79 to 0.09)
P = 0.12
⊕©©© very low
Pain: medium-term fol-
low-up
tDCS
77
(4)
Ineffective
-0.20 (-0.63 to 0.24)
P = 0.37
⊕⊕©© low
RINCE compared with sham for chronic pain
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Intervention: active RINCE
Comparison: sham RINCE
Outcomes: pain (VAS or NRS)
Pain: short-term follow-
up
tDCS all studies
91
(1)
Effective
-1.41 (-2.48 to -0.34) P
= 0.01
⊕©©© very low
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
CES: cranial electrotherapy stimulation; CI: confidence interval; NRS: numerical rating scale; RINCE: reduced impedance non-invasive
cortical electrostimulation; rTMS: repetitive transcranial magnetic stimulation; tDCS: transcranial direct current stimulation; VAS: visual
analogue scale
For full details of the GRADE judgements for each comparison see Appendix 6.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
This is an updated version of the original Cochrane review pub-
lished in 2010, Issue 9, on non-invasive brain stimulation tech-
niques for chronic pain (O’Connell 2010).
Description of the condition
Chronic pain is a common problem. When defined as pain of
greater than three months duration, prevalence studies indicate
that up to half the adult population suffer from chronic pain, and
10% to 20% experience clinically significant chronic pain (Smith
2008). In Europe, 19% of adults experience chronic pain of mod-
erate to severe intensity with serious negative implications for their
social and working lives and many of these receive inadequate
pain management (Breivik 2006). Chronic pain is a heterogenous
phenomenon that results from a wide variety of pathologies in-
cluding chronic somatic tissue injury such as arthritis, peripheral
nerve injury and central nervous system injury, as well as a range
of chronic pain syndromes such as fibromyalgia. It is likely that
different mechanisms of pain production underpin these different
causes of chronic pain (Ossipov 2006).
Description of the intervention
Brain stimulation techniques have been used to address a variety of
pathological pain conditions including fibromyalgia, chronic post-
stroke pain and complex regional pain syndrome (Cruccu 2007;
Fregni 2007;Gilula 2007), and clinical studies of both invasive and
non-invasive techniques have produced preliminary data show-
ing reductions in pain (Cruccu 2007; Fregni 2007; Lefaucheur
2008b). Various types of brain stimulation, both invasive and non-
invasive, are currently in clinical use for the treatment of chronic
pain (Cruccu 2007). Non-invasive stimulation techniques require
no surgical procedure and are therefore easier and safer to apply
than invasive procedures.
Repetitive transcranial magnetic stimulation (rTMS) involves
stimulation of the cerebral cortex (the outer layer of the brain) by a
stimulating coil applied to the scalp. Electric currents are induced
in the neurons (brain cells) directly using rapidly changing mag-
netic fields (Fregni 2007). Trains of these stimuli are applied to
the target region of the cortex to induce alterations in brain activ-
ity both locally and in remote brain regions (Leo 2007). A recent
meta-analysis suggested that rTMS may be more effective in the
treatment of neuropathic pain conditions (pain arising as a result
of damage to the nervous system, as in diabetes, traumatic nerve
injury, stroke, multiple sclerosis, epilepsy, spinal cord injury and
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cancer) with a central compared to a peripheral nervous system
origin (Leung 2009).
Transcranial direct current stimulation (tDCS) and cranial elec-
trotherapy stimulation (CES) involve the safe and painless applica-
tion of low-intensity (commonly≤ 2 mA) electrical current to the
cerebral cortex of the brain (Fregni 2007; Gilula 2007; Hargrove
2012). tDCS has been developed as a clinical tool for the mod-
ulation of brain activity in recent years and uses relatively large
electrodes that are applied to the scalp over the targeted brain area
to deliver a weak constant current (Lefaucheur 2008a). Recent
clinical studies have concluded that tDCS was more effective than
sham stimulation at reducing pain in both fibromyalgia and spinal
cord injury related pain (Fregni 2006a; Fregni 2006b). CES was
initially developed in the USSR as a treatment for anxiety and
depression in the 1950s and its use later spread to Europe and the
USA where it began to be considered and used as a treatment for
pain (Kirsch 2000). The electrical current in CES is commonly
pulsed and is applied via clip electrodes that are attached to the
patient’s earlobes. A Cochrane Review of non-invasive treatments
for headaches identified limited evidence that CES is superior to
placebo in reducingpain intensity after six to 10weeks of treatment
(Bronfort 2004). Reduced impedance non-invasive cortical elec-
trostimulation (RINCE) similarly applies an electrical current via
scalp electrodes but utilises specific stimulation frequencies which
are hypothesised to reduce electrical impedance from the tissues of
the skin and skull, allowing deeper cortical penetration and mod-
ulation of lower-frequency cortical activity (Hargrove 2012).
How the intervention might work
Brain stimulation techniques primarily seek to modulate activity
in brain regions by directly altering the level of brain activity. The
aim of brain stimulation in the management of pain is to reduce
pain by altering activity in the areas of the brain that are involved
in pain processing.
Both tDCS and rTMS have been shown to modulate brain ac-
tivity specific to the site of application and the stimulation pa-
rameters. As a general rule, low-frequency rTMS (≤ 1 Hz) results
in lowered cortical excitability at the site of stimulation, whereas
high-frequency stimulation (≥ 5 Hz) results in raised cortical ex-
citability (Lefaucheur 2008a; Pascual-Leone 1999). Similarly, an-
odal tDCS, wherein the anode electrode is placed over the cortical
target, results in a raised level of excitability at the target, whereas
cathodal stimulation decreases local cortical excitability (Nitsche
2008). It is suggested that the observed alterations in cortical ex-
citability (readiness for activity) following rTMS and tDCS that
last beyond the time of stimulation are the result of long-term
synaptic changes (Lefaucheur 2008a). Modulation of activity in
brain networks is also proposed as themechanism of action of CES
and RINCE therapy and it is suggested that the therapeutic effects
are primarily achieved by direct action upon the hypothalamus,
limbic system and/or the reticular activating system (Gilula 2007).
Imaging studies in humans suggest that motor cortex stimulation
may reduce pain by modulating activity in networks of brain areas
involved in pain processing, such as the thalamus, and by facilitat-
ing descending pain inhibitory mechanisms (Garcia-Larrea 1997;
Garcia-Larrea 1999; Peyron 2007).
Sham credibility issues for non-invasive brain
stimulation studies
An issue regarding the credibility of sham conditions specifically
for rTMS studies is whether the sham condition that is employed
controls for the auditory (clicking sounds of various frequen-
cies) and sensory stimulation that occurs during active stimula-
tion (Lisanby 2001; Loo 2000). Various types of sham have been
proposed including angling the coil away from the scalp (thus pre-
serving the auditory cues but not the sensation of stimulation),
using coils that mimic the auditory cues combined with gentle
scalp electrical stimulation to mask the sensation and simple inert
coils that reproduce neither the sound nor the sensation of active
stimulation. Failure to control for such cues may impact nega-
tively on patient blinding, particularly in cross-over design studies.
Lisanby 2001 and Loo 2000 suggest that an ideal sham condition
for rTMS should:
1. not stimulate the cortex;
2. be the same as active stimulation in visual terms and in
terms of its position on the scalp; and
3. not differ from active stimulation in terms of the acoustic
and afferent sensory sensations that it elicits.
Strategies have been developed to try to meet these criteria
(Borckardt 2008; Rossi 2007; Sommer 2006). There is evidence
that simply angling the coil away from the scalp at an angle of
less than 90° may still result in brain stimulation and not be truly
inert (Lisanby 2001). This strategy is also easily detected by the
recipient of stimulation. In these ways this type of sham might
obscure or exaggerate a real clinical effect of active stimulation.
In studies of tDCS the sham condition commonly involves the
delivery of a short initial period (30 seconds to one minute) of
identical stimulation to the active condition, at which point the
stimulation is ceased without the participant’s knowledge. There
is evidence that this achieves effective blinding of tDCS at stim-
ulation intensities of 1 mA in naive participants (Ambrus 2012;
Gandiga 2006), but at a stimulation intensity of 2 mA tDCS both
participant and assessor blinding has been shown to be inadequate,
since participants can distinguish the active condition more than
would be expected by chance and a proportion of those receiving
active stimulation develop a temporary but visible redness over
the electrode sites (O’Connell 2012). At 1.5 mA there are de-
tectable differences in the experience of tDCS that might com-
promise blinding (Kessler 2013), though a formal investigation of
the adequacy of blinding at this intensity has not been published
to date.
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Why it is important to do this review
This approach to pain treatment is relatively novel. It is important
to assess the existing literature robustly to ascertain the current level
of supporting evidence and to inform future research and potential
clinical use. Recent reviews have addressed this area and concluded
that non-invasive brain stimulation can exert a significant effect
on chronic pain, but they have restricted their findings to specific
cortical regions, types of painful condition or types of stimulation
and did not carry out a thorough assessment of study quality or
risk of bias (Lefaucheur 2008b; Leung 2009; Lima 2008).
O B J E C T I V E S
To review all randomised and quasi-randomised studies of non-
invasive cortical stimulation techniques in the treatment of chronic
pain. The key aims of the review were:
1. to critically evaluate the efficacy of non-invasive cortical
stimulation techniques compared to sham controls for chronic
pain; and
2. to critically evaluate the influence of altered treatment
parameters (i.e. stimulation method, parameters, dosage, site) on
the efficacy of non-invasive cortical stimulation for chronic pain.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-randomised trials
(e.g. by order of entry or date of birth) that utilise a sham control
group were included. We included parallel and cross-over study
designs. We included studies regardless of language.
Types of participants
We included studies involving male or female participants over the
age of 18 years with any chronic pain syndrome (with a duration
of more than threemonths). It was not anticipated that any studies
are likely to exist in a younger population. Migraine and other
headache studies were not included due to the episodic nature of
these conditions.
Types of interventions
We included studies investigating the therapeutic use of non-in-
vasive forms of brain stimulation (tDCS, rTMS CES or RINCE).
We did not include studies of electroconvulsive therapy (ECT) as
its mechanism of action (the artificial induction of an epileptic
seizure (Stevens 1996)) differs substantially from the other forms
of brain stimulation. Invasive forms of brain stimulation involving
the use of electrodes implantedwithin the brain and indirect forms
of stimulation, such as caloric vestibular stimulation and occipital
nerve stimulation, were also not included. In order to meet our
second objective of considering the influence of varying stimula-
tion parameters, we included studies regardless of the number of
stimulation sessions delivered, including single-dose studies.
Types of outcome measures
Primary outcomes
The primary outcome measure was change in self reported pain
using validated measures of pain intensity such as visual analogue
scales (VAS), verbal rating scales (VRS) or numerical rating scales
(NRS).
Secondary outcomes
Secondary outcomes that we extractedwhen available included self
reported disability data, quality of life measures and the incidence/
nature of adverse events.
Search methods for identification of studies
Electronic searches
For the OVID MEDLINE search, we ran the subject search with
the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity maximising version
(2008 revision) as referenced inChapter 6 and detailed in box 6.4c
of the Cochrane Handbook for Systematic Reviews of Interventions
Version 5.0.1 (Higgins 2011). We have slightly adapted this filter
to include the term ’sham’ in the title or abstract. The search strate-
gies are presented in Appendix 1 and included a combination of
controlled vocabulary (MeSH) and free-text terms. We based all
database searches on this strategy but appropriately revised them
to suit each database.
Electronic databases
We ran the original search for the review in November 2009 and
searched all databases from their inception. To identify studies
for inclusion in this update we searched the following electronic
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databases from 2009 to July 2013 to identify additional published
articles:
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2013, Issue 6);
• OVID MEDLINE & MEDLINE in Process to 23 July
2013;
• OVID EMBASE to 2013 week 29;
• PsycINFO to July week 3 2013;
• CINAHL to July 2013;
• LILACS to January 2013;
For full details of the search parameters including dates for this
update see Appendix 1; Appendix 2; Appendix 3.
Searching other resources
Reference lists
We searched reference lists of all eligible trials, key textbooks and
previous systematic reviews to identify additional relevant articles.
Unpublished data
We searched the National Research Register (NRR) Archive,
Health Services Research Projects in Progress (HSRProj), Current
Controlled Trials register (incorporating the meta-register of con-
trolled trials and the International Standard Randomised Con-
trolled Trial Number (ISRCTN)) to January 2013 to identify re-
search in progress and unpublished research.
Language
The search attempted to identify all relevant studies irrespective
of language. We assessed non-English papers and, if necessary,
translated with the assistance of a native speaker.
We sent a final list of included articles to two experts in the field
of therapeutic brain stimulation with a request that they review
the list for possible omissions.
Data collection and analysis
Selection of studies
Two review authors (NOC and BW) independently checked the
search results and included eligible studies. Initially two review
authors (NOC and BW) read the titles or abstracts (or both) of
identified studies.Where itwas clear from the study title or abstract
that the studywas not relevant or did notmeet the selection criteria
we excluded it. If it was unclear then we assessed the full paper,
as well as all studies that appeared to meet the selection criteria.
Disagreement was resolved through discussion between the two
review authors. Where resolution was not achieved a third review
author (LDS) considered the paper(s) in question.
Data extraction and management
Two review authors (NOC and BW) extracted data independently
using a standardised form that was piloted by both authors inde-
pendently on three randomised controlled trials of transcutaneous
electrical nerve stimulation prior to the searches. We resolved dis-
crepancies by consensus. The form included the following.
• ’Risk of bias’ assessment results.
• Country of origin.
• Study design.
• Study population - condition; pain type; duration of
symptoms; age range; gender split; prior management.
• Sample size - active and control groups.
• Intervention - stimulation site, parameters and dosage
(including number and duration of trains of stimuli and number
of pulses for rTMS studies).
• Type of sham.
• Credibility of sham (for rTMS studies - see below).
• Outcomes - mean post-intervention pain scores for the
active and sham treatment groups at all follow-up points.
• Results - short, intermediate and long-term follow-up.
• Adverse effects.
• Conflict of interest disclosure.
Assessment of risk of bias in included studies
We assessed risk of bias using the Cochrane ’Risk of bias’ assess-
ment tool outlined in Chapter 8 of the Cochrane Handbook for
Systematic Reviews of Interventions Version 5.0.1 (Higgins 2011).
The criteria assessed for parallel study designs (using low/high/un-
clear judgements) were: adequate sequence generation; adequate
allocation concealment; adequate blinding of assessors; adequate
blinding of participants; adequate assessment of incomplete out-
come data; whether free of suggestion of selective outcome report-
ing; and whether free of other bias.
The criteria assessed for cross-over study designs (using low/high/
unclear judgements) were: adequate sequence generation; whether
data were clearly free from carry-over effects; adequate blinding
of assessors; adequate blinding of participants; whether free of the
suggestion of selective outcome reporting; and whether free of
other bias.
For this update, in compliance with new author guidelines from
the Cochrane Pain, Palliative and Supportive Care review group
and the recommendations of Moore 2010 we added two criteria,
’study size’ and ’study duration’, to our ’Risk of bias’ assessment
using the thresholds for judgement suggested by Moore 2010:
Size (we rated studies with fewer than 50 participants per arm as
being at high risk of bias, those with between 50 and 199 partici-
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pants per arm at unclear risk of bias, and 200 or more participants
per arm at low risk of bias).
Duration (we rated studies with follow-up of less than two weeks
as being at high risk of bias, two to seven weeks at unclear risk of
bias and eight weeks or longer at low risk of bias).
Two review authors (NOCandBW) independently checked risk of
bias. Disagreement between review authors was resolved through
discussion between the two review authors. Where resolution was
not achieved a third review author (LDS) considered the paper(s)
in question.
Assessment of sham credibility
We rated the type of sham used in studies of rTMS for credibility:
as optimal (the sham controls for the auditory and sensory charac-
teristics of stimulation and is visually indistinguishable from real
stimulation (Lisanby 2001; Loo 2000)) and sub-optimal (fails to
account for either the auditory and sensory characteristics of stim-
ulation, or is visually distinguishable from the active stimulation,
or fails on more than one of these criteria). We made a judgement
of ’unclear’ where studies did not adequately describe the sham
condition.
In light of empirical evidence that tDCS may be inadequately
blinded at intensities of 2mA (O’Connell 2012), and of detectable
differences in the experience of tDCS at 1.5 mA (Kessler 2013),
for this update we assessed studies that used these stimulation in-
tensities to be at unclear risk of bias for participant and asses-
sor blinding. We chose ’unclear’ instead of ’high’ risk of bias as
the available evidence demonstrates the potential for inadequate
blinding rather than providing clear evidence that individual stud-
ies were effectively unblinded. We applied this rule to all newly
identified studies and retrospectively to studies identified in the
previous version of this review.
Two independent review authors (NOC and BW) performed rat-
ing of sham credibility. We resolved disagreement between review
authors through consensus. Where resolution was not achieved a
third review author (LDS) considered the paper(s) in question.
Where sham credibility was assessed as unclear or sub-optimal we
made a judgement of ’unclear’ for the criterion ’adequate blinding
of participants’ in the ’Risk of bias’ assessment.
Measures of treatment effect
We used standardised mean difference (SMD) to express the size
of treatment effect on pain intensity measured with a VAS orNRS.
In order to aid interpretation of the pooled effect size we back-
transformed the SMD to a 0 to 100 mm VAS format on the basis
of the mean standard deviation from trials using 0 to 100 mm
VAS. We considered the likely clinical importance of the pooled
effect size using the criteria proposed in the IMMPACT consensus
statement (Dworkin 2008). Specifically, we judged a decrease in
pain of < 15% as no important change, ≥ 15% as a minimally
important change, ≥ 30% as a moderately important change and
≥ 50% as a substantially important change.
Unit of analysis issues
We entered cross-over trials into a meta-analysis where it was clear
that these data were free of carry-over effects. We combined the
results of cross-over studies with parallel studies using the generic
inverse-variance method as suggested in the Cochrane Handbook
for Systematic Reviews of Interventions, section 16.4.6.2 (Higgins
2011). We imputed the post-treatment between-condition corre-
lation coefficient from an included cross-over study that presented
individual patient data and used this to calculate the standard er-
ror of the standardised mean difference (SE (SMD)). Where data
from the same cross-over trials were entered more than once into
the samemeta-analysis we corrected the number of participants by
dividing by the number times data from that trial were entered in
the meta-analysis. We calculated the SMD(SE) for parallel studies
in RevMan. For each study we entered the SMD (SE) into the
meta-analysis using the generic inverse-variance method.
Dealing with missing data
Where insufficient data were presented in the study report to enter
a study into the meta-analysis, we contacted the study authors to
request access to the missing data.
Data synthesis
We performed pooling of results where adequate data supported
this using RevMan 5 software (version 5.2) (RevMan 2012), with
a random-effects model. Where an analysis included parallel and
cross-over trials we used the generic inverse variance method (see
Unit of analysis issues). We conducted separate meta-analyses for
different forms of stimulation intervention (i.e. rTMS, tDCS,CES
and RINCE) and for short-term (0 to < 1week post-intervention),
mid-term (≥ 1 to 6 weeks post-intervention) and long-term (≥
6 weeks post-intervention) outcomes where adequate data were
identified.
Where more than one data point was available for short-term
outcomes, we used the first post-stimulation measure, and where
multiple treatmentswere givenwe took the first outcome at the end
of the treatment period. For medium-term outcomes where more
than one data point was available, we used the measure that fell
closest to the mid-point of this time period. We excluded studies
from the meta-analysis that we rated at high risk of bias on any
criteria, excluding the criteria ’study size’ and ’study duration’.
For this update we utilised the GRADE approach to assessing the
quality of a body of evidence (Guyatt 2008). To ensure consistency
of GRADE judgements we applied the following criteria to each
domain equally for all key comparisons of the primary outcome:
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• Limitations of studies: downgrade once if less than 75% of
included studies are at low risk of bias across all ’Risk of bias’
criteria.
• Inconsistency: downgrade once if heterogeneity is
statistically significant and the I2 value is more than 40%.
• Indirectness: downgrade once if more than 50% of the
participants were outside the target group.
• Imprecision: downgrade once if fewer than 400 participants
for continuous data and fewer than 300 events for dichotomous
data (Guyatt 2011).
• Publication bias: downgrade where there is direct evidence
of publication bias.
While we had planned to use GRADE in our initial protocol we
introduced these criteria specifically for this update.
Subgroup analysis and investigation of heterogeneity
We assessed heterogeneity using the Chi2 test to investigate its
statistical significance and the I2 statistic to estimate the amount.
Where significant heterogeneity (P < 0.1) was present we explored
subgroup analysis. Pre-planned comparisons included site of stim-
ulation, frequency of TMS stimulation (low ≤ 1 Hz, high ≥ 5
Hz), multiple versus single-dose studies and the type of painful
condition (central neuropathic versus peripheral neuropathic ver-
sus non-neuropathic pain versus facial pain (for each stimulation
type). Central neuropathic pain included pain due to identifiable
pathology of the central nervous system (e.g. stroke, spinal cord
injury), peripheral neuropathic pain included injury to the nerve
root or peripheral nerves, facial pain included trigeminal neuralgia
and other idiopathic chronic facial pains, and non-neuropathic
pain included all chronic pain conditions without a clear neuro-
pathic cause (e.g. chronic low back pain, fibromyalgia, complex
regional pain syndrome type I).
Sensitivity analysis
When sufficient datawere available, we conducted sensitivity anal-
yses on the following study factors: risk of bias, sham credibility
(for rTMS studies) and cross-over versus parallel-group designs.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Published data
In our original review the search strategy identified 1148 citations,
including 305 duplicates. See Appendix 4 and Appendix 5 for full
details of the search results from the original review. Screening
of the 843 unique citations by title and abstract identified 39 as
potentially eligible for the review. Three studies were identified
from handsearching of the reference lists of included studies of
which two were not retrievable in abstract or full manuscript form.
The level of agreement between review authors, calculated using
the kappa statistic for study eligibility based on title and abstract
alone, was 0.77. We identified three more papers that were not
picked up from the search strategy. We also deemed these to be
potentially eligible for the review. One of the experts contacted
to review the search results for possible omissions identified one
additional study. The full-text screening of the 44 citations identi-
fied 33 eligible studies (19 of rTMS, 422 participants randomised;
six of tDCS, 124 participants randomised; eight of CES, 391 par-
ticipants randomised) (André-Obadia 2006; André-Obadia 2008;
Boggio 2009; Borckardt 2009; Capel 2003; Carretero 2009; Cork
2004; Defrin 2007; Fenton 2009; Fregni 2005; Fregni 2006a;
Fregni 2006b;Gabis 2003; Gabis 2009; Hirayama 2006; Irlbacher
2006; Kang 2009; Katsnelson 2004; Khedr 2005; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Lichtbroun 2001; Mori 2010; Passard 2007;
Pleger 2004; Rollnik 2002; Saitoh 2007; Tan 2000; Tan 2006;
Valle 2009). The kappa level of agreement between authors for
eligibility from full-text screening was 0.87.
In this update we conducted a full search in February 2013 and
updated the search of the main databases on 12 June 2013 and
again on 24 July 2013. We included a further 23 completed stud-
ies with 773 participants randomised (range of n = 3 to 105,
see Figure 2 for a flow chart of the search process). Of these, 11
studies (324 participants randomised) investigated rTMS (Ahmed
2011; André-Obadia 2011; Avery 2013, Fregni 2011; Hosomi
2013; Jensen 2013; Lee 2012; Mhalla 2011; Picarelli 2010; Short
2011; Tzabazis 2013), eight studies (177 participants randomised)
investigated tDCS (Antal 2010; Jensen 2013; Mendonca 2011;
Portilla 2013; Riberto 2011; Soler 2010; Villamar 2013; Wrigley
2014), three studies (181 participants randomised) investigated
CES (Rintala 2010; Tan 2011; Taylor 2013), and one study inves-
tigated a novel form of stimulation (reduced impedance non-in-
vasive cortical electrostimulation (RINCE)) that did not fit neatly
into any of the three broad categories (Hargrove 2012, 91 partic-
ipants)). Overall this updated review included 56 studies (1710
participants randomised), with 30 trials of rTMS (746 participants
randomised), 14 trials of tDCS (301 participants randomised), 11
studies of CES (572 participants randomised) and one study of
RINCE stimulation (91 participants randomised).
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Figure 2. Study flow diagram for updated search.
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We identified an additional 11 conference abstracts that were not
related to full published studies (Acler 2012; Albu 2011; Ansari
2013; Fricova 2009; Fricova 2011; Klirova 2010; Klirova 2011;
Knotkova 2011; Pellaprat 2012; Schneider 2012; Ya ci 2013).
We contacted the authors of these abstracts to try to ascertain
whether they were unique studies or duplicates and to acquire full
study reports. Where we were unable to obtain this information
we placed these records in Studies awaiting classification. For two
of these abstracts the authors confirmed that they referred to stud-
ies that are either in the analysis/write-up stage or under review for
publication, and as such were unavailable for this review update
(Knotkova 2011; Schneider 2012). For the remaining abstracts
identified in this update our attempts to contact the authors were
not successful (Acler 2012; Albu 2011; Ansari 2013 Fricova 2009;
Fricova 2011; Klirova 2010; Klirova 2011; Pellaprat 2012; Ya ci
2013).We sent requests by email where possible in February 2013,
with a follow-up email in April and June 2013, for those identi-
fied in the first search of this update, and in June 2013 for those
identified by the second round of searching.
Unpublished data
In our original review the search strategy identified 5920 registered
studies. Screening of the studies by the register records identified
23 studies that might potentially produce relevant data. Of these,
seven were duplicated across trials registers, leaving 16 unique
registered studies. We contacted the contact author for each of
these studies by post or email with a request for any relevant data
that might inform the review. No data were available from any of
these studies for inclusion in this review.
In this update our search of the trials registers identified 599
records from which 11 relevant ongoing trials were identified. In
addition to the two ongoing studies remaining from the last up-
date (NCT00947622; NCT00815932); this makes a total of 13
ongoing studies identified. We contacted the contact author for
each of these studies by post or email with a request for any relevant
data that might inform the review. No data were available from
any of these studies for inclusion in this review. We sent initial
request emails for this update in April, and where no response was
received also in May and in June 2013. Unpublished data and a
full study report was provided for one study of rTMS identified
from the trials registers search of the last update of this review
(reference was Wajdik 2009, now Avery 2013).
Included studies
See Characteristics of included studies.
Country of origin and language of publication
All but one of the studies (Irlbacher 2006, written in German)
were written in English. Studies were undertaken in Brazil, Egypt,
Europe (France, Germany, Italy, Spain and the UK), Israel, Japan,
Russia, South Korea and the USA. Most studies were based in a
laboratory or outpatient pain clinic setting.
Type of stimulation, application and use
In total 30 studies investigated rTMS (Ahmed 2011; André-
Obadia 2006; André-Obadia 2008; André-Obadia 2011; Avery
2013; Borckardt 2009;Carretero 2009;Defrin 2007; Fregni 2005;
Fregni 2011; Hirayama 2006; Hosomi 2013; Irlbacher 2006;
Kang 2009;Khedr2005; Lee 2012; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Mhalla 2011; Onesti 2013; Passard 2007; Picarelli 2010; Pleger
2004; Rollnik 2002; Saitoh 2007; Short 2011; Tzabazis 2013).
Eleven studies investigated CES (Capel 2003; Cork 2004; Gabis
2003; Gabis 2009; Katsnelson 2004; Lichtbroun 2001; Rintala
2010; Tan 2000; Tan 2006; Tan 2011; Taylor 2013), 14 studies in-
vestigated tDCS (Antal 2010; Boggio 2009; Fenton 2009; Fregni
2006a; Fregni 2006b; Jensen 2013; Mendonca 2011; Mori 2010;
Portilla 2013; Riberto 2011; Soler 2010; Valle 2009; Villamar
2013;Wrigley 2014), and one study investigated RINCE stimula-
tion (Hargrove 2012). We had not been aware of RINCE therapy
until it was identified in this search update. While it bears simi-
larities with CES the author of the included trial suggested that
due to the specific unique stimulation parameters that differ from
conventional forms of CES, it represents a novel form of cortical
stimulation (Hargrove 2012).
Study designs
There were a mixture of parallel and cross-over study designs.
For rTMS there were 12 parallel studies (Ahmed 2011; Avery
2013; Carretero 2009; Defrin 2007; Fregni 2011; Khedr 2005;
Lee 2012; Mhalla 2011; Passard 2007; Picarelli 2010; Short
2011; Tzabazis 2013), and 18 cross-over studies (André-Obadia
2006; André-Obadia 2008; André-Obadia 2011, Borckardt 2009;
Fregni 2005; Hirayama 2006; Hosomi 2013; Irlbacher 2006;
Kang 2009; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur
2004; Lefaucheur 2006; Lefaucheur 2008; Onesti 2013; Pleger
2004; Rollnik 2002; Saitoh 2007). For CES there were eight paral-
lel studies (Gabis 2003; Gabis 2009; Katsnelson 2004; Lichtbroun
2001; Rintala 2010; Tan 2006; Tan 2011; Taylor 2013), and three
cross-over studies (Capel 2003; Cork 2004; Tan 2000), of which
we considered two as parallel studies, with only the opening phase
of the study considered in this review because subsequent phases
were unblinded (Capel 2003; Cork 2004). For tDCS there were
seven parallel studies (Fregni 2006a; Fregni 2006b; Mendonca
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2011; Mori 2010; Riberto 2011; Soler 2010; Valle 2009), and
seven cross-over studies (Antal 2010; Boggio 2009; Fenton 2009;
Jensen 2013; Portilla 2013; Villamar 2013; Wrigley 2014), of
which we considered one as a parallel study with only the open-
ing phase of the study considered in this review due to excessive
attrition after the first phase (Antal 2010).
Study participants
The included studies were published between 2000 and 2013. In
rTMS studies sample sizes at the study outset ranged from four to
70 participants. In CES studies sample size ranged from 19 to 105
participants, in tDCS studies sample size ranged from three to 41
participants and the single RINCE study recruited 91 participants.
Studies included a variety of chronic pain conditions. Nine rTMS
studies included participants with neuropathic pain of mixed ori-
gin; of these seven included a mix of central, peripheral and facial
neuropathic pain patients (André-Obadia 2006; André-Obadia
2008; André-Obadia 2011; Hirayama 2006; Hosomi 2013,
Lefaucheur 2004; Lefaucheur 2008), two included a mix of cen-
tral and peripheral neuropathic pain patients (Lefaucheur 2006;
Saitoh 2007), of which one study included a patient with phan-
tom limb pain (Saitoh 2007). One study included a mix of cen-
tral neuropathic pain and phantom limb pain patients (Irlbacher
2006). One study included a mix of central and facial neuropathic
pain patients (Lefaucheur 2001a), two rTMS studies included
only central neuropathic pain patients (Defrin 2007; Kang 2009),
one included only peripheral neuropathic pain patients (Borckardt
2009), and nine studies included non-neuropathic chronic pain
including fibromyalgia (Carretero 2009; Lee 2012; Mhalla 2011;
Passard 2007; Short 2011; Tzabazis 2013), chronic widespread
pain (Avery 2013), chronic pancreatitis pain (Fregni 2005; Fregni
2011), and complex regional pain syndrome type I (CRPSI)
(Picarelli 2010; Pleger 2004). One study included only phantom
limb pain (Ahmed 2011). Finally one study included a mix of pe-
ripheral neuropathic and non-neuropathic chronic pain (Rollnik
2002), including one participant with phantom limb pain and one
with osteomyelitis. The majority (17) of rTMS studies specified
chronic pain that was refractory to current medical management
(André-Obadia 2006; André-Obadia 2008, André-Obadia 2011;
Defrin 2007; Hirayama 2006; Hosomi 2013; Kang 2009; Khedr
2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Onesti 2013; Picarelli 2010;
Rollnik 2002; Saitoh 2007). This inclusion criterion was varyingly
described as intractable, resistant to medical intervention or drug
management.
Of the studies investigating CES, one study included participants
with pain related to osteoarthritis of the hip and knee (Katsnelson
2004), and two studied chronic back and neck pain (Gabis 2003;
Gabis 2009). Of these, the later study also included participants
with chronic headache but these data were not considered in
this review. Three studies included participants with fibromyalgia
(Cork 2004; Lichtbroun 2001; Taylor 2013), and three studies
included participants with chronic pain following spinal cord in-
jury (Capel 2003; Tan 2006; Tan 2011), although only one of
these reports specified that the pain was neuropathic (Tan 2011).
One study included participants with amixture of “neuromuscular
pain” excluding fibromyalgia of which back pain was reportedly
themost prevalent complaint (Tan 2000), although further details
were not reported. One study included participants with chronic
pain related to Parkinson’s disease (Rintala 2010).
Of the studies of tDCS one study included participants with a
mixture of central, peripheral and facial neuropathic pain (Boggio
2009), one study included participants with neuropathic pain sec-
ondary to multiple sclerosis (Mori 2010), three included partic-
ipants with central neuropathic pain following spinal cord in-
jury (Fregni 2006a; Soler 2010; Wrigley 2014), one with neu-
ropathic or non-neuropathic pain following spinal cord injury
(Jensen 2013), and six studies included non-neuropathic pain,
specifically chronic pelvic pain (Fenton 2009), and fibromyalgia
(Fregni 2006b; Mendonca 2011; Riberto 2011; Villamar 2013),
or a mixed group (Antal 2010). One study included participants
with neuropathic pain following burn injury (Portilla 2013). Four
studies of tDCS specified recruiting participants with pain that
was refractory tomedical management (Antal 2010; Boggio 2009;
Fenton 2009; Fregni 2006a). The study relating to RINCE stim-
ulation included participants with fibromyalgia (Hargrove 2012).
Most studies included both male and female participants except
the studies of Fenton 2009 (chronic pelvic pain) andFregni 2006b,
Valle 2009, Riberto 2011 andMhalla 2011; Lee 2012 (fibromyal-
gia), which recruited females only and Fregni 2006a (post-spinal
cord injury pain), which recruited only males. Two studies did
not present data specifying the gender distribution of participants
(Capel 2003; Katsnelson 2004).
Outcomes
Primary outcomes
All included studies assessed pain using self reported pain visual
analogue or numerical rating scales. There was variation in the
precise measure of pain (for example, current pain intensity, aver-
age pain intensity over 24 hours) and in the anchors used particu-
larly for the upper limit of the scale (e.g. “worst pain imaginable”,
“unbearable pain”, “most intense pain sensation”). Several studies
did not specify the anchors used.
All studies assessed pain at the short-term (< 1 week post-treat-
ment) follow-up stage. Twenty-three studies reported collecting
medium-term outcome data (≥ 1 to 6 weeks post-treatment)
(Ahmed 2011; André-Obadia 2008; Antal 2010; Borckardt 2009;
Carretero 2009; Defrin 2007; Fenton 2009; Fregni 2006a; Fregni
2006b; Fregni 2011; Gabis 2009; Kang 2009; Khedr 2005; Lee
2012; Lefaucheur 2001a;Mori 2010; Passard 2007; Picarelli 2010;
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Short 2011; Soler 2010; Tzabazis 2013; Valle 2009; Wrigley
2014). Only three studies collected controlled outcome data on
long-term (> 6 weeks post-treatment) follow-up (Avery 2013;
Kang 2009; Passard 2007).
Secondary outcomes
We only considered secondary outcomes that distinctly measured
self reported disability or quality of life for extraction and inclusion
in the Characteristics of included studies table. Nine studies used
measures of disability or pain interference (Avery 2013; Cork
2004; Kang 2009; Mhalla 2011; Passard 2007; Short 2011; Soler
2010; Tan 2000; Tan 2006), and 14 studies collected measures of
quality of life (Avery 2013; Fregni 2006b; Lee 2012; Lichtbroun
2001; Mhalla 2011; Mori 2010; Passard 2007; Picarelli 2010;
Riberto 2011; Short 2011; Tan 2011; Taylor 2013; Tzabazis 2013;
Valle 2009).
Adverse event reporting
Seventeen studies did not report any information regarding ad-
verse events (Ahmed 2011; André-Obadia 2011; Borckardt 2009;
Cork 2004; Defrin 2007; Gabis 2009; Jensen 2013; Kang 2009;
Katsnelson 2004; Khedr 2005; Lefaucheur 2006; Lefaucheur
2008; Lichtbroun 2001; Pleger 2004; Riberto 2011; Tan 2000;
Tan 2006).
Studies of rTMS
See Table 1 for a summary of stimulation characteristics utilised
in rTMS studies.
Stimulation location
The parameters for rTMS application varied significantly between
studies including by site of stimulation, stimulation parameters
and the number of stimulation sessions. The majority of rTMS
studies targeted the primary motor cortex (M1) (Ahmed 2011;
André-Obadia 2006; André-Obadia 2008; André-Obadia 2011;
Defrin 2007; Hirayama 2006; Hosomi 2013; Irlbacher 2006;
Kang 2009;Khedr2005; Lee 2012, Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Mhalla 2011; Onesti 2013; Passard 2007; Picarelli 2010; Pleger
2004; Rollnik 2002; Saitoh 2007). Of these, one study specified
stimulation of the right hemisphere (Kang 2009), one study spec-
ified the left hemisphere (Mhalla 2011), and two studies spec-
ified stimulation over the midline (Defrin 2007; Pleger 2004).
One study used a novel H-coil to stimulate the motor cortex of
the leg representation situated deep in the central sulcus (Onesti
2013), and the remainder stimulated over the contralateral cortex
to the side of dominant pain. One of these studies also investigated
stimulation of the supplementary motor area (SMA), pre-motor
area (PMA) and primary somatosensory cortex (S1) (Hirayama
2006). Two studies stimulated the dorsolateral pre-frontal cor-
tex (DLPFC), with two studies stimulating the left hemisphere
(Borckardt 2009; Short 2011), and two studies the right (Carretero
2009; Lee 2012). One study investigated stimulation of the left
and right secondary somatosensory cortex (SII) as separate treat-
ment conditions (Fregni 2005), and another investigated stimu-
lation to the right SII area (Fregni 2011). One study used a four-
coil configuration to target the anterior cingulate cortex (Tzabazis
2013).
Stimulation parameters
Frequency
Eleven studies investigated low-frequency (< 5 Hz) rTMS (André-
Obadia 2006;Carretero 2009; Fregni 2005; Fregni 2011; Irlbacher
2006; Lee 2012; Lefaucheur 2001b; Lefaucheur 2006; Lefaucheur
2008; Saitoh 2007; Tzabazis 2013). Of these, one study used a
frequency of 0.5 Hz in one treatment condition (Lefaucheur
2001b), and the rest used a frequency of 1 Hz. Twenty-seven
studies investigated high-frequency (≥ 5Hz) rTMS (Ahmed2011;
André-Obadia 2006; André-Obadia 2008; André-Obadia 2011;
Avery2013; Borckardt 2009;Defrin2007; Fregni 2005;Hirayama
2006;Hosomi 2013; Irlbacher 2006;Kang2009;Khedr2005; Lee
2012; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Mhalla 2011; Onesti 2013;
Passard 2007; Picarelli 2010; Pleger 2004; Rollnik 2002; Saitoh
2007; Short 2011). While the study by Tzabazis 2013 did apply
high-frequency stimulation to some participants, the allocation
of the high-frequency groups was not randomised in that study
(confirmed through correspondence with authors) and so those
data will not be considered further in this review as they do not
meet our inclusion criteria.
Other parameters
We observed wide variation between studies for various stimula-
tion parameters. The overall number of rTMS pulses delivered
varied from 120 to 4000. The study by Defrin 2007 reported
a total number of pulses of 500 although the reported stimula-
tion parameters of 500 trains, delivered at a frequency of 5 Hz
for 10 seconds would imply 25,000 pulses. Eight studies speci-
fied a posteroanterior or parasagittal orientation of the stimulating
coil (André-Obadia 2006; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Passard 2007; Picarelli 2010;
Short 2011), two studies specified a coil orientation 45º to the
midline (Ahmed 2011; Kang 2009), one study compared a pos-
teroanterior coil orientation with a medial-lateral coil orientation
(André-Obadia 2008), one used an H-coil (Onesti 2013), one
used a four-coil configuration (Tzabazis 2013), and the remaining
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studies did not specify the orientation of the coil. Within studies
that reported the information, the duration and number of trains
and the inter-train intervals varied. Two studies did not report this
information (Fregni 2005; Fregni 2011).
Type of sham
rTMS studies employed a variety of sham controls. In 11 stud-
ies the stimulating coil was angled away from the scalp to pre-
vent significant cortical stimulation (Ahmed 2011; André-Obadia
2006; André-Obadia 2008; Carretero 2009; Hirayama 2006;
Kang 2009; Khedr 2005; Lee 2012; Pleger 2004; Rollnik 2002;
Saitoh 2007), of which two studies also simultaneously electri-
cally stimulated the skin of the scalp in both the active and sham
stimulation conditions in order to mask the sensations elicited by
active rTMS and thus preserve participants’ blinding (Hirayama
2006; Saitoh 2007). The remaining studies utilised sham coils.
Of these, eight studies specified that the sham coil made simi-
lar or identical sounds to those elicited during active stimulation
(André-Obadia 2011; Borckardt 2009; Defrin 2007; Irlbacher
2006; Mhalla 2011; Passard 2007; Picarelli 2010; Tzabazis 2013),
and five specified that the sham coil made similar sounds, looked
the same and elicited similar scalp sensations as the real coil
(Avery 2013; Fregni 2011; Hosomi 2013; Onesti 2013; Short
2011). Six studies did not specify whether the sham coil con-
trolled for the auditory characteristics of active stimulation (Fregni
2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008).
Studies of CES
See Table 2 for a summary of stimulation characteristics utilised
in CES studies.
Stimulation device, parameters and electrode location
Seven studies of CES used the ’Alpha-stim’ CES device (Elec-
tromedical Products International, Inc, Mineral Wells, Texas,
USA). This device uses two ear clip electrodes that attach to each
of the participant’s ears (Cork 2004; Lichtbroun 2001; Rintala
2010; Tan 2000; Tan 2006; Tan 2011; Taylor 2013), and these
studies utilised stimulation intensities of 100 µA with a frequency
of 0.5Hz. One study (Capel 2003) used a device manufactured by
Carex (Hemel Hempstead, UK) that also used earpiece electrodes
and delivered a stimulus intensity of 12 µA.
Two studies used the ’Pulsatilla 1000’ device (Pulse Mazor In-
struments, Rehavol, Israel) (Gabis 2003; Gabis 2009). The elec-
trode array for this device involved an electrode attached to each
of the participant’s mastoid processes and one attached to the fore-
head; current is passed to the mastoid electrodes. One study used
the ’Nexalin’ device (Kalaco Scientific Inc, Scottsdale, AZ, USA)
(Katsnelson 2004). With this device current is applied to a fore-
head electrode and returned via electrodes placed behind the pa-
tient’s ears. These three studies utilised significantly higher current
intensities than those using ear clip electrodes with intensities of
4 mA (Gabis 2003; Gabis 2009), and 11 to 15 mA (Katsnelson
2004).
All CES studies gavemultiple treatment sessions for each treatment
group with variation between the number of treatments delivered.
Type of sham
Eight studies utilised inert sham units (Capel 2003; Cork 2004;
Lichtbroun 2001; Rintala 2010; Tan 2000; Tan 2006; Tan 2011;
Taylor 2013). These units were visually indistinguishable from the
active devices. Stimulation at the intensities used is subsensation
and as such it should not have been possible for participants to
distinguish between the active and sham conditions.
Two studies utilised an “active placebo” treatment unit (Gabis
2003; Gabis 2009). This sham device was visually indistinguish-
able and delivered a current of much lower intensity (≤ 0.75 mA)
than the active stimulator to evoke a similar sensation to ensure
patient blinding. Similarly, Katsnelson 2004 utilised a visually in-
distinguishable sham device that delivered brief pulses of current
of < 1 mA. The placebo conditions used in these three studies
delivered current at much greater intensities than those used in
the active stimulation conditions of the other CES studies.
Studies of tDCS
See Table 3 for a summary of stimulation characteristics utilised
in tDCS studies.
Stimulation parameters and electrode location
Two studies of tDCS stimulated the dorsolateral prefrontal cor-
tex in one treatment group (Fregni 2006b; Valle 2009). Thir-
teen studies stimulated the motor cortex (Antal 2010; Boggio
2009; Fenton 2009; Fregni 2006a; Fregni 2006b; Jensen 2013;
Mori 2010; Portilla 2013; Riberto 2011; Soler 2010; Valle 2009;
Villamar 2013; Wrigley 2014). Of these, nine stimulated the cor-
tex contralateral to the side of worst pain (Boggio 2009; Fregni
2006a; Fregni 2006b; Mori 2010; Portilla 2013; Riberto 2011;
Soler 2010; Villamar 2013; Wrigley 2014), of which six studies
stimulated the opposite hemisphere to the dominant hand where
pain did not have a unilateral dominance (Fregni 2006a; Fregni
2006b; Jensen 2013; Riberto 2011; Soler 2010; Wrigley 2014).
Three studies stimulated the left hemisphere for all participants
(Antal 2010; Valle 2009; Villamar 2013). One study of chronic
pelvic pain stimulated the opposite hemisphere to the dominant
hand in all participants (Fenton 2009). One study specifically in-
vestigated the use of tDCS in conjunction with transcutaneous
electrical nerve stimulation (TENS) therapy (Boggio 2009). We
extracted data comparing active tDCS and shamTENSwith sham
16Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
tDCS and sham TENS for the purposes of this review. One ap-
plied anodal or cathodal stimulation to the left motor cortex or to
the right supraorbital area (Mendonca 2011).
Six studies delivered a current intensity of 2 mA for 20 minutes
once a day for five days (Antal 2010; Fregni 2006a; Fregni 2006b;
Mori 2010; Valle 2009; Wrigley 2014). One study applied a cur-
rent intensity of 1 mA once a day for two days (Fenton 2009), and
four studies applied one treatment per stimulation condition at an
intensity of 2 mA for 20 minutes (Boggio 2009; Mendonca 2011;
Jensen 2013; Villamar 2013). One study delivered 10 stimulation
sessions of 20 minutes at 2 mA once weekly for 10 weeks (Riberto
2011), and another delivered 10 sessions once a day, with a visual
illusion condition or a sham visual illusion condition for 10 con-
secutive weekdays (Soler 2010).
All studies of tDCS utilised a sham condition whereby active
stimulation was ceased after 30 seconds without the participants’
knowledge.
Excluded studies
See Characteristics of excluded studies.
In our original review we excluded 11 studies after consideration
of the full study report.Of these, one was not a study of brain stim-
ulation (Frentzel 1989), two did not assess self reported pain as
an outcome (Belci 2004; Johnson 2006), four were not restricted
to participants with chronic pain (Evtiukhin 1998; Katz 1991;
Longobardi 1989; Pujol 1998), one study was unclear on the du-
ration of participants’ symptoms (Avery 2007), two were single
case studies (Silva 2007; Zaghi 2009), one study presented dupli-
cate data from a study already accepted for inclusion (Roizenblatt
2007, duplicate data from Fregni 2006b), and one did not employ
a sham control (Evtiukhin 1998).
For this update we excluded a further 17 reports, after considera-
tion of the full study report. Nine reports referred to studies which
had already been included in the previous version of this review,
one was not a study of brain stimulation (Carraro 2010), two
were not clearly in a chronic pain population (Choi 2012a; Choi
2012b), one was not a randomised controlled trial (O’Connell
2013), one reported uncontrolled long-term follow-up data from
an included study (Hargrove 2012a), one employed an interven-
tion that was not designed to alter cortical activity directly through
electrical stimulation (Nelson 2010), and one included some par-
ticipantswhodidnotmeet our criterionof chronic pain (Bolognini
2013). A final study was screened by a Russian translator and ex-
cluded on the basis that it did not employ a sham control for
tDCS (Sichinava 2012). Finally one citation referred to a booklet
of conference proceedings which contained no relevant citations.
Risk of bias in included studies
Risk of bias varied across studies for all of the assessment criteria.
For a summary of ’Risk of bias’ assessment across studies see Figure
1.
Sequence generation
For the criterion ’adequate sequence generation’ we awarded cross-
over trials a judgement of ’low risk of bias’ where the study report
mentioned that the order of treatment conditionswas randomised.
Since this criterion has a greater potential to introduce bias in
parallel designs we only awarded a judgement of ’low risk of bias’
where the method of randomisation was specified and adequate.
We judged 14 trials as having an unclear risk of bias (Antal
2010; Carretero 2009; Cork 2004; Defrin 2007; Hargrove 2012;
Katsnelson 2004; Lee 2012; Mendonca 2011; Picarelli 2010;
Riberto 2011; Rintala 2010; Tan 2006; Taylor 2013; Tzabazis
2013), as they did not specify the method of randomisation used
or the description was not clear. We judged two studies as having
a high risk of bias for this criterion (Ahmed 2011; Khedr 2005),
as the reports suggested that patients were allocated depending on
the day of the week on which they were recruited, which we did
not judge as being genuinely random.
Allocation concealment
We only considered for the criterion ’Adequate concealment of
allocation’ studies with parallel designs or from which only data
from the first phase of the study were included (i.e. we them con-
sidered as parallel studies). Seventeen studies did not report con-
cealment of allocation and we judged them as ’unclear’ (Antal
2010; Carretero 2009; Cork 2004; Defrin 2007; Fregni 2011;
Hargrove 2012; Katsnelson 2004; Lee 2012; Mendonca 2011;
Passard 2007; Picarelli 2010; Riberto 2011; Rintala 2010; Soler
2010; Tan 2006; Taylor 2013; Tzabazis 2013), and we judged two
studies as having a high risk of bias for this criterion since the
method of randomisation employed would not have supported
concealment of allocation (Ahmed 2011; Khedr 2005).
Blinding
Blinding of assessors
While many studies used self reported pain outcomes we consid-
ered that the complex nature of the intervention, and the level
of interaction this entails between participants and assessors, sug-
gested that a lack of blinding of the researchers engaged in the
collection of outcomes might potentially introduce bias. As such,
where blinding of assessors was not clearly stated we made a judge-
ment of ’unclear’ for this criterion.
Sixteen studies did not specify whether they blinded outcome as-
sessors (André-Obadia 2011; Borckardt 2009; Hirayama 2006;
Irlbacher 2006; Lee 2012; Lefaucheur 2001a; Lefaucheur 2001b;
Lefaucheur 2004; Lefaucheur 2006; Onesti 2013; Picarelli 2010;
Pleger 2004; Rollnik 2002; Saitoh 2007; Tan 2000; Tzabazis
2013), while we judged the majority of studies of tDCS at unclear
risk of bias on this criterion (Boggio 2009; Fregni 2006a; Fregni
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2006b; Jensen 2013; Mori 2010; Portilla 2013; Riberto 2011;
Soler 2010; Valle 2009; Villamar 2013;Wrigley 2014), since there
is evidence that assessor blindingmay be compromised at the stim-
ulation intensities used (O’Connell 2012).
Blinding of participants
rTMS studies
All studies attempted to blind participants. However, due to the
difficulties involved in producing a robust sham control in rTMS
studies (see Assessment of risk of bias in included studies) wemade
an assessment of sham credibility. Where the coil was angulated
or angulated and elevated away from the scalp, this is potentially
distinguishable both visually and by the sensory effects of stimula-
tion. Two studies simultaneously electrically stimulated the scalp
during rTMS stimulation to mask the differences in sensation be-
tween conditions (Hirayama 2006; Saitoh 2007). However, by an-
gulating the coil away from the scalp participants may have been
able to visually distinguish between the conditions. Where sham
coils were utilised they usually did not control for the sensory as-
pects of stimulation. We assessed most rTMS studies as having
sub-optimal sham control conditions and we therefore assessed
them as having an ’unclear’ risk of bias. Four rTMS studies in-
cluded in this update utilised modern sham coils that are visu-
ally indistinguishable, emit the same noise during stimulation and
elicit similar scalp sensations (Avery 2013; Fregni 2011; Onesti
2013; Short 2011). These studies met the criteria for an optimal
sham condition and as such we judged them at low risk of bias for
participant blinding.
Similarly with tDCS studies, due to evidence that blinding of
participants to the stimulation condition may be compromised at
intensities of 1.5 mA and above, we judged the majority of tDCS
studies at unclear risk of bias on this criterion (Boggio 2009; Fregni
2006a; Fregni 2006b; Jensen 2013; Mori 2010; Portilla 2013;
Riberto 2011; Soler 2010; Valle 2009; Villamar 2013; Wrigley
2014).
We assessed all studies of CES as having a low risk of bias for this
criterion.
Incomplete outcome data
We assessed 11 studies as having an unclear risk of bias for
this criterion (Ahmed 2011; André-Obadia 2006; André-Obadia
2011; Boggio 2009; Cork 2004; Fregni 2011; Hargrove 2012;
Katsnelson 2004; Lefaucheur 2006; Lichtbroun 2001; Tzabazis
2013). Ahmed 2011 and Fregni 2011 did not report the level of
drop-out from their studies. In the study of André-Obadia 2006,
two participants (17% of the study cohort) did not complete the
study and this was not clearly accounted for in the data analysis.
This was also the case for Boggio 2009, where two participants
(25% of the cohort) failed to complete the study. Five studies did
not clearly report levels of drop-out (Cork 2004; Katsnelson 2004;
Lefaucheur 2006; Lichtbroun 2001; Tzabazis 2013), of which
one reported recruiting 16 participants in the full study report
(Tzabazis 2013), but an earlier abstract report of the same study
reported the recruitment of 45 participants (Schneider 2012). We
assessed three studies as having a high risk of bias for this criterion
(Antal 2010; Irlbacher 2006; Tan 2000). In the Antal 2010 study,
of 23 participants recruited only 12 completed the full cross-over.
In the study by Irlbacher 2006, only 13 of the initial 27 partici-
pants completed all of the treatment conditions. In the studies of
Lee 2012 and Rintala 2010, attrition exceeded 30% of the ran-
domised cohort. In the study by Tan 2000, 17 participants did not
complete the study (61% of the cohort) and this was not clearly
accounted for in the analysis. We considered this level of with-
drawal unsustainable.
Selective reporting
We assessed studies as having a high risk of bias for this criterion
where the study report did not produce adequate data to assess
the effect size for all groups/conditions, and these data were not
made available upon request. We assessed 11 studies as having
a high risk of bias for this criterion (Capel 2003; Cork 2004;
Fregni 2005; Fregni 2011; Katsnelson 2004; Lichtbroun 2001;
Mendonca 2011;Onesti 2013; Portilla 2013; Tzabazis 2013; Valle
2009). We judged two studies as being at unclear risk of bias
(Fregni 2006a; Fregni 2006b). In the reports of these studies data
were not presented in a format that could be easily interpreted. On
request data were available from these two studies for the primary
outcome at baseline and short-term follow-up but not for other
follow-up points. We assessed the remaining studies as having a
low risk of bias for this criterion. For this update, we first made
requests for data (by email where possible) in February 2013, with
repeat emails sent where necessary inMarch, April and June 2013.
For studies identified in the second round of searches we made
requests in June 2013 and we made the final round of requests
on 1 August 2013. If these data are made available in time for
future updates then we can revise judgements on this criterion
accordingly.
Study size
We rated three studies at unclear risk of bias (Hosomi 2013;
Lefaucheur 2004; Tan 2011), with all remaining studies rated at
high risk of bias on this criterion.
Study duration
We rated seven studies at low risk of bias on this criterion
(Ahmed 2011; Avery 2013; Gabis 2009; Mhalla 2011; Passard
2007; Picarelli 2010; Valle 2009), 19 studies at unclear risk
of bias (André-Obadia 2008; André-Obadia 2011; Antal 2010;
Borckardt 2009; Carretero 2009; Defrin 2007; Fenton 2009;
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Fregni 2006a; Fregni 2006b; Fregni 2011; Hosomi 2013; Kang
2009; Khedr 2005; Lee 2012; Mori 2010; Onesti 2013; Soler
2010; Tzabazis 2013; Wrigley 2014), and the remaining studies at
high risk of bias (André-Obadia 2006; Boggio 2009; Capel 2003;
Cork 2004; Fregni 2005; Gabis 2003; Hargrove 2012; Hirayama
2006; Irlbacher 2006; Jensen 2013; Katsnelson 2004; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Lichtbroun 2001; Mendonca 2011; Pleger
2004; Portilla 2013; Riberto 2011; Rintala 2010; Rollnik 2002;
Saitoh 2007; Short 2011; Tan 2000; Tan 2006; Tan 2011; Taylor
2013; Villamar 2013) .
Other potential sources of bias
Carry-over effects in cross-over trials
We judged one study as unclear on this criterion as no pre-stimula-
tion data were provided and no investigation of carry-over effects
was discussed in the study report (Fenton 2009). In one cross-
over study baseline differences between the sham and the 10 Hz
stimulation condition were notable (Saitoh 2007). A paired t-test
did not show a significant difference (P > 0.1) and we judged this
study as having a low risk of bias for carry-over effects. We judged
another study at unclear risk of bias on this criterion as the nec-
essary data were not available in the study report from which to
make a judgement (Portilla 2013).
Other sources of bias
Two studies did not present baseline data for key outcome variables
and we judged them as ’unclear’ (Fregni 2011; Tzabazis 2013).
Three studies demonstrated baseline imbalances: one study on
pain intensity levels (Defrin 2007), one study on Brief Pain Inven-
tory pain interference, SF-36 pain sub-scale and coping strategies
(Tan 2011) and one study on duration of pain, education, age
and economic activity (Riberto 2011). We judged these studies
at unclear risk of bias for these reasons. One study of CES did
not clearly present relevant baseline group characteristics of the
included participants and we judged it as being at high risk of
bias for this criterion (Katsnelson 2004). One study of CES also
applied electrical stimulation to the painful body area as part of
the treatment, which may have affected the final outcomes (Tan
2000). Two studies of CES used an “active placebo condition” that
delivered a level of cortical stimulation that was greater than that
used in the active arm of other CES studies (Gabis 2003; Gabis
2009). It is possible that delivering cortical stimulation in the sham
group might mask differences between the sham and active con-
dition. Also such a large difference in current intensity compared
with other studies of CES might be a source of heterogeneity. We
judged these three studies as ’unclear’ on this criterion. We judged
one study at high risk of bias on this criterion due to imbalances
between the groups at baseline on the duration of pain, education,
age and economic activity (Riberto 2011).
Effects of interventions
See: Summary of findings for the main comparison
For a summary of all core findings see Summary of findings for
the main comparison.
Primary outcome: pain
Repetitive transcranial magnetic stimulation (rTMS) for
short-term relief of chronic pain
The primary meta-analysis (Analysis 1.1) pooled data from all
rTMS studies with low or unclear risk of bias (excluding the
risk of bias criteria ’study size’ and ’study duration’) where data
were available (n = 528), including cross-over and parallel de-
signs, using the generic inverse variance method (André-Obadia
2006; André-Obadia 2008; André-Obadia 2011; Borckardt 2009;
Carretero 2009; Defrin 2007; Hirayama 2006; Hosomi 2013;
Kang 2009; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur
2004; Lefaucheur 2006; Lefaucheur 2008; Mhalla 2011; Passard
2007; Pleger 2004; Pleger 2004; Rollnik 2002; Saitoh 2007; Short
2011). We excluded the studies by Ahmed 2011, Khedr 2005,
Irlbacher 2006 and Lee 2012, as we classified them as having a high
risk of bias on at least one criterion. We were unable to include
data from five studies (Fregni 2005; Fregni 2011; Onesti 2013;
Picarelli 2010; Tzabazis 2013 combined n = 86), as the necessary
data were not available in the study report or upon request by
the submission date of this update. We imputed the correlation
coefficient used to calculate the standard error (SE) (standardised
mean difference (SMD)) for cross-over studies (0.764) from data
extracted fromAndré-Obadia 2008 (as outlined inUnit of analysis
issues) and we entered the SMD (SE) for each study into a generic
inverse variance meta-analysis. We divided the number of partici-
pants in each cross-over study by the number of comparisonsmade
by that study entered into the meta-analysis. For parallel studies
we calculated the standard error of themean (SEM) from the 95%
confidence intervals of the standardised mean difference (SMD)
and entered both the SMD and the SEM into the meta-analysis.
We then entered this into the meta-analysis with the SMD using
the generic inverse variance method.
We observed substantial heterogeneity (I2 = 67%, P < 0.01) and in-
vestigated this using pre-planned subgroup analysis. Categorising
studies by high (≥ 5Hz) or low (< 5Hz) frequency rTMS demon-
strated a significant difference between subgroups (P < 0.01) and
reduced heterogeneity in the low-frequency group (n = 81, I2 =
0%). In this group there was no evidence of an effect of low-fre-
quency rTMS for short-term relief of chronic pain (SMD 0.15,
95% confidence interval (CI) -0.01 to 0.3, P = 0.07). While high-
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frequency stimulation demonstrated a significant effect (SMD -
0.27, 95% CI -0.35 to -0.20, P < 0.01), we observed substantial
heterogeneity in this (n = 447, I2 = 64%). Separating studies that
delivered a single treatment per condition from those that deliv-
eredmultiple treatment sessions did not reduce heterogeneity sub-
stantially in multiple-dose studies (n = 225, I2 = 75%) or single-
dose studies (n = 303, I2 = 61%) (Analysis 1.2).
There were insufficient data to support the planned subgroup anal-
ysis by the type of painful condition as planned. However, when
the analysis was restricted to studies including only well-defined
neuropathic pain populations (Analysis 1.3 excluding Carretero
2009; Mhalla 2011; Passard 2007; Pleger 2004; Rollnik 2002;
Short 2011), there was little impact on heterogeneity (I2 = 71% P
< 0.01). In the subgroup of non-neuropathic pain studies overall
heterogeneity remained significant and high (I2 = 56%, P = 0.04)
(Analysis 1.4).
rTMS motor cortex
Restricting the analysis to single-dose studies of high-frequency
stimulation of the motor cortex (n = 233) reduced heterogene-
ity (I2 = 31%, P = 0.13) (Analysis 1.5). In this group the pooled
SMD was -0.39 (95% confidence interval (CI) -0.51 to -0.27,
P < 0.01). We back-transformed the SMD to a mean difference
using the mean standard deviation of the post-treatment sham
group score of the studies included in this analysis (1.87). We
then used this to estimate the real percentage change on a 0 to
100 mm visual analogue scale (VAS) of active stimulation com-
pared with the mean post-stimulation score from the sham groups
of the included studies (6.2). This equated to a reduction of 7.3
mm (95% CI 5 mm to 9.5 mm), or a percentage change of 12%
(95% CI 8% to 15%) of the control group outcome. This es-
timate does not reach the pre-established criteria for a minimal
clinically important difference (≥ 15%). Of the included studies
in this subgroup, nine did not clearly report blinding of assessors
and we awarded them a judgement of ’unclear’ risk of bias for
this criterion (André-Obadia 2011; Hirayama 2006; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Pleger 2004; Rollnik 2002; Saitoh 2007). Sensitivity analysis re-
moving these studies reduced heterogeneity to I2 = 0% although
only three studies were preserved in the analysis (André-Obadia
2006; André-Obadia 2008; Lefaucheur 2008). There remained a
statistically significant difference between sham and active stim-
ulation although the SMD reduced to -0.31 (95% CI -0.49 to -
0.13). This equates to a percentage change of 9% (95% CI 4%
to 15%) in comparison with sham stimulation. For multiple-dose
studies of high-frequency motor cortex stimulation heterogeneity
was high (n = 157, I2 = 71%, P < 0.01), but the pooled effect was
not significant (SMD -0.07, 95% CI -0.41 to 0.26, P = 0.68).
When the analysis was restricted to studies of single-dose, high-
frequency motor cortex stimulation in well-defined neuropathic
pain populations (excludingdata fromPleger 2004;Rollnik 2002),
there was little effect on the pooled estimate (SMD -0.43, 95%CI
-0.57 to -0.30) or heterogeneity (I2 = 31%, not significant). When
we applied the same process to multiple-dose studies of high-
frequency motor cortex stimulation (excluding data from Passard
2007) heterogeneity remained high (I2 = 62%, P = 0.03) with no
significant pooled effect.
Sensitivity analysis
To assess whether the imputation of standard errors for cross-over
studies was robust we repeated the analysis with the correlation
coefficient reduced to 0.66 and increased to 0.86. This had no
marked effect on the overall analysis (Analysis 1.6; Analysis 1.7).
The same process was applied to the subgroup analysis of single-
dose studies of high-frequency motor cortex stimulation (Analysis
1.8; Analysis 1.9). This had a negligible impact on the effect size
or the statistical significance of this subgroup.
To assess the impact of excluding the studies of Ahmed 2011,
Irlbacher 2006, Khedr 2005 and Lee 2012, we performed the
analysis with data from these studies included (Analysis 1.10).
While this produced a modest increase in the SMD it increased
heterogeneity from69%to74%. InclusionofAhmed 2011,Khedr
2005 and Lee 2012 to the multiple-dose studies of high-frequency
motor cortex stimulation subgroup increased heterogeneity (I2 =
88%, P < 0.01), though the subgroup demonstrated an effect that
approached statistical significance (SMD -0.50, 95% CI -0.99 to
-0.01, P = 0.05) (Analysis 1.11). Inclusion of the Irlbacher 2006
study in the single-dose studies of high-frequency motor cortex
stimulation subgroup caused a slight decrease in the pooled effect
size (SMD -0.36, 95% CI -0.48 to -0.24) with no impact on
heterogeneity.
Small study effects/publication bias
We investigated small study effects using Egger’s test. The results
are not suggestive of a significant influence of small study effects.
rTMS prefrontal cortex
Restricting the analysis to studies that stimulated the dorsolateral
pre-frontal cortex (DLPFC) included four studies (n = 68) (Avery
2013; Borckardt 2009; Carretero 2009; Short 2011) (Analysis
1.12). We excluded the study by Lee 2012 due to its high risk of
bias. The pooled effect was non-significant (P = 0.36) with sub-
stantial heterogeneity (I2 = 82%, P < 0.01). Restricting the analy-
sis to high-frequency studies (Avery 2013; Borckardt 2009; Short
2011), the effect remained non-significant (P = 0.33) with high
heterogeneity (I2 = 85%, P < 0.01). The only remaining low-fre-
quency study (Carretero 2009, n = 26) was not suggestive of a sig-
nificant effect (SMD 0.16, 95% CI -0.29 to 0.61). It is worthy of
note that the only study in the analysis which individually demon-
strated a significant effect was very small (n = 4) and its removal
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from the analysis makes heterogeneity non-significant (Borckardt
2009).
Sensitivity analysis
To assess the impact of excluding the study of Lee 2012, we per-
formed the analysis with data from this study included (Analysis
1.13). The overall effect remained non-significant (P = 0.27) with
high heterogeneity (I2 =76%,P<0.01). Restricting this to low-fre-
quency studies (Carretero 2009; Lee 2012) brought heterogeneity
down to a non-significant level (I2 = 16%, P = 0.28), though the
effect remained non-significant. Restricting the analysis to high-
frequency studies (Borckardt 2009; Lee 2012; Short 2011), the
effect remained non-significant (P = 0.25) though heterogeneity
remained high (I2 = 74%, P < 0.01). Restricting the analysis to
low-frequency studies (Carretero 2009; Lee 2012), the effect re-
mained non-significant (P = 0.92) with no heterogeneity (I2 =
16%, P = 0.28).
rTMS for medium-term relief of chronic pain (< 6 weeks
post-treatment)
Seven studies provided data on medium-term pain outcomes
(Avery 2013; Carretero 2009; Hosomi 2013; Lefaucheur 2001a;
Kang 2009; Passard 2007; Short 2011). We excluded the studies
by Ahmed 2011, Khedr 2005 and Lee 2012 as we classified them
as having a high risk of bias. The analysis included 184 partici-
pants (Analysis 1.14). Overall heterogeneity was high (I2 = 57%, P
= 0.02) and no significant effect was observed (SMD -0.18, 95%
CI -0.43 to 0.06, P = 0.15). Restricting the analysis to studies of
prefrontal cortex stimulation (Avery 2013; Carretero 2009; Short
2011) demonstrated no significant effect (SMD -0.03, 95% CI -
0.52 to 0.35). Studies of motor cortex stimulation also demon-
strated no significant effect (SMD -0.22, 95% CI -0.52 to 0.07,
P = 0.14) although heterogeneity was high (I2 = 72%, P < 0.01).
We performed sensitivity analysis to assess the impact of exclud-
ing the studies by Ahmed 2011, Khedr 2005 and Lee 2012 on
the basis of risk of bias (Analysis 1.15). Including these studies
increased heterogeneity (I2 = 76%, P < 0.01) though the effect
reached significance overall (SMD -0.43, 95% CI -0.76 to -0.10)
and specifically for high-frequency studies (SMD -0.48, 95% CI
-0.83 to -0.13) (I2 = 79%, P < 0.01).
rTMS for long-term relief of chronic pain (≥ 6 weeks post-
treatment)
Three studies provided data for long-term pain relief (Avery 2013;
Kang 2009; Passard 2007) (Analysis 1.16). The analysis included
59 participants. There was no heterogeneity (I2 = 0%, P = 0.95).
The analysis demonstrated no significant effect (SMD -0.12, 95%
CI -0.46 to 0.21, P = 0.47). Sensitivity analysis to assess the im-
pact of excluding the study of Ahmed 2011 due to its high risk of
bias continued to demonstrate no significant effect, though het-
erogeneity was introduced (Analysis 1.17, I2 = 68%, P = 0.03).
Cranial electrotherapy stimulation (CES) for short-term
pain relief
Six studies provideddata for this analysis (Gabis 2003;Gabis 2009;
Rintala 2010; Tan 2006; Tan 2011; Taylor 2013) (Analysis 2.1, n
= 270). We excluded the study by Rintala 2010 due to high risk
of attrition bias. All studies utilised a parallel-group design and
so we used a standard inverse variance meta-analysis using SMD.
Four studies did not provide the necessary data to enter into the
analysis (Capel 2003; Cork 2004; Katsnelson 2004; Lichtbroun
2001, combined n = 228) and we classified two studies as being at
high risk of bias on criteria other than ’free of selective outcome
reporting’ (Katsnelson 2004; Tan 2000). The studies by Gabis
2003 and Gabis 2009 differ substantially from the other included
studies on the location of electrodes and the intensity of the current
provided. Despite this, there was no heterogeneity (I2 = 0%). No
individual study in this analysis demonstrates superiority of active
stimulation over sham and the results of the meta-analysis do not
demonstrate statistical significance (SMD -0.24, 95% CI -0.48 to
0.01, P = 0.06). Sensitivity analysis, including the study by Rintala
2010, did not meaningfully affect the results (SMD -0.21, 95%
CI -0.45 to 0.02, P = 0.07).
There were insufficient data to perform a meta-analysis for
medium or long-term pain outcomes for CES.
Transcranial direct current stimulation (tDCS) for short-
term pain relief
Adequate data were available from 11 studies (Antal 2010; Boggio
2009; Fenton 2009; Fregni 2006a; Fregni 2006b; Jensen 2013;
Mori 2010; Riberto 2011; Soler 2010; Villamar 2013; Wrigley
2014) for this analysis (n = 193). We were unable to include data
from Mendonca 2011 and Valle 2009 (combined n = 71) as the
necessary data were not reported in the study report or available
upon request to the authors.We only included first-stage data from
the study of Antal 2010 (n = 12) due to the unsustainable level of
attrition following this stage. We analysed data using the generic
inverse variance method. We imputed the correlation coefficient
(0.635) used to calculate the SE (SMD) for cross-over studies from
data extracted from Boggio 2009 (see Unit of analysis issues). One
study compared two distinct active stimulation conditions to one
sham condition (Fregni 2006b). Combining the treatment con-
ditions was considered inappropriate as each involved stimulation
of different locations and combination would hinder subgroup
analysis. Instead we included both comparisons separately with
the number of participants in the sham control group divided by
the number of comparisons. The overall meta-analysis did not
demonstrate a significant effect of active stimulation (SMD -0.18,
95% CI -0.46 to 0.09, P = 0.19) (Analysis 3.1), but heterogene-
ity was significant (I2 = 49%, P = 0.02). Subgrouping studies by
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multiple or single dose did not demonstrate a significant subgroup
difference (test for subgroup differences P = 0.89) and decreased
heterogeneity in the single-dose subgroup (I2 = 0%, P = 0.53) but
increased heterogeneity in the multiple-dose subgroup (I2 = 62%,
P < 0.01). Analysis restricted to comparisons of activemotor cortex
stimulation (single and multiple-dose studies (n = 183, Analysis
3.2) reduced heterogeneity substantially (I2 = 33%, P = 0.13) but
did not demonstrate a statistically significant effect (SMD -0.23,
95% CI -0.48 to 0.01, P = 0.06). This lack of effect was consistent
for the subgroups of single-dose studies (SMD -0.18, 95% CI -
0.41 to 0.05, P = 0.13) and multiple-dose studies (SMD -0.35,
95% CI -0.79 to 0.09, P = 0.12).
To assess whether the imputation of standard errors for cross-over
studieswas robustwe repeated the analyseswith the imputed corre-
lation coefficient reduced and increased by a value of 0.1 (Analysis
3.3; Analysis 3.4; Analysis 3.5; Analysis 3.6). When the correla-
tion was decreased the analysis including both single andmultiple-
dose studies of motor cortex tDCS stimulation only approached,
but did not reach, statistical significance (SMD -0.24, 95% CI -
0.48 to 0.00, P = 0.05).
Small study effects/publication bias
We investigated small study effects using Egger’s test. The results
are not suggestive of a significant influence of small study effects.
tDCS for medium-term pain relief (1 to < 6 weeks post-
treatment)
Five studies provided adequate data for this analysis (Antal 2010;
Fenton 2009; Mori 2010; Soler 2010, Wrigley 2014, pooled n
= 87) (Analysis 3.7). There was no significant heterogeneity (I
2 = 31%, P = 0.21) and the pooled effect was not statistically
significant (SMD -0.20, 95% CI -0.63 to 0.24, P = 0.37).
Reduced impedance non-invasive cortical electrostimulation
(RINCE) for short-term pain relief
The one study that investigatedRINCE stimulation demonstrated
a positive effect on pain (mean difference (0 to 10 pain scale) -
1.41, 95% CI -2.48 to -0.34, P < 0.01) (Analysis 4.1; Hargrove
2012).
Secondary outcomes: disability and quality of life
rTMS for disability/pain interference: short-term follow-up
Five studies provided data on disability/pain interference at short-
term follow-up (Avery 2013; Kang 2009; Mhalla 2011; Passard
2007; Short 2011). Pooling of these studies (Analysis 1.18; n
= 119) demonstrated no significant effect on pain interference
(SMD -0.29, 95% CI -0.87 to 0.29, P = 0.33) with substantial
heterogeneity (I2 = 71%, P < 0.01). All of these studies delivered
multiple doses of high-frequency stimulation. Two studies stimu-
lated the DLPFC (Avery 2013; Short 2011) and three stimulated
the motor cortex (Kang 2009; Mhalla 2011; Passard 2007). Sub-
grouping studies by stimulation site had no impact on heterogene-
ity.
rTMS for disability/pain interference: medium-term follow-
up (1 to < 6 weeks post-treatment)
Four studies provided data on disability/pain interference at
medium-term follow-up (Avery 2013; Kang 2009; Mhalla 2011;
Passard 2007). Pooling of these studies (Analysis 1.19; n = 99)
demonstrated no significant effect (SMD -0.37, 95% CI -1.07 to
0.33, P = 0.3) with significant heterogeneity (I2 = 78%, P < 0.01).
All studies delivered multiple sessions of high-frequency stimula-
tion. Of these, one study stimulated theDLPFC (Avery 2013) and
the remaining studies stimulated the motor cortex (Kang 2009;
Mhalla 2011; Passard 2007). Removing the study of Avery 2013
did not decrease heterogeneity (I2 = 85%, P < 0.01).
rTMS for disability/pain interference: long-term follow-up (≥
6 weeks post-treatment)
Three studies provided data on disability/pain interference at long-
term follow-up (Avery 2013; Kang 2009; Passard 2007). Pooling
of these studies demonstrated no significant effect (SMD -0.23,
95% CI -0.62 to 0.16, P = 0.24) without significant heterogeneity
(I2 = 15%, P = 0.31) (Analysis 1.20).
rTMS for quality of life: short-term follow-up
Three studies provided data on quality of life at short-term follow-
up (Mhalla 2011; Passard 2007; Short 2011). We were unable
to include data from Tzabazis 2013, as the size of the treatment
groups was not clear from the study report. All studies used the
Fibromyalgia Impact Questionnaire so we were able to use the
mean difference as the measure of effect. Pooling data from these
studies (Analysis 1.21; n = 80) demonstrated a significant effect
(mean difference (MD) -10.38, 95% CI -14.89 to -5.87, P <
0.01) with no heterogeneity (I2 = 0%, P = 0.99). Expressed as a
percentage of the mean post-stimulation score in the sham groups
from the included studies (58.3) this equates to a 18% (95% CI
10% to 26%) reduction in fibromyalgia impact.
rTMS for quality of life: medium-term follow-up (1 to < 6
weeks post-treatment)
The same three studies provided data on quality of life at medium-
term follow-up (Mhalla 2011; Passard 2007; Short 2011). All stud-
ies used the Fibromyalgia Impact Questionnaire so we were able
to use the mean difference as the measure of effect. Pooling data
22Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
from these studies (Analysis 1.22; n = 80) demonstrated a signifi-
cant effect (MD -11.49, 95% CI -17.04 to -5.95, P < 0.01) with
no heterogeneity (I2 = 0%, P = 0.63). Expressed as a percentage
of the mean post-stimulation score in the sham groups from the
included studies (57.8) this equates to a 20% (95% CI 10% to
29%) reduction in fibromyalgia impact.
rTMS for quality of life: long-term follow-up (≥ 6 weeks
post-treatment)
Data were only available from one study (Passard 2007, n = 30)
for quality of life at long-term follow-up. This study demonstrated
no significant effect (MD -0.61, 95% CI -1.34 to 0.12) (Analysis
1.23).
CES for quality of life: short-term follow-up
Two studies provided quality of life data for this analysis (Tan 2011;
Taylor 2013). One study used the physical component score of the
SF-12 and the other used the Fibromyalgia Impact Questionnaire.
However, one study demonstrated a baseline imbalance of the SF-
12 that exceeded in size any pre-post stimulation change (Tan
2011). Therefore we considered it inappropriate to enter this into
a meta-analysis. The study by Taylor 2013 (n = 36) demonstrated
a positive effect on this outcome (SMD -1.25, 95% CI -1.98 to -
0.53) (Analysis 2.3).
tDCS for quality of life
Two studies provided adequate data for this analysis (Mori 2010;
Riberto 2011, pooled n = 32). Of these, Mori 2010 used the
Multiple Sclerosis Quality of Life 54 scale (MS-QoL-54) and
Riberto 2011 used the SF-36 (total score). The pooled effect was
significant (SMD 0.88, 95% CI 0.24 to 1.53, P < 0.01) with no
heterogeneity (I2 = 0%, P = 0.41) (Analysis 3.9). At medium-term
follow-up only Mori 2010 (n = 19) provided data and the effect
of tDCS on quality of life was not significant.
RINCE for quality of life
The one study of RINCE therapy demonstrated no significant
effect on quality of life (Fibromyalgia Impact Questionnaire) (
Analysis 4.2) .
Adverse events
rTMS
Minor
Of the rTMS studies that reported adverse events, nine studies
reported none (André-Obadia 2006; André-Obadia 2008; Fregni
2005; Hirayama 2006; Lefaucheur 2001a; Lefaucheur 2001b;
Lefaucheur 2004; Onesti 2013; Saitoh 2007). Carretero 2009 re-
ported neck pain or headache symptoms in six out of 14 partic-
ipants in the active stimulation group compared with two out of
12 in the sham group. One participant in the active stimulation
group reported worsening depression and four participants in the
sham group reported symptoms of nausea and tiredness. Passard
2007 reported incidence of headaches (four out of 15 participants
in the active group versus five out of 15 in the sham group), feel-
ings of nausea (one participant in the active group), tinnitus (two
participants in the sham group) and dizziness (one participant in
the sham group). Rollnik 2002 reported that one participant ex-
perienced headache, but it is unclear in the report whether this
was following active or sham stimulation. Avery 2013 reported a
range of reported sensations including headache, pain at the stim-
ulation site, muscle aches/fatigue, dizziness and insomnia, though
there were no clear differences in the frequency of these events
between the two groups. Mhalla 2011 reported that nine patients
(five following active stimulation and four following sham stimu-
lation) reported transient headache, and one participant reported
transient dizziness after active stimulation. Picarelli 2010 found
six reports of headache following active stimulation and four fol-
lowing sham stimulation, and two reports of neck pain following
active stimulation with four reports following sham stimulation.
Short 2011 reported that there were few side effects and Hosomi
2013 reported no difference between real and sham rTMS for
minor adverse events. In the study by Fregni 2011, the incidence
of headache and neck pain was higher in the active stimulation
group than in the sham group. Forty-one participants reported
headache after active stimulation compared to 19 after sham and
18 participants reported neck pain after active stimulation com-
pared with three after sham. Following four-coil rTMS, Tzabazis
2013 reported no serious adverse events. The incidence of scalp
pain, headache, lightheadedness, back pain, otalgia, hot flashes and
pruritis was more commonly reported following sham stimulation
than active stimulation. Neck pain (14% of participants following
active stimulation versus no participants following sham) and nau-
sea (19% of participants following active stimulation verus 11%
following sham) were more common with active stimulation.
Major
Both Lee 2012 and Picarelli 2010 reported one incidence of seizure
following high-frequency active stimulation.
CES
Four studies of CES reported the incidence of adverse events
(Capel 2003; Gabis 2003; Rintala 2010; Tan 2011). In these stud-
ies no adverse events were reported. Rintala 2010 reported no ma-
jor adverse events. In the active stimulation group they reported
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incidences of pulsing, tingling, tickling in ears (three participants),
tender ears (one participant) and pins and needles feeling near
bladder (one participant). In the sham group they reported drowsi-
ness (one participant), warm ears (one participant) and headache
after one session (one participant). Tan 2011 reported only mild
adverse events with a total of 41 reports in the active stimulation
group and 56 in the sham group. Of note, sensations of ear pulse/
sting/itch/electric sensations or ear clip tightness seemed more
common in active group than the sham group (12 versus six inci-
dents). Through correspondence with the authors of Taylor 2013,
we confirmed that there were no adverse events reported.
tDCS
Most studies of tDCS reported the incidence of adverse events. Of
these, four studies reported none (Fregni 2006a; Mendonca 2011;
Mori 2010; Portilla 2013). Boggio 2009 reported that one par-
ticipant experienced headache with active stimulation. The study
by Fenton 2009 reported three cases of headache, two of neck
ache, one of scalp pain and five of a burning sensation over the
scalp in the active stimulation group versus one case of headache
in the sham stimulation group. Fregni 2006b reported one case of
sleepiness and one of headache in response to active stimulation
of the DLPFC, three cases of sleepiness and three of headache
with active stimulation of M1 and one case of sleepiness and
two of headache in response to sham stimulation. Soler 2010
recorded three reports of headache, all following active stimula-
tion. Villamar 2013 reported that the vast majority of participants
reported a mild to moderate tingling or itching sensation during
both active and sham stimulation that faded over a few minutes
but no other adverse effects. Valle 2009 reported “minor and un-
common” side effects, such as skin redness and tingling, which
where equally distributed between active and sham stimulation.
Antal 2010 recorded reports of tingling, moderate fatigue, tired-
ness, headache and sleep disturbances, though there were no large
differences in the frequency of these between the active and sham
stimulation groups. Wrigley 2014 reported only “mild to moder-
ate” side effects with no significant difference between active and
sham over the 24-hour post-stimulation period. These included
sleepiness (70% of participants following active, 60% following
sham), fatigue, inertia (60% of participants following active, 30%
following sham), lightheadedness (20% of participants during ac-
tive and sham treatment) and headache (10% of participants dur-
ing active and sham treatment).
Four studies monitored for possible effects on cognitive function
using the Mini Mental State Examination questionnaire (Boggio
2009; Fregni 2006a; Fregni 2006b; Valle 2009) and three of these
also used a battery of cognitive tests including the digit-span mem-
ory test and the Stroop word-colour test (Boggio 2009; Fregni
2006a; Fregni 2006b) and simple reaction time tasks (Fregni
2006a). No studies demonstrated any negative influence of stim-
ulation on these outcomes. No studies of tDCS reported severe or
lasting side effects. Jensen 2013 andRiberto 2011 did not consider
adverse events in their study reports.
RINCE
Hargrove 2012 reported a low incidence of side effects from
RINCE stimulation including short-lived headache (two partici-
pants in the active group, one in the sham group), eye movement/
flutter during stimulation (one active, one sham), restlessness (one
active and none sham) and nausea (one active and none sham).
GRADE judgements
GRADE judgements for all core comparisons of the primary out-
come can be found in Table 4. For all comparisons the highest
rating of the quality of evidence was ’low’.
D I S C U S S I O N
Summary of main results
This update has included a substantial number of new studies.
Despite this, for rTMS and CES our findings have not altered
substantially from the previous version of this review. However,
for tDCS the inclusion of these new data have altered the outcome
of our analyses, which no longer suggest a statistically significant
effect of tDCS over sham. We recommend that previous readers
should re-read this update.
Repetitive transcranial magnetic stimulation (rTMS)
for chronic pain
Meta-analysis of all rTMS studies in chronic pain demonstrated
significant heterogeneity. Predetermined subgroup analysis sug-
gests a short-term effect of single-dose, high-frequency rTMS ap-
plied to the motor cortex on chronic pain. This effect is small
and does not conclusively exceed the threshold of minimal clinical
significance. The evidence from multiple-dose studies of rTMS
demonstrates conflicting results with substantial heterogeneity
both overall and when the analysis is confined to high-frequency
motor cortex studies. Low-frequency rTMS does not appear to be
effective. rTMS applied to the pre-frontal cortex does not appear
to be effective. That the majority of studies in this analysis are at
unclear risk of bias, particularly for participant blinding, suggests
that the observed effect sizes might be exaggerated. While there is
substantial unexplained heterogeneity the available evidence does
not suggest a significant effect of rTMS in the medium term. The
limited evidence at long-term follow-up consistently suggests no
effect of rTMS.
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Cranial electrotherapy stimulation (CES) for chronic
pain
The evidence from trials where it is possible to extract data is not
suggestive of a significant beneficial effect of CES on chronic pain.
While there are substantial differences within the trials in terms
of the populations studied and the stimulation parameters used,
there is no measurable heterogeneity and no trial shows a clear
benefit of active CES over sham stimulation.
Transcranial direct current stimulation (tDCS) for
chronic pain
Meta-analysis of all tDCS studies in chronic pain demonstrated
significant heterogeneity. Predetermined subgroup analyses did
not demonstrate a statistically significant effect of tDCSon chronic
pain despite many of the studies included in this review being
at unclear risk of bias for participant and assessor blinding. The
evidence available at medium-term follow-up does not suggest a
significant effect of tDCS.
Reduced impedance non-invasive cortical
electrostimulation (RINCE) stimulation for chronic
pain
There is one small trial suggesting a positive effect of RINCE
stimulation over sham for chronic pain. This trial is at unclear risk
of bias due to possible attrition bias. As such, further research is
needed to confirm this exploratory finding.
Adverse effects
rTMS, CES, tDCS and sham stimulation are associated with tran-
sient adverse effects such as headache, scalp irritation and dizzi-
ness, but reporting of adverse effects was inconsistent and did not
allow for a detailed analysis. There were two incidences of seizure
following active rTMS, which occurred in separate studies. For
all forms of stimulation adverse events reporting is inconsistent
across studies.
Secondary outcome measures
The available evidence does not suggest an effect of rTMS on
disability/pain interference levels at any follow-up point. There is
insufficient evidence from which to draw conclusions regarding
CES or tDCS for pain interference or disability.
Limited evidence suggests that rTMS and tDCS have positive ef-
fects on quality of life. This finding in rTMS is difficult to inter-
pret as it arises from multiple-dose studies which together do not
demonstrate an effect on pain intensity levels. Any hypothesised
effects of non-invasive brain stimulation techniques on quality of
life would presumably be through the reduction of pain. Given
this inconsistency between outcomes for rTMS and the limited
amount of data available to these analyses, we would recommend
that this finding should be interpreted with caution.
Overall completeness and applicability of
evidence
For rTMS we were unable to include data from five full published
studies (Fregni 2005; Fregni 2011, Onesti 2013; Picarelli 2010;
Tzabazis 2013, combined n = 86). In addition, we identified six
studies of rTMS published in abstract format for which we have
not been able to acquire full study reports. A conservative estimate
of the combined number of participants that those studies might
add, assuming that some reports refer to the same study, is 243.
We were unable to extract the relevant data from four studies
of CES (Capel 2003; Cork 2004; Katsnelson 2004; Lichtbroun
2001). This may have impacted upon the results of our meta-
analysis although one of those studies would have been excluded
from the meta-analysis as we judged it as being at risk of bias on
criteria other than selective outcome reporting (Katsnelson 2004).
We were also unable to extract the relevant data from two stud-
ies of tDCS (Mendonca 2011; Valle 2009), and these data were
not made available upon request to the study authors. These data
would have significantly contributed to the power of the meta-
analysis by the introduction of a further 71 participants and may
have altered our conclusions. In addition, we identified three stud-
ies of tDCS (Acler 2012; Albu 2011; Knotkova 2011, combined
n = 87) published in abstract format, one of which is currently
being re-analysed by the study authors and as such the data were
not available (Knotkova 2011), and for two of which we were un-
successful in our efforts to contact the authors (Acler 2012; Albu
2011).
For both rTMS and tDCS there are a number of ongoing stud-
ies identified through the trials registers searches. Of these, two
registered trials that were identified in the original version of this
review have not yet been published and our attempts to contact
the authors were unsuccessful (NCT00947622; NCT00815932).
We hope that future updates of this review will include the afore-
mentioned data.
Quality of the evidence
Using the GRADE criteria we judged the quality of evidence for
all comparisons as low or very low-quality. In large part this is due
to issues of blinding and of precision and to a degree it reflects
the early stage of research development that these technique are
at. The majority of studies of rTMS were at unclear risk of bias.
The predominant reason for this was the use of sub-optimal sham
controls that were unable to control for all possible sensory cues
associated with active stimulation. A number of studies did not
clearly report blinding of assessors and sensitivity analysis exclud-
ing those studies reduced both heterogeneity and the pooled effect
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size. It could be reasonably argued that the presence of a subgroup
of single-dose studies of high-frequency stimulation specific to the
motor cortex that does demonstrate superiority over sham with
acceptable levels of heterogeneity is evidence for a specific clinical
effect of rTMS. It should be considered, however, that high-fre-
quency rTMS is associated with more intense sensory and audi-
tory cues that might plausibly elicit a larger placebo response, and
many of the included studies were unable to control conclusively
for these factors. The pooled effect size for the high-frequency
studies of motor cortex rTMS does not meet our predetermined
threshold for clinical significance. This estimate is based solely on
studies that delivered a single dose of rTMS. It is feasible that a
single dose may be insufficient to induce clinically meaningful im-
provement. These single-dose studies included in the analysis are
best characterised as proof of principle studies which sought to test
whether rTMS could modulate pain, rather than full-scale clinical
studies with the aim of demonstrating clinical utility. However the
combined evidence from studies of rTMS that delivered multiple
doses (excluding studies judged as being at high risk of bias), while
demonstrating substantial heterogeneity, does not indicate a sig-
nificant effect on pain.
Similarly, we judged no study of tDCS as having a low risk of bias
on all criteria. While there is evidence that the sham control used
in tDCS does achieve effective blinding of participants at stimu-
lation intensities of 1 mA (Gandiga 2006), evidence has emerged
since the last version of this review which indicates that at 1.5
mA the sensory profile of stimulation differs between active and
sham stimulation (Kessler 2013), and at 2 mA participant and
assessor blinding may be compromised (O’Connell 2012). Meta-
epidemiological evidence demonstrates that incomplete blinding
in controlled trials that measure subjective outcomes may exag-
gerate the observed effect size by around 25% (Wood 2008). It is
therefore reasonable to expect that incomplete blinding may have
exaggerated the effect sizes seen in the current analyses of rTMS
and tDCS. The non-significant trend towards a positive effect of
CES and tDCS over sham should be considered in this light.
No study of CES could be judged as having a low risk of bias
across all criteria. Despite this, no study from which data were
available demonstrated a clear advantage of active over sham stim-
ulation. There was substantial variation in the stimulation param-
eters used between studies. Notably three studies utilised an “active
placebo” control in which stimulating current was delivered but
at much lower intensities (Gabis 2003; Gabis 2009; Katsnelson
2004). These intensities well exceed those employed in the active
stimulation condition of other studies of CES devices and as such
it could be hypothesised that they might induce a therapeutic ef-
fect themselves. This could possibly disadvantage the active stim-
ulation group in these studies. However, the data available in the
meta-analysis do not suggest such a trend and statistical hetero-
geneity between studies entered into the analysis was low.
All of the included studies may be considered to be small in terms
of sample size and we reflected this in our ’Risk of bias’ assess-
ment. The prevalence of small studies increases the risk of publi-
cation or small study bias, wherein there is a propensity for neg-
ative studies to not reach full publication. There is evidence that
this might lead to an overly positive picture for some interven-
tions (Dechartres 2013; Moore 2012; Nüesch 2010). In a review
of meta-analyses, Dechartres 2013 demonstrated that trials with
fewer than 50 participants, which reflects the majority of studies
included in this review, returned effect estimates that were on av-
erage 48% larger than the largest trials and 23% larger than esti-
mates from studies with sample sizes of more than 50. Similarly,
in a recent Cochrane review of amitriptyline neuropathic pain and
fibromyalgia (Moore 2012), smaller studies were associated with
substantially lower numbers needed to treat (NNTs) for treatment
response than larger studies. In their recommendations for estab-
lishing best practice in chronic pain systematic reviews, the authors
of Moore 2010 suggest that study size should be considered an
important source of bias. It is therefore reasonable to consider that
the evidence base for all non-invasive brain stimulation techniques
is at risk of bias on the basis of sample size. We did not downgrade
any of the GRADE judgements on the basis of publication bias
as there was no direct evidence. However, it is accepted that ex-
isting approaches to detecting publication bias are unsatisfactory.
To an extent our GRADE judgements reflect this risk through the
assessment of imprecision and the limitations of included studies.
It should be noted that even where a pooled estimate includes a
large number of participants, if it is dominated by small studies,
as are all comparisons in this review, then it is prone to small study
effects.
Potential biases in the review process
There is substantial variation between the included studies of
rTMS and tDCS. Studies varied in terms of the clinical popula-
tions included, the stimulation parameters and location, the num-
ber of treatment sessions delivered and in the length of follow-
up employed. This heterogeneity is reflected in the I2 statistic for
the overall rTMS and tDCS meta-analyses. However, pre-planned
subgroup investigation significantly reduced this heterogeneity.
Themajority of rTMS and tDCS studies specifically recruited par-
ticipants whose symptoms were resistant to current clinical man-
agement andmost rTMS studies specifically recruited participants
with neuropathic pain. As such it is important to recognise that
this analysis in large part reflects the efficacy of rTMS and tDCS
for refractory chronic pain conditions and may not accurately re-
flect their efficacy across all chronic pain conditions.
One study included in the in the analysis of rTMS studies demon-
strated a difference in pain levels between the two groups at base-
line that exceeded the size of the difference observed at follow-up
(Defrin 2007). Specifically, the group that received sham stimula-
tion reported less pain at baseline than those in the active stimu-
lation group. The use in the current analysis of a between-groups
rather than a change from baseline comparison is likely to have af-
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fected the results although the study contributes only 1.5% weight
to the overall meta-analysis and the study itself reported no differ-
ence in the degree of pain reduction between the active and sham
stimulation groups.
Themethod used to back-transform the pooled standardisedmean
difference (SMD) to a visual analogue scale and subsequent cal-
culation of the effect as a percentage improvement rests upon the
assumption that the standard deviation and the pain levels used
are representative of the wider body of evidence and should be
considered an estimate at best. Representing average change scores
on continuous scales is problematic in chronic pain studies since
response to treatments has been found to display a bimodal dis-
tribution (Moore 2013). More plainly, some participants demon-
strate a substantial response to pain therapies while many demon-
strate little or no response with few individual participants demon-
strating a response similar to the average. As a consequence the
meaning of the average effect sizes seen in this review is difficult to
interpret. This had led to the recommendation that chronic pain
trials employ responder analysis based on predetermined cut-offs
for a clinically important response (≥ 30% reduction in pain for
a moderate benefit, ≥ 50% reduction for a substantial benefit)
(Dworkin 2008; Moore 2010). Very few studies identified in this
review presented the results of responder analyses and so this type
of meta-analysis was not possible. However, where statistically sig-
nificant effects were observed in this review they were small, which
would indicate that if there is a subgroup of ’responders’ to active
stimulation who demonstrate moderate or substantial benefits it
is likely to include a small number of participants.
Agreements and disagreements with other
studies or reviews
The European Federation of Neurological Societies (EFNS) pub-
lished guidelines on the use of neurostimulation therapy for
chronic neuropathic pain in 2007 (Cruccu 2007), following a re-
view of the existing literature. Using a narrative synthesis of the ev-
idence they similarly concluded that there was moderate evidence
(two randomised controlled trials) that high-frequency rTMS (≥
5 Hz) of the motor cortex induces significant pain relief in cen-
tral post-stroke pain and several other neuropathic conditions, but
that the effect is modest and short-lived. They did not recommend
its use as a sole clinical treatment but suggested that it might be
considered in the treatment of short-lasting pain.
Leung 2009 performed a meta-analysis of individual patient data
from studies of motor cortex rTMS for neuropathic pain con-
ditions. Whilst the analysis was restricted to studies that clearly
reported the neuroanatomical origin of participants’ pain (and
therefore excluded some of the studies included in the current
analysis) the overall analysis suggests a similar effect size of 13.7%
improvement in pain (excluding the study of Khedr 2005). The
authors also performed an analysis of the influence of the neuro-
anatomical origins of pain on the effect size. They noted a trend
suggestive of a larger treatment effect in central compared with
peripheral neuropathic pain states although this did not reach sta-
tistical significance. While the data in the current review were not
considered sufficient to support a detailed subgroup analysis by
neuro-anatomical origin of pain, the exclusion of studies that did
not specifically investigate neuropathic pain did not significantly
affect the overall analysis and the two multiple-dose studies of mo-
tor cortex rTMS for central neuropathic pain that were included
failed to demonstrate superiority of active over sham stimulation
(Defrin 2007; Kang 2009).
All but one of the included studies in the review by Leung 2009
delivered high-frequency (≥ 5Hz) rTMS and no clear influence of
frequency variations was observed within this group. The authors
suggest that the number of doses delivered may be more crucial
to the therapeutic response than the frequency (within the high-
frequency group), based on the larger therapeutic response seen in
the study of Khedr 2005 that was excluded from the current anal-
ysis. This review preceded the studies by Defrin 2007 and Kang
2009 that did not demonstrate superiority of active over sham
stimulation. While there are limited data to test this proposition
robustly the result of our subgroup analysis of studies of high-
frequency motor cortex rTMS does not suggest a benefit of active
stimulation over sham.
Lima and Fregni undertook a systematic review and meta-analysis
of motor cortex stimulation for chronic pain (Lima 2008). They
pooled data from rTMS and tDCS studies. While the report states
that data were collected on mean between-group pain scores they
are not presented. The authors present the pooled data for the
number of responders to treatment across studies. They conclude
that the number of responders is significantly higher following ac-
tive stimulation compared with sham (risk ratio 2.64, 95% con-
fidence interval (CI) 1.63 to 4.30). In their analysis the threshold
for treatment response is defined as a global response according to
each study’s own definition and as such it is difficult to interpret
and may not be well standardised. They note a greater response
to multiple doses of stimulation, an observation that is not re-
liably reflected in the current review. Additionally they included
the study of Khedr 2005 (excluded from this review due to high
risk of bias) and Canavero 2002 (excluded on title and abstract as
it is not a randomised or quasi-randomised study). The current
review also includes a number of motor cortex rTMS studies pub-
lished since that review (André-Obadia 2008; Defrin 2007; Kang
2009; Lefaucheur 2006; Lefaucheur 2008; Passard 2007; Saitoh
2007). Neither the review of Leung 2009 nor Lima 2008 applied
a formal quality or ’Risk of bias’ assessment. While the current
review also suggests a small, significant short-term benefit of high-
frequency motor cortex rTMS in the treatment of chronic pain
the effect is small, appears short-term and although the pooled
estimate approaches the threshold of minimal clinical significance
it is possible that it might be inflated by methodological biases in
the included studies.
A recent systematic review of tDCS and rTMS for the treatment
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of fibromyalgia concluded that the evidence demonstrated reduc-
tions in pain similar to US Food and Drug Administration (FDA)
approved pharmaceuticals for this condition and recommended
that rTMS or tDCS should be considered, particularly where other
therapies have failed (Marlow 2013). This review included ran-
domised and non-randomised studies, did not undertake meta-
analysis and took a “vote-counting” approach to identifying sig-
nificant effects based primarily on each included study’s report of
statistical testing.While our analysis did not specifically investigate
a subgroup of studies in fibromyalgia participants, we would sug-
gest that the methodology chosen by Marlow 2013 does not offer
the most rigorous approach to establishing effect size, particularly
in light of the inconsistency seen among the included studies of
that review. Indeed given the degree of uncertainty that remains
regarding the efficacy these interventions it could be suggested
that the application of tDCS or rTMS for this or other conditions
would ideally be limited to the clinical research situation.
Luedtke 2012 systematically reviewed studies of tDCS for chronic
pain and experimental pain. Unlike our review they excluded the
study by Fenton 2009, as it was judged to be at high risk of bias
on the grounds of unclear randomisation procedure and due to a
lack of clarity of participant withdrawal, and Boggio 2009 due to
the level of drop-out. The results of their meta-analysis are broadly
consistent with those presented in the last iteration of this review
and similarly conclude that the evidence is insufficient to allow
definite conclusions but that there is low-level evidence that tDCS
may be effective for chronic pain. However, the inclusion of new
studies in this update has rendered these analyses non-significant.
Moreno-Duarte 2013 recently reviewed the evidence for a variety
of electrical and magnetic neural stimulation techniques for the
treatment for chronic pain following spinal cord injury, including
rTMS, tDCS and CES, including both randomised and non-ran-
domised studies. They found that the results varied across studies,
though trials of tDCS were consistently positive, and concluded
that further research is needed and that there is a need to develop
methods to decrease the variability of treatment response to these
interventions. However, it is worth noting that this review did not
include the recent negative study of tDCS for post-spinal cord
injury pain by Wrigley 2014, and also that variability in observed
treatment “responses” may simply represent the play of chance
rather than evidence of a specific group of responders.
Kirsch 2000 reviewed studies of CES in the management of
chronic pain and concluded in favour of its use. The review did not
report any formalised search strategy, inclusion criteria or quality
assessment and discussed a number of unpublished studies that re-
main unpublished at the time of the current review. Using a more
systematic methodology and including papers published since that
review, we found that the data that were available for meta-anal-
ysis do not suggest a statistically or clinically important benefit
of active CES over sham. Our analysis included 270 participants.
While this is not particularly large it does suggest that if there is an
effect of CES on chronic pain it is either small, or that the number
of responders is likely to be small.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Low or very low-quality evidence suggests that low-frequency
repetitive transcranial magnetic stimulation (rTMS), or rTMS ap-
plied to the prefrontal cortex, are not effective for the treatment
of chronic pain. Subgroup analysis suggests that single doses of
high-frequency rTMS of the motor cortex have small short-term
effects on chronic pain that do not meet our threshold of mini-
mum clinical importance (low-quality evidence) and may be ex-
aggerated by the dominance of small studies and other sources of
bias. The pooled evidence from multiple-dose studies of high-fre-
quency rTMS is heterogenous but does not demonstrate a signifi-
cant effect (very low-quality evidence). As such it is not currently
clear whether rTMS represents a useful clinical tool. Very low-
quality evidence suggests that transcranial direct current stimula-
tion (tDCS) is not effective for treating chronic pain and low-qual-
ity evidence suggests that tDCS applied to the motor cortex is not
effective. Low-quality evidence suggests that cranial electrotherapy
stimulation (CES) is not effective. Due to various biases and limi-
tations within the evidence base it is likely that future studies may
have a substantial impact upon the estimates of effects presented.
Due to this uncertainty, any clinical application of non-invasive
brain stimulation techniques would be most appropriate within a
clinical research setting rather than in routine clinical care.
Implications for research
The existing evidence across all forms of non-invasive brain stim-
ulation is dominated by small studies with unclear risk of bias and
there is a need for larger, rigorously controlled trials. All studies of
non-invasive brain stimulation techniques should measure, record
and clearly report adverse events from both active and sham stim-
ulation. Future trials should also consider the IMMPACT rec-
ommendations for the design of trials in chronic pain (Dworkin
2008; Dworkin 2009; Dworkin 2010; Turk 2008), to ensure that
outcomes, thresholds for clinical importance and study designs
are optimal, and should endeavour to ensure that published study
reports are compliant with the CONSORT statement (Schulz
2010).
In rTMS the evidence base is dominated by studies of intractable
neuropathic pain and there is little evidence from which to draw
conclusions regarding other types of chronic pain. Most of the in-
cluded rTMS studies are affected by the use of sub-optimal sham
conditions thatmay adversely impact uponblinding. Future rTMS
research should consider employing recently developed sham coils
that control for all of the sensory aspects of stimulation. Such coil
systems should be robustly validated as reliable and valid sham
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controls. We have recently recommended that while there remains
a case for exploring alternative stimulation targets and parameters,
there is a more urgent need to examine robustly the more promis-
ing findings within the existing data through large, rigorous, ade-
quately blinded trials that deliver a reasonable dose and investigate
effects over a meaningful timescale (O’Connell 2011). A data-led
approach suggests that high-frequency stimulation of the motor
cortex is a logical focus for this effort. Until a body of this type
of research is generated there will be continued uncertainty as to
whether rTMS has genuine clinical utility for chronic pain.
Future studies of tDCS should give consideration to the integrity
of participant blinding, particularly when utilising stimulation
intensities that exceed 1 mA and should possess adequate sample
sizes to reduce uncertainty.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmed 2011
Methods Parallel, quasi-randomised controlled trial
Participants Country of study: Egypt
Setting: Dept of Neurology, hospital-based
Condition: chronic phantom limb pain
Prior management details: unresponsive to various pain medications
n = 27, 17 active and 10 sham
Age, mean (SD): active group 52.01 (12.7), sham group 53.3 (13.3)
Duration of symptoms, mean (SD) months: active group 33.4 (39.3), sham group 31.9
(21.9)
Gender distribution: active group 13 M, 4 F; sham group 6 M, 4 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20 Hz; coil orientation not specified, no. of trains
10; duration of trains 10 sec; ITI 50 sec; total no. pulses 2000
Stimulation location: M1 stump region
Number of treatments: x 5, daily
Control type: sham - coil angled away from scalp
Outcomes Primary: pain VAS (anchors not reported), LANNS
When taken: post-stimulation session 1 and 5 and at 1 month and 2 months post-
treatment
Secondary: none relevant
Notes Adverse events: not reported
Conflict of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Comment: not true randomisation
Quote: “patients were randomly assigned
to 2 groups depending on the day of the
week on which they were recruited”
Allocation concealment (selection bias) High risk Comment: givenmethod of randomisation
allocation concealment not viable
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: levels of drop-out not reported
Selective reporting (reporting bias) Low risk Comment: primary outcomes presented in
full
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Ahmed 2011 (Continued)
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Low risk Quote: “The second author evaluated these
measures blindly, without knowing the
type of TMS”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment -
sub-optimal. Coil angled away from scalp.
Does not control for sensory characteristics
of active stimulation and is visually distin-
guishable
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Low risk > 8 weeks follow-up
André-Obadia 2006
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 14
Age: 31 to 66; mean 53 (SD 11)
Duration of symptoms: mean 6.9 years (SD 4)
Gender distribution: 10 M, 4 F
Interventions Stimulation type: rTMS figure of 8 coil
Stimulation parameters:
Condition 1: frequency 20Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 2: frequency 1 Hz; coil orientation lateromedial; no. of trains 1; duration of
trains 26 min, total no. pulses 1600
Condition 3: sham - same as for condition 2 with coil angled away perpendicular to
scalp
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 1 for each condition
Outcomes Primary: VAS 0 to 10 cm, anchors “no pain” to “unbearable pain”
When taken: immediately post-stimulation then daily for 1 week
Secondary: none
Notes Data requested from authors and received
Risk of bias
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André-Obadia 2006 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were consecutively as-
signed to a randomization scheme gen-
erated on the web site Randomization.
com (Dallal GE, http://www.randomiza-
tion.com, 2008). We used the second gen-
erator, with random permutations for a 3-
group trial. The randomization sequence
was concealed until interventions were as-
signed.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 2 participants lost to follow-up and not ac-
counted for in the data analysis. Given the
small sample size it may influence the re-
sults
Selective reporting (reporting bias) Low risk Pain outcomes reported for all participants.
Change from baseline figures given; point
measures requested from study authors and
received
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “To ensure the double blind evalu-
ation effects, the physician applying mag-
netic stimulation was different from the
one collecting the clinical data, who in turn
was not aware of themodality of rTMS that
had been used in each session.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment
“sub optimal”. Coil angled away from scalp
and not in contact in sham condition.Does
not control for sensory characteristics of ac-
tive stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Comment: a 2-week wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk < 2 weeks follow-up
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André-Obadia 2008
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: France
Setting: laboratory-based
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 30
Age: 31 to 72, mean 55 (SD 10.5)
Duration of symptoms: mean 5 years (SD 3.9)
Gender distribution: 23 M, 7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 20Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 2: frequency 20 Hz, coil orientation lateromedial; no. of trains 20; duration
of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 3: sham - same as for active conditions with coil angled away perpendicular
to scalp
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 1 for each condition
Outcomes Primary: 0 to 10 NRS (anchors “no pain” to “unbearable pain”)
When taken: daily for 2 weeks post-stimulation
Secondary: none
Notes Data requested from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the order of sessions was ran-
domised (by computerized random-num-
ber generation)”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2 participants apparently lost to
follow-up and not obviously accounted for
in the analysis. However, this is less than
10% and is unlikely to have strongly influ-
enced the results
Selective reporting (reporting bias) Low risk Comment: medial-lateral coil orientation
condition data not presented but provided
by authors on request
Other bias Low risk Comment: no significant other bias de-
tected
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André-Obadia 2008 (Continued)
Adequate blinding of assessors? Low risk Quote: “The physician who applied the
procedure received from a research assistant
one sealed envelope containing the order of
the rTMS sessions for a given patient. The
order remained unknown to the physician
collecting clinical data.”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment -
sub-optimal. Coil angled away from scalp
and not in contact in sham condition.Does
not control for sensory characteristics of ac-
tive stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Comment: a 2-week wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment:≥ 2weeks but < 8weeks follow-
up
André-Obadia 2011
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory-based
Condition: chronic neuropathic pain (mixed)
Prior management details: resistant to conventional pharmacological treatment
n = 45
Age: 31 to 72 (mean 55)
Duration of symptoms: “chronic”
Gender distribution: 28 M, 17 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20 Hz; coil orientation not specified, no. of trains
20; duration of trains 4 sec; ITI 84 sec; total no. pulses 1600
Stimulation location: M1 hand area
Number of treatments: 1 per group
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = unbearable pain
When taken: daily for 2 weeks following each stimulation
Secondary: none relevant
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André-Obadia 2011 (Continued)
Notes Adverse events: not reported
Funding source: charity-funded
Conflict of interest: declaration - no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not
specified but less likely to introduce bias in a
cross-over design
Quote: “separated into 2 groups determined
by the randomization”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no mention of drop-out/with-
drawal
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported for all
groups and further data made available upon
request to authors
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Unclear risk Comment: no mention of blinded assessors
Adequate blinding of participants? Unclear risk Comment: the authors state “Because the first
step of the procedure (motor hotspot and mo-
tor threshold determination)that induced mo-
tor contractions was identical in placebo and
active sessions and the stimulation differed
only when intensities below motor threshold
were applied, no patient perceived any differ-
ence between the 2 types of rTMS”
However, the sensation on the scalp may dif-
fer and no formal evaluation of blinding pre-
sented
Free from carry-over effects? Low risk Comment: 2-week wash-out period observed
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-
up
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Antal 2010
Methods Cross-over randomised controlled trial
Participants Country of study: Germany
Setting: laboratory setting
Condition: mixed chronic pain, neuropathic and non-neuropathic
Prior management details: therapy-resistant
n = 23, 10 in parallel (6 active, 4 sham), 13 crossed over
Age: active only group 28 to 70, sham only group 50 to 70, cross-over group 41 to 70
Duration of symptoms: chronic 1.5 to 25 years (mean 7.4)
Gender distribution: 6 M, 17 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: anode - left M1 hand area, cathode right supraorbital
Number of treatments: x 5, daily
Control type: sham tDCS
Outcomes Primary: pain VAS 0 to 10; VAS anchors 0 = no pain, 10 = the worst pain possible
When taken: x 3, daily - averaged for daily pain
Secondary: none relevant
Notes Funding: government funding
Conflicts of interest: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomization was performed using
the order of entrance into the study.”
Comment: may not be truly random from
description
Allocation concealment (selection bias) Unclear risk Comment: not mentioned though unlikely
given the randomisation technique. This is a
potentially significant source of bias given that
only the parallel results were used in this re-
view due to high levels of attrition after the
first phase
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: the high level of drop-out renders
the cross-over results at high risk of bias. This
is less of an issue where only the parallel results
from the first phase are used - first-phase data
only used in the analysis
Selective reporting (reporting bias) Low risk Comment: while not all outcomes at all time
points were included in the study report the
authors have provided all requested data
44Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Antal 2010 (Continued)
Other bias Low risk Comment: no other sources of bias detected
Adequate blinding of assessors? Low risk Comment: 1 mA intensity and operator
blinded
Quote: “The stimulators were coded using a
five letter code, programmed by one of the
department members who otherwise did not
participate in the study. Therefore neither the
investigator not the patient knew the type of
the stimulation”
Adequate blinding of participants? Low risk Comment: see above
Free from carry-over effects? Low risk Comment: patients were excluded if pain had
not returned to normal. This, however, repre-
sents a threat with regard to attrition bias
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-
up
Avery 2013
Methods Parallel RCT
Participants Country of study: USA
Setting: unclear
Condition: chronic widespread pain
Prior management details: not reported
n = 19
Age mean (SD): active 54.86 (7.65), sham 51.09 (10.02)
Duration of symptoms (months mean (SD)): 15.64 (6.93)
Gender distribution: all female
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 120% RMT;
no. of trains 75; duration of trains 4 sec; ITI 26 sec; total no. pulses 3000
Stimulation location: left DLPFC
Number of treatments: 15 sessions over 4 weeks
Control type: sham coil - controls for visual, auditory and scalp sensory cues
Outcomes Primary: pain NRS 0 to 10 anchors not reported
When taken: end of treatment period, 1 month following and 3 months following
Secondary: pain interference BPI
Adverse events: multiple minor; no clear difference in incidence between active and sham
stimulation
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Avery 2013 (Continued)
Notes Government-funded study, manufacturer loaned stimulator
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “At the completion of the baseline assessment, patients
were randomly assigned to either real TMS or sham stimula-
tion using a computerized randomization program that uses an
adaptive randomization and stratification strategy.”
Allocation concealment (selection bias) Low risk Quote: “Based on the randomization, a ”smart card“ which de-
termined whether the real TMS or sham coil would be admin-
istered was assigned to a particular patient. The card had only
a code number that did not reveal the randomization.” “The
research coordinator blind to the randomization repeated the
baseline assessments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “To examine differences in changes in outcomes over
time between TMS and comparison group subjects, we esti-
mated random coefficient models following the intent-to-treat
principle.”
“11 were randomized to the sham group and 8 were random-
ized to the TMS group. However, one subject randomized to
the TMS had a baseline BIRS score of 4 which was well below
the BIRS score of 8 required for randomization. Because of this
incorrect randomization, this subject was excluded from the ef-
ficacy analyses, but was included in the analysis of side effects.
The clinical characteristics of those correctly randomized are in
Table 1. One subject in the TMS dropped out after the 10th
session because of lack of response and is included in the analy-
ses.”
Comment: of 2 drop-outs from the TMS group, 1 was excluded
(reasons given)
Selective reporting (reporting bias) Low risk Comment: all outcomes presented in full in study report
Other bias Low risk No other bias detected
Adequate blinding of assessors? Low risk Quote: “The research coordinator blind to the randomization
repeated the baseline assessments of pain, functional status, de-
pression, fatigue, and sleep before the 1st and after the 5th, the
10th, and the 15th TMS sessions as well as 1 week, 1 month,
and 3 months after the last TMS treatment except for the SF-
36, neuropsychological tests, audiometry and the dolorimetry
which were only done at baseline and one week after the 15th
TMS session.”
Comment: while TMS physicians guessed beyond chance the
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Avery 2013 (Continued)
raters were separate from this process
Adequate blinding of participants? Low risk Quote: “... sham stimulation with the electromagnet blocked
within the coil by a piece of metal so the cortex was not stim-
ulated. The coils appeared identical. Electrodes were attached
to the left side of the forehead for each subject for each ses-
sion. Those receiving the sham stimulation received an electrical
stimulus to the forehead during the sham stimulation. Those
receiving the real TMS received no electrical stimulation to the
electrodes. Both groups experienced a sensation in the area of the
left forehead. In addition, all subjects were given special earplugs
and received an audible noise during the stimulation to mask
any possible sound differences between the TMS and sham con-
ditions.”
Comment: optimal sham - controls for visual, sensory and au-
ditory cues. Formal testing - blinding appears robust
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: > 8 weeks follow-up
Boggio 2009
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management
n = 8
Age: 40 to 82; mean 63.3 (SD 5.6)
Duration of symptoms: 1 to 20 years; mean 8.3 (SD 5.6)
Gender distribution: 2 M, 6 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 30 minutes
Condition 1: active tDCS/active TENS
Condition 2: active tDCS/sham TENS
Condition 3: sham tDCS/sham TENS
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 1 for each condition
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: VAS 0 to 10 anchors “no pain” to “worst possible pain”
When taken: pre and post each stimulation
Secondary: none
Notes
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Boggio 2009 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “All the patients received the 3
treatments.... in a randomised order (we
used a computer generated randomisation
list with the order of entrance).”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 2 participants lost to follow-up.
It is unclear how these data were accounted
for as there are no missing data apparent in
the results tables. However, this may have
an impact given the small sample size
Selective reporting (reporting bias) Low risk Comment: primary outcome data pre-
sented clearly and in full
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Quote: “All evaluations were carried out by
a blinded rater”
Comment: there is evidence that assessor
blinding of tDCS may be inadequate at 2
mA intensity (see Assessment of risk of bias
in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that partici-
pant blinding of tDCS may be inadequate
at 2 mA intensity (see Assessment of risk of
bias in included studies)
Free from carry-over effects? Low risk Comment: a 48-hour wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
Quote: “To analyze whether there was a
carryover effect, we initially performed and
showed that the baselines for the 3 condi-
tions were not significantly different (P =
0.51). We also included the variable order
in our model and this model also showed
that order is not a significant term (P = 0.
7).”
Study Size High risk Comment: < 50 participants per treatment
arm
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Boggio 2009 (Continued)
Study duration High risk Comment: < 2 weeks follow-up
Borckardt 2009
Methods Cross-over randomised controlled trial; 2 conditions
Participants Country of study: USA
Setting: laboratory
Condition: peripheral neuropathic pain
Prior management details: not specified
n = 4
Age: 33 to 58; mean 46 (SD 11)
Duration of symptoms: 5 to 12 years; mean 10.25 (SD 3.5)
Gender distribution: 1 M, 3 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 100% RMT;
no. of trains 40; duration of trains 10 sec; ITI 20 sec; total no. pulses 4000
Stimulation location: L pre-frontal cortex
Number of treatments: 3 over a 5-day period
Control type: neuronetics sham coil (looks and sounds identical)
Outcomes Primary: average daily pain 0 to 10 Likert scale, anchors “no pain at all” to “worst pain
imaginable”
When taken: post-stimulation for each condition (unclear how many days post) and
daily for 3 weeks post-stimulation
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The order (real first or sham first)
was randomised”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out
Selective reporting (reporting bias) Low risk Comment: all results reported clearly and
in full
Other bias Low risk Comment: no significant other bias de-
tected
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Borckardt 2009 (Continued)
Adequate blinding of assessors? Unclear risk Comment: not specified
Adequate blinding of participants? Unclear risk Quote: “Twoof the four participants (50%)
correctly guessed which treatment periods
were real and sham, which is equal to
chance. All four of the participants ini-
tially said that they did not know which
was which, and it was not until they were
pushed to ”make a guess“ that they were
able to offer an opinion about which ses-
sions were real and which were sham.”
Comments: sham credibility assessment -
sub-optimal. Sham coil controls for au-
ditory cues and is visually indistinguish-
able from active stimulation but does not
control for sensory characteristics of active
stimulation
Free from carry-over effects? Low risk Comment: a 3-week wash-out period was
observed. Presented average pain values are
very similar pre- each condition
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment:≥ 2weeks but < 8weeks follow-
up
Capel 2003
Methods Partial cross-over randomised controlled trial. NB: only first-phase results were consid-
ered therefore the trial was considered as having a parallel design
Participants Country of study: UK
Setting: residential educational centre
Condition: post-SCI pain (unclear whether this is neuropathic or otherwise)
Prior management details: unclear
n = 30
Age: unclear
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters: frequency 10Hz; pulse width 2msec; intensity 1 2µA; duration
53 min
Stimulation location: ear clip electrodes
Number of treatments: x 2, daily for 4 days
Control type: sham CES unit indistinguishable from active unit
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Capel 2003 (Continued)
Outcomes Primary: 0 to 10 VAS “level of pain”, anchors not specified
When taken: daily during the treatment period
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method equivalent to picking
out of a hat
Quote: “Subjects would be randomly as-
signed into two groups according to their
choice of treatment device... The devices
were numbered for identification, but nei-
ther the administrators nor the recipients
of the treatment could distinguish between
the devices.”
Allocation concealment (selection bias) Low risk Comment: this is achieved through the
method of randomisation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 3 subjects withdrew (not vol-
untarily) and while the data are not clearly
accounted for in the data analysis this con-
stitutes 10% of the overall cohort and is
unlikely to have strongly influenced the re-
sults
Quote: “Three of the 30 subjects included
were withdrawn from the study after com-
mencement, one of whom developed an
upper respiratory infection, and two oth-
ers were withdrawn from the study be-
cause their medication (either H2 antago-
nist anti-ulcer or steroidal inhalant) were
interacting with the TCET treatment.”
Selective reporting (reporting bias) High risk Comment: pain score values are not pro-
vided for any time point
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
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Capel 2003 (Continued)
Adequate blinding of participants? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Carretero 2009
Methods Parallel randomised clinical trial
Participants Country of study: Spain
Setting: outpatient clinic
Condition: fibromyalgia (with major depression)
Prior management details: unclear
n = 26
Age: active group 47.5 (SD 5.7), sham group 54.9 (SD 4.9)
Duration of symptoms: unclear “chronic”
Gender distribution: 2 M, 24 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 1 Hz; coil orientation not specified; 110% RMT; no.
of trains 20; duration of trains 60 sec; ITI 45 sec; no. of pulses 1200
Stimulation location: R dorsolateral prefrontal cortex
Number of treatments: up to 20 on consecutive working days
Control type: coil angled 45º from the scalp
Outcomes Primary: Likert pain scale 0 to 10, anchors “no pain” to “extreme pain”
When taken: 2 weeks, 4 weeks and 8 weeks from commencement of study
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant in each group did not
complete the study. Unlikely to have strongly influ-
enced the findings
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Carretero 2009 (Continued)
Selective reporting (reporting bias) Low risk Comment: outcomes presented clearly and in full
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: patients and raters (but not the treating physi-
cian) were blind to the procedure
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-opti-
mal. Coil angled 45º away from scalp. Does not con-
trol for sensory characteristics of active stimulation
and is visually distinguishable
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Cork 2004
Methods Cross-over randomised controlled trial (to be considered as parallel - first treatment phase
only as 2nd unblinded)
Participants Country of study: USA
Setting: pain clinic
Condition: fibromyalgia
Prior management details: unclear
n = 74
Age: 22 to 75; mean 53
Duration of symptoms: 1 to 21 years; mean 7.3
Gender distribution: 4 M, 70 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width unclear; intensity 100 µA; wave-
form shape modified square wave biphasic 50% duty cycle; duration 60 min
Stimulation location: ear clip electrodes
Number of treatments: ? daily for 3 weeks
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: 0 to 5 numerical pain intensity scale, anchors “no pain” to “worst pain imag-
inable”
When taken: immediately following the 3-week treatment period
Secondary: Oswestry Disability Index
When taken: immediately following the 3-week treatment period
Notes Adverse events: not reported
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not
specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not
specified
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: drop-out rate not reported
Selective reporting (reporting bias) High risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Adequate blinding of participants? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Study Size High risk Comment: < 50 participants per treatment
arm (considered as a parallel trial - 1st phase
only)
Study duration High risk Comment: < 2 weeks follow-up
Defrin 2007
Methods Parallel randomised controlled trial
Participants Country of study: Israel
Setting: outpatient department
Condition: post-SCI central neuropathic pain
Prior management details: refractory to drug, physical therapy and complementary ther-
apy management
n = 12
Age: 44 to 60; mean 54 (SD 6)
Duration of symptoms: > 12 months
Gender distribution: 7 M, 4 F
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Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 115% RMT; no.
of trains 500; duration of trains 10 sec; ITI 30 sec; total no. pulses 500 reported, likely
to have been 25,000 judging by these parameters
Stimulation location: motor cortex - midline
Number of treatments: x 10, x 1 daily on consecutive days
Control type: sham coil - visually the same and makes similar background noise
Outcomes Primary: 15 cm 0 to 10 VAS pain intensity, anchors “no pain sensation” to “most intense
pain sensation”
When taken: pre and post each stimulation session
Secondary: McGill pain questionnaire
When taken: 2- and 6-week follow-up period
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not speci-
fied
Quote: “Patients were randomised into 2 groups
that received either real or sham rTMS”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only one participant withdrew for “lo-
gistic reasons”. Unlikely to have strongly influ-
enced the findings
Selective reporting (reporting bias) Low risk Comment: while group means/SD are not pre-
sented in the study report, the study authors have
provided the requested data
Other bias Unclear risk Comment: baseline differences observed in pain
intensity levels (higher in active group)
Adequate blinding of assessors? Low risk Quote: “The patients as well as the person con-
ducting the outcome measurements were blind to
the type of treatment received.”
Adequate blinding of participants? Unclear risk Quote: “Two coils were used; real and sham, both
of which were identical in shape and produced a
similar background noise.”
Comment: sham credibility assessment - sub-op-
timal. Sham coil controls for auditory cues and is
visually indistinguishable from active stimulation,
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but does not control for sensory characteristics of
active stimulation over the scalp. Given that stim-
ulation was delivered at 110% RMT active stim-
ulation, but not sham, it is likely to have elicited
muscle twitches in peripheral muscles
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Fenton 2009
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: unclear
Condition: chronic pelvic pain
Prior management details: refractory to treatment
n = 7
Age: mean 38
Duration of symptoms: mean 80 months
Gender distribution: all F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: M1 dominant hemisphere
Number of treatments: 2
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: VAS overall pain, pelvic pain, back pain, migraine pain, bladder pain, bowel
pain, abdomen pain and pain with intercourse Anchors not specified
When taken: daily during stimulation and then for 2 weeks post each condition
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out reported
Selective reporting (reporting bias) Low risk Comment: variance measures not presented
for group means post-stimulation but data
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provided by author on request
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “All other personnel in the study, in-
cluding the investigators, study coordinators,
participants, and their families, and all primary
medical caregivers, were blinded.”
Adequate blinding of participants? Low risk Quote: “All other personnel in the study, in-
cluding the investigators, study coordinators,
participants, and their families, and all primary
medical caregivers, were blinded.”
Free from carry-over effects? Unclear risk Comments: pre-stimulation data are not pre-
sented and no formal investigation for carry-
over effects is discussed
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment: < 2 weeks follow-up
Fregni 2005
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: laboratory
Condition: chronic pancreatitis pain
Prior management details: not specified
n = 5
Age: 44 (SD 11)
Duration of symptoms: not specified, “chronic”
Gender distribution: not specified
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 1 Hz; coil orientation not specified; 90% RMT; no.
of trains not specified; duration of trains not specified; ITI not specified; total no. pulses
1600
Stimulation location: left and right secondary somatosensory area (SII)
Number of treatments: 1 for each condition
Control type: sham, “specially designed sham coil”. No further details
Outcomes Primary: pain VAS, anchors not specified
When taken: after each stimulation session
Secondary: none
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The order of stimulation was ran-
domised and counterbalanced across patients
using a Latin square design.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out reported
Selective reporting (reporting bias) High risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time point for the sham condition
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “Patients were blinded to treatment
condition, and a blinded rater evaluated anal-
gesic use, patient’s responses in a Visual Ana-
logue Scale (VAS) of pain.... immediately after
each session of rTMS.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment “un-
clear”. Type of sham coil not specified
Free from carry-over effects? Low risk Quote: “Importantly, baseline pain scoreswere
not significantly different across the six condi-
tions of stimulation... speaking against carry-
over effect.”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Fregni 2006a
Methods Parallel randomised controlled trial
Participants Country of study: Brazil
Setting: laboratory
Condition: post-SCI central neuropathic pain
Prior management details: refractory to drug management
n = 17
Age: mean 35.7 (SD 13.3)
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Fregni 2006a (Continued)
Duration of symptoms: chronic > 3/12
Gender distribution: 14 M, 3 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: motor cortex (contralateral tomost painful side or dominant hand)
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS 0 to 10 cm, anchors “no pain” to “worst pain possible”
When taken: before and after each stimulation and at 16-day follow-up
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the
order of entrance in the study and a previous
randomisation list generated by a computer us-
ing random blocks of six (for each six patients,
two were randomised to sham and four to active
tDCS) in order to minimize the risk of unbal-
anced group sizes.”
Allocation concealment (selection bias) Low risk Comment: the use of a pre-generated randomisa-
tion list should ensure this
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “... we analyzed the primary and secondary
endpoints using the intention-to-treat method in-
cluding patients who received at least one dose
of the randomised treatment and had at least one
post-baseline efficacy evaluation. We used the last
evaluation carried out to the session before the
missed session, assuming no further improvement
after the dropout, for this calculation.”
Selective reporting (reporting bias) Unclear risk Comment: pain score numerical values are not
provided clearly in the study report with measures
of variance for any time point. On request data
were available for the primary outcome at one
follow-uppoint but not for other follow-up points
Other bias Low risk Comment: no significant other bias detected
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Fregni 2006a (Continued)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding
of tDCSmay be inadequate at 2mA intensity (see
Assessment of risk of bias in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant
blinding of tDCS may be inadequate at 2 mA in-
tensity (see Assessment of risk of bias in included
studies)
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Fregni 2006b
Methods Parallel randomised controlled trial; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 32
Age: 53.4 (SD 8.9)
Duration of symptoms: condition 1: 8.4 (SD 9.3) years; condition 2: 10.0 (SD 7.8)
years; condition 3: 8.1 (SD 7.5) years
Gender distribution: 0 M, 32 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: condition 1: dorsolateral prefrontal cortex; condition 2: motor
cortex; condition 3: shammotor cortex. All conditions contralateral to most painful side
or dominant hand
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS 0 to 10 cm, anchors not specified
When taken: at the end of the stimulation period and at 21-day follow-up
Secondary: quality of life: Fibromyalgia Impact Questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomizationwas performedus-
ing the order of entry into the study and
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Fregni 2006b (Continued)
a previous computer-generated randomisa-
tion list, using random blocks of 6 patients
(for each 6 patients, 2 were randomised to
each group) in order to minimize the risk
of unbalanced group sizes.”
Allocation concealment (selection bias) Low risk Comment: the use of a pre-generated ran-
domisation list should have adequately en-
sured this
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “One patient (in the M1 group)
withdrew, and the few missing data were
considered to be missing at random. We
analyzed data using the intent-to-treat
method and the conservative last observa-
tion carried forward approach.”
Selective reporting (reporting bias) Unclear risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for most time points in the study re-
port. On request data were available for the
primary outcome at 1 follow-up point but
not for other follow-up points
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor
blinding of tDCS may be inadequate at 2
mA intensity (see Assessment of risk of bias
in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that partici-
pant blinding of tDCS may be inadequate
at 2 mA intensity (see Assessment of risk of
bias in included studies)
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment:≥ 2weeks but < 8weeks follow-
up
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Fregni 2011
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: chronic visceral pain (chronic pancreatitis)
Prior management details: most on continuous opioid therapy,most had received surgery
for their pain
n = 17, 9 in active group, 8 in sham group
Age mean (SD): active group 41.11 (11.27), sham group 46.71 (13.03)
Duration of symptoms: > 2 years
Gender distribution: 14 F, 3 M
Interventions Stimulation type: rTMS
Stimulation parameters:frequency 1 Hz; coil orientation not specified, no. of trains 1;
duration of trains not specified; intensity 70% maximum stimulator output, total no.
pulses 1600
Stimulation location: SII
Number of treatments: 10, x 1 daily (weekdays only)
Control type: sham rTMS coil
Outcomes Primary: pain VAS; 0 = no pain, 10 = most intense pain imaginable
When taken: daily pain logs for 3 weeks pre-intervention, daily post-stimulation during
intervention period and at 3-week follow-up
Secondary: none relevant
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised (using a computer generated
list with blocks of 4)”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: drop-out/withdrawal not reported
Selective reporting (reporting bias) High risk Comment: reporting of pain scores is incomplete across all time
points
Other bias Unclear risk Comment: baseline values not presented by group for key out-
come variables
Adequate blinding of assessors? Low risk Quote: “The pain evaluation was carried out by a blinded asses-
sor”
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Adequate blinding of participants? Low risk Quote “The sham and real TMS coils looked identical and were
matched for weight and acoustic artefact. This sham coil induces
a similar tapping sensation and generates the same clicking noise
as the real TMS coil, but without induction of a significant
magnetic field and secondary current.”
Comment: sham appears optimal
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Gabis 2003
Methods Parallel randomised controlled trial
Participants Country of study: USA
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 20
Age: 20 to 77
Duration of symptoms: 0.5 to 40 years
Gender distribution: 9 M, 11 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 msec; intensity ≤ 4 mA;
waveform shape biphasic asymmetric; duration 30 min
Stimulation location: 3 electrodes, 1 attached to either mastoid process and 1 to the
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: “active placebo” units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list.”
63Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gabis 2003 (Continued)
Allocation concealment (selection bias) Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list.
At enrolment in the study, the investigator as-
signed the next random number in that patient’s
category. The investigator did not have access to
the randomisation list until after the study was
completed.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all participants completed the study
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
most time points in the study report the study
authors have provided the requested data
Other bias Unclear risk Comment: an active placebo that delivers current
may not be inert and may bias against between
group differences (0.75 mA exceeds the intensity
of the active arms of other CES trials)
Adequate blinding of assessors? Low risk Quote: “The active placebo device was indistin-
guishable to the patient and medical team.”
Adequate blinding of participants? Low risk Quote: “The active placebo device was indistin-
guishable to the patient and medical team from
the real TCES device - it was designed to give the
patient the feeling of being treated, inducing an
individual sensation of skin numbness or muscle
contraction”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Gabis 2009
Methods Parallel randomised controlled trial
Participants Country of study: Israel
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 75 (excluding headache participants)
Age: mean 53.9, range 22 to 82
Duration of symptoms: 0.5 to 40 years
Gender distribution: 35 M, 40 F
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Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 msec; intensity ≤ 4 mA;
waveform shape biphasic asymmetric; duration 30 min
Stimulation location: 3 electrodes, 1 attached to either mastoid process and 1 to the
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: “active placebo” units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation; 3 weeks and 3 months following treatment
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list”
Allocation concealment (selection bias) Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list.
At enrolment, the investigator assigned the next
random number in that patient’s category. The
investigator did not have access to the randomi-
sation list until study completion.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is indicated, comparing
the results with the number enrolled
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes are re-
ported clearly and in full
Other bias Unclear risk Comment: an active placebo that delivers current
may not be inert and may bias against between
group differences (0.75 mA exceeds the intensity
of the active arms of other CES trials)
Adequate blinding of assessors? Low risk Quote: “The investigator did not have access to
the randomisation list until study completion”
Adequate blinding of participants? Low risk Quote: “The placebo device was indistinguishable
from the active device”
Study Size High risk Comment: < 50 participants per treatment arm
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Study duration Low risk Comment: > 8 weeks follow-up
Hargrove 2012
Methods Parallel RCT
Participants Country of study: USA
Setting: “professional clinical setting”
Condition: fibromyalgia
Prior management details: no recent remission of symptoms
n = 91
Age: active group 48 to 54.7, sham group 51 to 57
Duration of symptoms: active group mean 17.12 years, sham group mean 17.5 years
Gender distribution: reported for completers only 71 F, 6 M
Interventions Stimulation type: RINCE (reduced impedance non-invasive cortical electrostimulation)
Stimulation parameters: current density 0.3 mA/cm2, stimulation duration 11 minutes,
frequency 10 kHz carrier signal delivered at 40Hz
Stimulation location: parietal region (international 10/20 site PZ), ground leads fixed to
earlobes
Number of treatments: x 2 weekly for 11 weeks
Control type: non-activated identical stimulation unit
Outcomes Primary: FIQ pain VAS; 0 = no pain, 10 = unbearable pain
When taken: end of treatment period
Secondary: total FIQ score
Notes Lead author declares an intellectual property interest in the technology and is a share-
holder in a company seeking to develop the technology for commercialisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: per protocol analysis used, drop-out rate 6/45 (13%)
in active group and 8/46 (17%) in sham group
Selective reporting (reporting bias) Low risk Comment: data reported on all outcomes and supplementary
data made available by the study author
Other bias Low risk Comment: no other biases detected
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Adequate blinding of assessors? Low risk Quote: “The investigators were blinded to the settings, and no
element of hardware or software gave any indication as to which
setting had been assigned to the subject.”
Adequate blinding of participants? Low risk Quote: “The combined involvement of low driving potentials
and high carrier frequencies creates a signal that is subthreshold
for perceptibility.....Subjects could not feel the signal regardless
of group, and therefore could not tell if they were receiving
treatment or not”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Hirayama 2006
Methods Cross-over randomised controlled trial; 5 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: intractable deafferentation pain (mixed central, peripheral and facial)
Prior management details: intractable
n = 20
Age: 28 to 72 years
Duration of symptoms: 1.5 to 24.3 years, mean 6.4 (SD 6)
Gender distribution: 13 M, 7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 90% RMT; no.
of trains 10; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Stimulation location: condition 1: motor cortex; condition 2: primary sensory cortex;
condition 3: pre-motor area; condition 4: supplementary motor area; condition 5: sham
Number of treatments: 1 for each condition
Control type: coil angled 45º from scalp with synchronised electrical scalp stimulations
to mask sensation
Outcomes Primary: pain intensity VAS, anchors not specified
When taken: 0, 30, 60, 90, 180 minutes post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Quote: “All targets were stimulated in ran-
dom order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All 20 patients underwent all
planned sessions of navigation- guided
rTMS”
Selective reporting (reporting bias) Low risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point but data provided
upon request
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not re-
ported
Adequate blinding of participants? Unclear risk Quote: “The patientswere unable to distin-
guish sham stimulation from actual rTMS,
because the synchronized electrical stim-
ulation applied to the forehead made the
forehead spasm, as was the case with actual
TMS”
Comment: sham credibility assessment -
sub-optimal. Sensory and auditory aspects
are controlled for but angulation of coil
away from the scalp may be visually distin-
guishable
Free from carry-over effects? Low risk Comment: authors provided requested
data. Appears free of carry-over effects
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
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Hosomi 2013
Methods Cross-over RCT
Participants Country of study: Japan
Setting: multicentre, laboratory-based
Condition: mixed neuropathic pain
Prior management details: pain persisted despite “adequate treatments”
n = 70 of which 64 analysed
Age mean (SD): 60.7 (10.6)
Duration of symptoms: 58.2 (10.6)
Gender distribution: 40 M, 24 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 5 Hz; coil orientation para-sagittal, no. of trains 10;
duration of trains 10 sec; ITI 50 sec, intensity 90% RMT, total no. pulses per session
500
Stimulation location: M1 corresponding to painful region
Number of treatments: 10, x 1 daily (consecutive working days)
Control type: sham coil
Outcomes Current daily pain 0 to 100 VAS (anchors not reported), SF McGill
Adverse events
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Before the patient enrolment, the independent data
center developed a randomization program to assign each pa-
tient to one of 2 treatment groups (1:1). A real rTMS period
was followed by a sham period in group A, and a real rTMS
period came after a sham period in group B. We used Pocock
and Simon’s minimization method to stratify treatment groups
according to institution, age (< 60 or P60 years), sex, and under-
lying disease (a cerebral lesion or not), and the Mersenne twister
for random number generation.”
Allocation concealment (selection bias) Low risk Quote: “After confirmation of patient eligibility, the data center
received a registration form from an assessor who collected ques-
tionnaires and assessed adverse events, and then sent an assign-
ment notice to an investigator who conducted the rTMS inter-
vention. Patientswere identified by sequential numbers thatwere
assigned by the data center. Patients and assessors were blind to
group assignment until the study was completed. The data cen-
ter was responsible for assigning patients to a treatment group,
data management, central monitoring, and statistical analyses.”
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: drop-out low (total 6 from recruited 70 participants)
Quote: “Seventy patients were enrolled and randomly assigned
to 2 groups. Of these patients, one patient never
came to the hospital after the registration, and a suicidal wish
became apparent before the start of the intervention in another
patient. Sixty-eight patients received the interventions and 64
patients were included in the intention-to-treat analysis after
excluding 4 patients without any data collection.”
Selective reporting (reporting bias) Low risk Comment: while full numerical means and SDs are not reported
for all time points all data were made available upon request to
the study authors
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Low risk Quote: “Patients and assessors were blind to group assignment
until the study was completed.”
Adequate blinding of participants? Low risk Quote: “Realistic sham stimulation [32] was implemented in
this study. Ten trains of electrical stimuli at 2 times the intensity
of the sensory threshold (one train, 50 stimuli at 5 Hz; inter
train interval, 50 s) were delivered with a conventional electrical
stimulator through the electrodes fixed on the head. The cortical
effect of the cutaneous electrical stimulationwas considered to be
negligible at this intensity because of the high electrical resistance
of the skull and brief duration of the stimulation [32]. A figure-8
coil, which did not connect to a magnetic stimulator, was placed
on the head in the same manner as a real rTMS session. Another
coil, which discharged simultaneously with the electrical stimuli,
was placed near the unconnected coil to produce the same sound
as real rTMS, but not to stimulate the brain.”
Comment: sham controls for sensory auditory and visual cues
Free from carry-over effects? Low risk Quote: “To evaluate carry-over effects, Grizzle’s test for carry-
over effect was applied to the values at day 0 for each period ...
Grizzle’s test showed no carry-over effects in VAS and SF-MPQ”
Study Size Unclear risk Comment: > 50 but < 200 participants per treatment condition
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
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Irlbacher 2006
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: Germany
Setting: laboratory
Condition: phantom limb pain (PLP) and central neuropathic pain (CNP)
Prior management details: unclear
n = 27
Age: (median) PLP 46.6, CNP 51.1
Duration of symptoms: mean PLP 15.2 (SD 14.8), CNP 3.9 (SD 4.1)
Gender distribution: 16 M, 11 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 1 Hz; coil orientation not specified; 95% RMT; no. of trains
not specified; duration of trains not specified; ITI not specified; total no. pulses 500
Condition 2: frequency 5 Hz; coil orientation not specified; 95% RMT; no. of trains
not specified; duration of trains not specified; ITI not specified; total no. pulses 500
Condition 3: sham frequency 2 Hz; coil orientation not specified; no. of trains not
specified; duration of trains not specified; ITI not specified; total no. pulses 500
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil; mimics sight and sound of active treatment
Outcomes Primary: 0 to 100 mm VAS pain intensity, anchors “no pain” and “most intense pain
imaginable”
When taken: pre- and post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 13 of 27 participants did not
complete all treatment conditions and this
drop-out is not clearly accounted for in the
analysis
Selective reporting (reporting bias) Low risk Comment: primary outcome data pre-
sented clearly and in full
Other bias Low risk Comment: no significant other bias de-
tected
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Irlbacher 2006 (Continued)
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Sham credibility assessment - sub-optimal.
Sham coil controls for auditory cues and is
visually indistinguishable from active stim-
ulation but does not control for sensory
characteristics of active stimulation
Free from carry-over effects? Low risk Quote: “The VAS values before the stimu-
lation showed no significant differences in
the various types of treatment”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Jensen 2013
Methods Cross-over RCT
Participants Country of study: USA
Setting: laboratory
Condition: post-spinal cord injury pain (neuropathic and non-neuropathic)
Prior management details: not reported
n = 31 randomised
Age: 22 to 77
Duration of symptoms (months): > 6 months
Gender distribution: 22 M, 8 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: M1 contralateral to painful side or on left where pain bilateral
Number of treatments: 1
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: 0 to 10 NRS; 0 = no pain, 10 = most intense pain sensation imaginable. An
average of current, least, worst and average pain scores
When taken: post-stimulation
Secondary: none relevant
Notes Adverse events not reported
Government-funded
Risk of bias
Bias Authors’ judgement Support for judgement
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Jensen 2013 (Continued)
Random sequence generation (selection
bias)
Low risk Quote “The remaining 31 individuals were randomly assigned
to receive the five procedure conditions in one of five orders,
using a Latin square design.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: of 31 randomised there are data from 28 following
active tDCS and 27 following sham
Selective reporting (reporting bias) Low risk Comment: outcomes adequately reported
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Free from carry-over effects? Low risk Comment: baseline pain levels pre active and sham tDCS session
appear equivalent
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Kang 2009
Methods Cross-over randomised controlled trial
Participants Country of study: South Korea
Setting: university hospital outpatient setting
Condition: post-SCI central neuropathic pain
Prior management details: resistant to drug, physical or complementary therapies
n = 11
Age: 33 to 75, mean 54.8
Duration of symptoms: chronic
Gender distribution: 6 M, 5 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation angled 45º posterolaterally;
80% RMT; no. of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: R motor cortex, hand area
Number of treatments: 5, x 1 daily
Control type: coil elevated and angled away from the scalp
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Kang 2009 (Continued)
Outcomes Primary: NRS average pain over last 24 hours, anchors “no pain sensation” to “most
intense pain sensation imaginable”
When taken: immediately after the 3rd and 5th treatments and 1, 3, 5 and 7 weeks after
the end of the stimulation period
Secondary: BPI - pain interference (surrogate measure of disability)
When taken: as for the NRS
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The real and sham rTMS stimula-
tions were separated by 12 weeks and per-
formed in a random order according to the
prepared allocation code.”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no participants withdrew after re-
ceiving the first treatment condition
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes are
reported clearly and in full
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “... a different researcher collected the
clinical data; the latter researcher was not
aware of the type of rTMS (real or sham)”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled away from scalp and not
in contact in shamcondition.Does not control
for sensory characteristics of active stimulation
and is visually distinguishable
Free from carry-over effects? Low risk Comment: a 12-week wash-out period was
observed. The pre-stimulation baseline scores
closely match
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-
up
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Katsnelson 2004
Methods Parallel randomised controlled trial; 3 conditions
Participants Country of study: Russia
Setting: unclear
Condition: hip and knee osteoarthritis
Prior management details: unclear
n = 64
Age: unclear
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 11
to 15 mA; waveform shape: condition 1 symmetric, condition 2 asymmetric; duration
40 min
Stimulation location: appears to be 1 electrode attached to either mastoid process and 1
to the forehead
Number of treatments: 5, x 1 daily for 5 consecutive
Control type: sham unit - visually indistinguishable from active units
Outcomes Primary: 0 to 10 NRS, anchors “no pain” to “very painful”
When taken: unclear. Likely to be pre and post each stimulation session and then daily
for 1 week after
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “If subjects passed all criteria they
were randomly assigned to one of the two
active treatments or the sham treatment.”
Comment: method of randomisation not
specified
Allocation concealment (selection bias) Unclear risk Comment: not specified
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: drop-out level not specified
Selective reporting (reporting bias) High risk Comment: it is unclear in the report which
time points are reported for primary out-
comes
Other bias High risk Comment: the reporting of baseline group
characteristics is insufficient
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Katsnelson 2004 (Continued)
Adequate blinding of assessors? Low risk Quote: “The physicians, like all other par-
ticipants in the study, were unaware of
which treatment each subject received.”
Adequate blinding of participants? Low risk Quote: “The physicians, like all other par-
ticipants in the study, were unaware of
which treatment each subject received.”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Khedr 2005
Methods Parallel randomised controlled trial
Participants Country of study: Egypt
Setting: university hospital neurology department
Condition: neuropathic pain, mixed central (post-stroke) and facial (trigeminal neural-
gia) pain
Prior management details: refractory to drug management
n = 48
Age: post-stroke 52.3 (SD 10.3), trigeminal neuralgia 51.5 (SD 10.7)
Duration of symptoms: post-stroke 39 months (SD 31), trigeminal neuralgia 18 months
(SD 17)
Gender distribution: 8 M, 16 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20 Hz; coil orientation not specified; 80% RMT; no.
of trains 10; duration of trains 10 sec; ITI 50 sec; total no. pulses 2000
Stimulation location: motor cortex contralateral to the side of worst pain
Number of treatments: 5, x 1 on consecutive days
Control type: coil elevated and angled away from scalp
Outcomes Primary: pain VAS, anchors not specified
When taken: post 1st, 4th and 5th stimulation session and 15 days after the last session
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Patients were randomly assigned to one
of the two groups, depending on the day of the
week on which they were recruited.”
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Khedr 2005 (Continued)
Comment: not truly random
Allocation concealment (selection bias) High risk Comment: the method of sequence generation
makes concealment of allocation unlikely
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is apparent from the data
presented
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
all time points in the study report, the study au-
thors have provided the requested data
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “The second author evaluated these mea-
sures blindly-that is, without knowing the type of
rTMS”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-op-
timal. Coil angled away from scalp and not in
contact in sham condition. Does not control for
sensory characteristics of active stimulation and is
visually distinguishable
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Lee 2012
Methods Parallel RCT
Participants Country of study: Korea
Setting: outpatient clinic
Condition: fibromyalgia
Prior management details: none reported
n = 22
Age mean (SD): low-frequency group 45.6 (9.6), high-frequency group 53 (4.2), sham
group 51.3 (6.2)
Duration of symptoms (months mean (SD)): low-frequency group: 47.2 (20.1), high-
frequency group 57.1 (6.4), sham group 44.7 (10.3)
Gender distribution: all female
Interventions Stimulation type: rTMS
Stimulation parameters:
Low-frequency group: frequency 1 Hz; coil orientation not specified, no. of trains 2;
duration of trains 800 sec; ITI 60 sec; total no. pulses 1600
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Lee 2012 (Continued)
High-frequency group: frequency 10 Hz; coil orientation not specified, no. of trains 25;
duration of trains 8 sec; ITI 10 sec; total no. pulses 2000
Stimulation location: right DLPFC (low-frequency), left M1 (high-frequency)
Number of treatments: 10, x 1 daily (weekdays only) for 2 weeks
Control type: sham - coil orientated away from scalp
Outcomes Primary: 0 to 100 mm pain VAS; 0 = none, 100 = an extreme amount of pain
When taken: post-treatment and at 1 month follow-up
Secondary: Fibromyalgia Impact Questionnaire
Notes Comment: no information on adverse events given relating to those participants who
did not complete all sessions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: no intention-to-treat analysis described - appears
to be per protocol. 3/8 in low-frequency group, 2/5 in high-
frequency group and 2/5 in sham group
Selective reporting (reporting bias) Low risk Comment: point measures presented in full for all outcomes
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not specified
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - sub-optimal. Coil an-
gled away from scalp. Does not control for sensory characteris-
tics of active stimulation and is visually distinguishable
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Lefaucheur 2001a
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: intractable neuropathic pain (mixed central and facial)
Prior management details: refractory to drug management
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Lefaucheur 2001a (Continued)
n = 14
Age: 34 to 80, mean 57.2
Duration of symptoms: not specified “chronic”
Gender distribution: 6 M, 8 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 80% RMT; no.
of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil used (? inert)
Outcomes Primary: 0 to 10 VAS, anchors not specified
When taken: daily for 12 days post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Two different sessions of rTMS sep-
arated by 3 weeks at least were randomly per-
formed in each patient.”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is apparent from the
data presented
Selective reporting (reporting bias) Low risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time point in the report but were provided
by authors on request
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. This study uses the same sham coil as
that used in Lefaucheur 2004, which in that
paper is stated as not meeting the criteria for
an ideal sham
Free from carry-over effects? Low risk Comment: 3/52wash-out periodmakes carry-
over effects unlikely
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Lefaucheur 2001a (Continued)
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Lefaucheur 2001b
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: refractory to drug management
n = 18
Age: 28 to 75, mean 54.7
Duration of symptoms: not specified “chronic”
Gender distribution: 11 M, 7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 80% RMT; no. of trains
20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Condition 2: frequency 0.5Hz; coil orientation posteroanterior; no. of trains 1; duration
of trains 20 minutes; total no. pulses 600
Condition 3: sham - same as for condition 1 with sham coil
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: 5 to 10 minutes post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “To study the influence of the fre-
quency of stimulation, three different sessions
of rTMS separated by three weeks at least were
randomly performed in each patient”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is apparent from the
data presented
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Lefaucheur 2001b (Continued)
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes are
reported clearly and in full
Other bias Unclear risk Comment: the results of some of the planned
data analysis (ANOVAof group differences af-
ter each condition) are not reported. However,
adequate data are available for inclusion in the
meta-analysis
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. This study uses the same sham coil as
that used in Lefaucheur 2004, which in that
paper is stated as not meeting the criteria for
an ideal sham
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and no
clear imbalance in pre-stimulation pain scores
between conditions
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Lefaucheur 2004
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management
n = 60
Age: 27 to 79, mean 54.6
Duration of symptoms: not specified “chronic”
Gender distribution: 28 M, 32 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
no. of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil
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Lefaucheur 2004 (Continued)
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: 5 minutes post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “one of the following two protocols
was applied in a random order”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is apparent from the
data presented
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes are
reported clearly and in full
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Quote: “ideal sham...which should be per-
formed by means of a coil similar to the real
one in shape, weight, and location on the
scalp, producing a similar sound and similar
scalp skin sensation, but generating no electri-
cal field within the cortex. Such a sham coil
has not yet been designed, and at present, the
sham coil used in this study is to our knowl-
edge the more valid for clinical trials.”
Comments: sham credibility assessment - sub-
optimal
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and no
clear imbalance in pre-stimulation pain scores
between conditions
Study Size Unclear risk Comment: > 50 but < 200 participants per
treatment condition
Study duration High risk Comment: < 2 weeks follow-up
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Lefaucheur 2006
Methods Cross-over randomised controlled trial, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: unilateral chronic neuropathic pain (mixed central and peripheral)
Prior management details: refractory to drug management
n = 22
Age: 28 to 75, mean 56.5 (SD 2.9)
Duration of symptoms: 2 to 18 years, mean 5.4 (SD 4.1)
Gender distribution: 12 M, 10 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 6 sec; ITI 54 sec; total no. pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; no. of trains
1; duration of trains 20 minutes; total no. pulses 1200
Condition 3: sham coil
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: pre and post-stimulation
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Three sessions of motor cortex
rTMS, separated by at least 3 weeks, were
performed in random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: level of drop-out not reported
and unclear from the data presented
Selective reporting (reporting bias) Low risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point in the study report
but were provided by the authors on re-
quest
Other bias Low risk Comment: no significant other bias de-
tected
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Lefaucheur 2006 (Continued)
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is only re-
ported for measures of cortical excitability
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment -
sub-optimal. This study uses the same sham
as Lefaucheur 2004, which in that paper
is stated as not meeting the criteria for an
ideal sham
Free from carry-over effects? Low risk Quote: “Post hoc tests did not reveal any
differences between the three pre-rTMS as-
sessments regarding excitability values or
pain levels”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Lefaucheur 2008
Methods Cross-over randomised controlled trial, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management for at least 1 year
n = 46
Age: 27 to 79, mean 54.2
Duration of symptoms: chronic > 1 year
Gender distribution: 23 M, 23 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 6 sec; ITI 54 sec; total no. pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; no. of trains
1; duration of trains 20 minutes; total no. pulses 1200
Condition 3: sham coil
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS, anchors not specified
When taken: pre- and post-stimulation
Secondary: none
Notes Adverse events: not reported
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Lefaucheur 2008 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Three different sessions of rTMS.
.... were performed in a random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2 participants dropped out but
this is < 5% of the cohort. Unlikely to have
strongly influenced the findings
Selective reporting (reporting bias) Low risk Comment: results for all outcomes are re-
ported clearly and in full
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “In all cases, the examiner was
blinded to the type of rTMS administered.
”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment -
sub-optimal. This study uses the same sham
coil as that used in Lefaucheur 2004, which
in that paper is stated as not meeting the
criteria for an ideal sham
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and
no clear imbalance in pre-stimulation pain
scores between conditions
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Lichtbroun 2001
Methods Parallel randomised controlled study
Participants Country of study: USA
Setting: outpatient fibromyalgia clinic
Condition: fibromyalgia
Prior management details: unclear
n = 60
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Lichtbroun 2001 (Continued)
Age: 23 to 82, mean 50
Duration of symptoms: 1 to 40 years, mean 11
Gender distribution: 2 M, 58 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; 50% duty cycle; intensity 100 µA; waveform
shape biphasic square wave; duration 60 min
Stimulation location: ear clip electrodes
Number of treatments: 30, x 1 daily for consecutive days
Control type: sham unit - indistinguishable from active unit
Outcomes Primary: 10-point self rating pain scale, anchors not specified
When taken: post-stimulation (not precisely defined)
Secondary: quality of life - 0 to 10 VAS scale (data not reported)
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the subjects were randomly assigned
into three separate groups by an office secretary
who drew their names, which were on separate
sealed slips of paper in a container”
Allocation concealment (selection bias) Low risk Comment: probably, given the quote above
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-out levels are not specified in the report.
Intention-to-treat analysis not discussed in the
report
Selective reporting (reporting bias) High risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time points in the study report
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “All subjects, staff, the examining physi-
cian and the psychometrician remained blind to
the treatment conditions”
Adequate blinding of participants? Low risk Comment: see previous quote
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
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Mendonca 2011
Methods Parallel randomised controlled trial
Participants Country of study: Brazil/USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported
n = 30 (6 per group)
Age, mean (SD): 43.2 (9.8)
Duration of symptoms: not reported
Gender distribution: 28 F, 2 M
Interventions Stimulation type: tDCS
Stimulation parameters: simulation intensity 2 mA, 20 minutes duration
Stimulation location: Group 1 cathodal M1; Group 2 cathodal supraorbital; Group 3
anodal M1; Group 4 anodal supraorbital; Group 5 sham
Number of treatments: 1 session
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS; 0 = no pain, 10 = worst possible pain
When taken: immediately post-stimulation
Secondary: none relevant
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not speci-
fied
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-outs occurred
Selective reporting (reporting bias) High risk Nonumerical data are provided for any post-treat-
ment clinical outcome. Data not provided upon
request to authors
Other bias Low risk No other bias detected
Adequate blinding of assessors? Unclear risk Comment: 2 mA intensity used - empirical evi-
dence that assessor blinding may be sub-optimal
at this intensity
Adequate blinding of participants? Unclear risk Comment: 2 mA intensity used - empirical evi-
dence that participant blinding may be sub-opti-
mal at this intensity
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Mendonca 2011 (Continued)
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Mhalla 2011
Methods Parallel RCT
Participants Country of study: France
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported but concomitant treatments allowed
n = 40
Age, mean (SD): active group 51.8 (11.6), sham group 49.6 (10)
Duration of symptoms (mean (SD) years): active group 13 (12.9), sham group 14.1 (11.
9)
Gender distribution: all female
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior, no. of trains
15; duration of trains 10 sec; ITI 50 sec, intensity 80% RMT, total no. pulses 1500
Stimulation location: left M1
Number of treatments: 14, x 1 daily for 5 days, x 1 weekly for 3 weeks, x 1 fortnightly
for 6 weeks, x 1 monthly for 3 months
Control type: sham coil, does not control for sensory cues
Outcomes Primary: pain NRS; 0 = no pain, 10 = maximal pain imaginable
When taken: day 5, 3 weeks, 9 weeks, 21 weeks, 25 weeks
Secondary: BPI interference scale, Fibromyalgia Impact Questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly assigned to 2 groups...with
equal numbers in each group. A study nurse prepared the con-
cealed allocation schedule by computer randomisation of these
2 treatment groups to a consecutive number series; the nurse
had no further participation in the trial. Patients were assigned
in turn to the next consecutive number.”
Allocation concealment (selection bias) Low risk Comment: see quote above
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 25% drop-out at long-term follow-up but intention-
to-treat analysis used with BOCF imputation
88Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mhalla 2011 (Continued)
Selective reporting (reporting bias) Low risk Comment: no numeric point measures provided for the primary
outcome but provided upon request to the authors
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Low risk Quote: “Both patients and investigators were blind to treatment
group. Cortical excitability measurements and transcranial stim-
ulation were performed by an independent investigator not in-
volved in the selection or clinical assessment of the patients.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - sham coil controls for
sound and appearance but not the skin sensation of stimulation
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: > 8 weeks follow-up
Mori 2010
Methods Parallel randomised controlled trial
Participants Country of study: Italy
Setting: laboratory
Condition: neuropathic pain secondary to multiple sclerosis
Prior management details: refractory to drug management and medication discontinued
over previous month
n = 19
Age: 23 to 69, mean 44.8 (SD 27.5)
Duration of symptoms: 1 to 10 years, mean 2.79 (SD 2.64)
Gender distribution: 8 M, 11 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: 0 to 100 mm VAS pain, anchors “no pain” to “worst possible pain”
When taken: end of treatment period and x 1 weekly over 3-week follow-up
Secondary: quality of life, multiple sclerosis quality of life-54 scale (MSQoL-54)
When taken: as for primary outcome
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
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Mori 2010 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the
order of entrance in the study and a previous ran-
domization list generated by a computer.”
Allocation concealment (selection bias) Low risk Comment: likely given that the randomisation list
was generated pre-study
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-outs observed
Quote: “... none of the patients enrolled discon-
tinued the study.”
Selective reporting (reporting bias) Low risk Comment: between-group means are not pre-
sented clearly to allowmeta-analysis but data pro-
vided on request
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding
of tDCSmay be inadequate at 2mA intensity (see
Assessment of risk of bias in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant
blinding of tDCS may be inadequate at 2 mA in-
tensity (see Assessment of risk of bias in included
studies)
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Onesti 2013
Methods Randomised cross-over trial
Participants Country of study: Italy
Setting: laboratory
n = 25
Condition: neuropathic pain from diabetic neuropathy
Prior management details: resistant to standard therapies for at least 1 year
Age mean (SD): 70.6 (8.5)
Duration of symptoms (months mean (SD)): not reported
Gender distribution: 9 F 14 M
Interventions Stimulation type: rTMS using H-coil
Stimulation parameters: frequency 20 Hz; coil orientation H coil, no. of trains 30;
duration of trains 2.5 sec; ITI 30 sec, intensity 100% RMT, total no. pulses 1500
Stimulation location: M1 lower limb (deep in central sulcus)
Number of treatments: 5 per condition on consecutive days
90Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Onesti 2013 (Continued)
Control type: sham coil, controls for scalp sensory, auditory and visual cues
Outcomes Primary: pain VAS 0 to 100, no pain to worst possible pain
When taken: immediately post-stimulation, 3 weeks post-stimulation
Secondary: none relevant
Notes COI: 2 authors have links to the manufacturer of the H-coil
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “After enrolment, patients were randomly as-
signed in a 1:1 ratio to two counterbalanced arms by re-
ceiving a sequential number from a computer-generated
random list.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 2 patients lost to follow-up
Selective reporting (reporting bias) High risk Comment: data are not presented by stimulation condi-
tion - rather they are grouped by the order in which in-
terventions were delivered. No SDs presented. Data re-
quested
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Unclear risk Comment: while study is described as “double blind”
there is no specific mention of blinding assessors
Adequate blinding of participants? Low risk Quote: “Sham stimulation was delivered with a sham coil
placed in the helmet encasing the active rTMS coil. The
sham coil produced a similar acoustic artefact and scalp
sensation as the active coil and could also mimic the facial
muscle activation induced by the active coil. It induced
only a negligible electric field inside the brain because its
non-tangential orientation on the scalp and components
cancelling the electric field ensured that it rapidly reduced
the field as a function of distance”
Comment: controls for visual auditory and sensory as-
pects of stimulation
Free from carry-over effects? Low risk Comment: 5-weekwash-out period observedwith no dif-
ference at T3
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
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Passard 2007
Methods Parallel randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 30
Age: active group: 52.6 (SD 7.8), sham group 55.3 (SD 8.9)
Duration of symptoms: active group: 8.1 (SD 7.9), sham group: 10.8 (SD 8.6)
Gender distribution: 1 M, 29 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
no. of trains 25; duration of trains 8 sec; ITI 52 sec; total no. pulses 2000
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 10, x 1 daily for 10 working days
Control type: sham rTMS coil. Mimics sight and sound of active treatment
Outcomes Primary: 0 to 10 NRS of average pain intensity over last 24 hours, anchors “no pain” to
“maximal pain imaginable”
When taken: daily during treatment period and at 15, 30 and 60 days post-treatment
follow-up
Secondary: Fibromyalgia Impact Questionnaire
When taken: as for primary outcome
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “patients who met all inclusion criteria
were randomly assigned, according to a computer-
generated list, to two groups”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: equal drop-out in each group and ap-
propriately managed in the data analysis
Quote: “All randomized patients with a baseline
and at least one post-baseline visit with efficacy
data were included in the efficacy analyses (intent
to treat analysis).”
“All the patients received the full course of treat-
ment and were assessed on D15 and D30. Four
patients (two in each treatment group) withdrew
from the trial between days 30 and 60.”
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Passard 2007 (Continued)
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
all time points in the study report, the study au-
thors have provided the requested data
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “... investigators were blind to treatment
group.”
Adequate blinding of participants? Unclear risk Quote: “Sham stimulation was carried out with
the ’Magstim placebo coil system’, which physi-
cally resembles the active coil and makes similar
sounds.”
Comment: sham credibility assessment - sub-op-
timal. Sham coil controls for auditory cues and is
visually indistinguishable from active stimulation
but does not control for sensory characteristics of
active stimulation over the scalp
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: ≥ 8 weeks follow-up
Picarelli 2010
Methods Parallel randomised controlled trial
Participants Country of study: Brazil
Setting: laboratory
Condition: CRPS type I
Prior management details: refractory to best medical treatment
n = 23
Age mean (SD): active group 43.5 (12.1), sham group 40.6 (9.9)
Duration of symptoms (months mean (SD)): active group 82.33 (34.5), sham group 79.
27 (32.1)
Gender distribution: 14 F, 9 M
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10Hz; coil orientation posteroanterior, no. of trains
25; duration of trains 10 sec; ITI 60 sec, intensity 100% RMT, total no. pulses 2500
Stimulation location: M1 contralateral to painful limb
Number of treatments: 10, x 1 daily on consecutive weekdays
Control type: sham coil - does not control for sensory cues
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “most severe pain”
When taken: after first and last session then 1 and 3 months post-treatment
Secondary: quality of life SF-36, not reported
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Picarelli 2010 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: while states “randomized” themethod
of randomisation is not reported
Allocation concealment (selection bias) Unclear risk Allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant dropped out at fol-
low-up
Selective reporting (reporting bias) Low risk Comment: data presented for primary outcome.
While this is not adequate formeta-analysis is does
not really constitute selectivity. No response re-
ceived to request for full data access
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Unclear risk Comment: study described as “double-blinded”
but assessor blinding not specifically reported
Adequate blinding of participants? Unclear risk Comment: sham sub-optimal as it does not con-
trol for scalp sensation. Study reported that num-
ber who guessed the condition correctly was sim-
ilar but no formal data or analysis is reported
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: ≥ 8 weeks follow-up
Pleger 2004
Methods Cross-over randomised controlled trial
Participants Country of study: Germany
Setting: laboratory
Condition: complex regional pain syndrome type I
Prior management details: drug management ceased for 48 hours prior to study
n = 10
Age: 29 to 72, mean 51
Duration of symptoms: 24 to 72 months, mean 35
Gender distribution: 3 M, 7 F
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Pleger 2004 (Continued)
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation unspecified; 110% RMT; no.
of trains 10; duration of trains 1.2 sec; ITI 10 sec; total no. pulses 120
Stimulation location: motor cortex hand area
Number of treatments: 1 for each condition
Control type: coil angled 45º away from scalp
Outcomes Primary: 0 to 10 VAS current pain intensity, anchors “no pain” to “most extreme pain”
When taken: 30 sec, 15, 45 and 90 min post-stimulation
Secondary: none
When taken: 30 seconds, 15, 45 and 90 minutes post-stimulation
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a computerized random gen-
erator, five patients were first assigned to the
placebo group (sham rTMS), while the others
were treated using verum rTMS”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out is apparent from the
data presented
Selective reporting (reporting bias) Low risk Comment: while sham group results not pre-
sented in the study report, the study authors
have provided the requested data
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled 45º away from scalp.
Does not control for sensory characteristics of
active stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Quote: “The initial pain intensities (VAS)
were similar prior to verum and sham rTMS
(Student’s paired t-test, P = 0.47). The level of
intensity was also independent of whether the
patients were first subjected to sham or verum
rTMS (P > 0.05).”
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Pleger 2004 (Continued)
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Portilla 2013
Methods Randomised cross-over study
Participants Country of study: USA
Setting: laboratory
Condition: post-burn neuropathic pain
Prior management details: varied
n = 3
Age range: 34 to 52
Duration of symptoms: > 6 months
Gender distribution: 2 F 1 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 minutes
Stimulation location: M1 contralateral to most painful side
Number of treatments: 1 per condition
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst pain ever felt”
When taken: before and after stimulation
Secondary: none relevant
Notes Departmentally funded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “subjects were randomized to either active tDCS
or sham stimulation.”
Comment: method of randomisation not specified but
less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all 3 patients completed study
Selective reporting (reporting bias) High risk Comment: no numeric data provided for pain outcomes
Other bias Low risk Comment: no other bias detected
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Portilla 2013 (Continued)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that participant blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
Free from carry-over effects? Unclear risk Comment: 1-week wash-out observed but no data re-
ported for pain outcome so unable to assess this issue
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Riberto 2011
Methods Parallel RCT
Participants Country of study: Brazil
Setting: rehabilitation clinic
Condition: fibromyalgia
Prior management details: none reported
n = 23
Age mean (SD): active group 58.3 (12.1), sham group 52.4 (11.5)
Duration of symptoms, months (mean (SD)): active group 9.9 (11.8), sham group 6.4
(10.3)
Gender distribution: all female
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 minutes
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 10, x 1 weekly for 10 weeks
Control type: sham tDCS (switched off after 30 seconds stimulation)
Both groups received 4 months rehabilitation programme
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst pain”
When taken: immediately at end of 4-month rehabilitation programme
Secondary: quality of life SF36, Fibromyalgia Impact Questionnaire
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: states simple randomisation method butmethod not
described
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Riberto 2011 (Continued)
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-outs
Selective reporting (reporting bias) Low risk Comment: while numeric data on the primary outcome not
reported in study report the authors have made it available upon
request
Other bias Unclear risk Comment: there are group imbalances at baseline on the dura-
tion of pain, education, age and economic activity
Adequate blinding of assessors? Unclear risk Comment: 2mA intensity used - empirical evidence that assessor
blinding may be sub-optimal at this intensity
Adequate blinding of participants? Unclear risk Comment: 2 mA used, which may threaten assessor blinding,
though formal analysis of blinding appears acceptable
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Rintala 2010
Methods Parallel RCT
Participants Country of study: USA
Setting: outpatient clinic, patients take device home
Condition: pain related to Parkinson’s disease
Prior management details: not reported
n = 19 (reduced to 13 through drop-out)
Age mean (SD): active group 74.7 (7.8), sham group 74.4 (8.3)
Duration of symptoms: > 6 months
Gender distribution: 15 M, 4 F
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
µA; waveform shape not specified; duration 40 minutes per session
Stimulation location: earlobe clips
Number of treatments: 42, x 1 daily for 42 days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: pain VAS 0 to 10, anchors not reported
When taken: at the end of the treatment period
Secondary: none
Notes Comments: equipment provided by CES manufacturer as an “unrestricted gift”
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Rintala 2010 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: states randomised but method of randomisation not
reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: > 30% drop-out
Selective reporting (reporting bias) Low risk Comment: mean (SD) pain scores reported for both groups pre-
and post-stimulation
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Low risk Comment: participants and the study co-ordinator were blinded
to group assignment and the code sheet indicating which devices
were active and which were sham was kept by another person
who was not in contact with the participants
Adequate blinding of participants? Low risk Comment: see above comment
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Rollnik 2002
Methods Cross-over randomised controlled trial
Participants Country of study: Germany
Setting: pain clinic
Condition: chronic pain (mixed musculoskeletal and neuropathic)
Prior management details: “intractable”
n = 12
Age: 33 to 67, mean 51.3 (SD 12.6)
Duration of symptoms: mean 2.7 (SD 2.4)
Gender distribution: 6 M, 6 F
Interventions Stimulation type: rTMS, circular coil for arm symptoms, double cone coil for leg symp-
toms
Stimulation parameters: frequency 20 Hz; coil orientation not specified; 80% RMT; no.
of trains 20; duration of trains 2 sec; ITI not specified; total no. pulses 800; treatment
duration 20 minutes
Stimulation location: motor cortex (midline)
Number of treatments: x 1 for each condition
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Rollnik 2002 (Continued)
Control type: coil angled 45º away from the scalp
Outcomes Primary: 0 to 100 mm VAS pain intensity, anchors “no pain” to “unbearable pain”
When taken: 0, 5, 10 and 20 minutes post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “sham and active stimulation were
given in a random order”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant withdrew due
to “headaches”. Unlikely to have strongly in-
fluenced the findings
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values
are not provided clearly with measures of vari-
ance for all time points in the study report,
the study authors have provided the requested
data
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled 45º away from scalp.
Does not control for sensory characteristics
of active stimulation over the scalp and is vi-
sually distinguishable. Given that stimulation
was delivered at 110% RMT active stimula-
tion, but not sham, is likely to have elicited
muscle twitches in peripheral muscles
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the
study report but clear from unpublished data
provided by the study authors (baseline mean
group pain scores: active stimulation 65.1 (SD
16), sham stimulation 66.9 (SD 17.4))
Study Size High risk Comment: < 50 participants per treatment
arm
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Rollnik 2002 (Continued)
Study duration High risk Comment: < 2 weeks follow-up
Saitoh 2007
Methods Cross-over randomised controlled trial, 4 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: intractable
n = 13
Age: 29 to 76, mean 59.4
Duration of symptoms: 2 to 35 years, mean 10.2 (SD 9.7)
Gender distribution: 7 M, 6 F
Interventions Stimulation type: rTMS figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation not specified; 90% RMT; no. of trains
5; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Condition 2: frequency 5 Hz; coil orientation not specified; 90% RMT; no. of trains
10; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Condition 3: frequency 1 Hz; coil orientation not specified; 90% RMT; no. of trains 1;
duration of trains 500 sec; total no. pulses 500
Condition 4: sham, coil angled 45º from scalp with synchronised electrical scalp stimu-
lations to mask sensation
Stimulation location: motor cortex over the representation of the painful area
Number of treatments: 1 for each condition
Outcomes Primary: VAS pain, anchors not specified
When taken: 0, 15, 30, 60, 90 and 180 minutes post-stimulation
Secondary: none
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “rTMS was applied to all the pa-
tients at frequencies of 1, 5, and 10 Hz and
as a sham procedure in random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All 13 patients participated in
all planned sessions of navigation-guided
rTMS”
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Saitoh 2007 (Continued)
Comment: no drop-outs observed
Selective reporting (reporting bias) Low risk Comment: while pain score numerical val-
ues are not provided clearly with measures
of variance for all time points in the study
report, the study authors have provided the
requested data
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not re-
ported
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment -
sub-optimal. Sensory and auditory aspects
are controlled for but angulation of coil
away from the scalp may be visually distin-
guishable
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the
study report but paired t-tests on unpub-
lished baseline data provided by the study
authors suggest that carry-over was not a
significant issue
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Short 2011
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: naive to TMS
n = 20
Age mean (SD): active group 54.2 (8.28) sham group 51.67 (18.19)
Duration of symptoms, years mean (SD): active group 12.1 (7.75), sham group 10.10
(12.81)
Gender distribution: 84% female
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation para-sagittal, no. of trains 80;
duration of trains 5 sec; ITI 10 sec, intensity 120% RMT, total no. pulses per session
4000
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Short 2011 (Continued)
Stimulation location: left DLPFC
Number of treatments: 10, x 1 daily (working days) for 2 weeks
Control type: sham coil
Outcomes Primary: pain VAS; 0 = ”no pain“, 10 = ”worst pain“
When taken: after 1 and 2 weeks of treatment, then 1 week and 2 weeks post-treatment
Secondary: Fibromyalgia Impact Questionnaire, Brief Pain Inventory function scale
Notes Adverse events: no data provided.
COI: 1 researcher has received research grants from the device manufacturer and holds
patents for TMS technology
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”Patients were randomly assigned (random generator
software developed by JJB in the Brain Stimulation Laboratory)
Allocation concealment (selection bias) Low risk Quote: “A co investigator not directly involved in ratings or
treatment released treatment condition to the TMS operator”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: full reporting of primary outcomes
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Low risk Quote: “Amasked continuous rater assessed patients at baseline,
at the end of each treatment week, and at the 2 follow-up weeks.
Importantly the continuous rater did not administer the TMS,
minimizing the chances of unmasking due to events during the
TMS treatment session.”
Adequate blinding of participants? Low risk Quote: “A specially designed shamTMS coil is used for all sham
conditions that produces auditory signals identical to active coils
but shielded so that actual stimulation does not occur. However,
subjects do experience sensory stimulation that is difficult to
distinguish from real rTMS”
Comment: sensory, auditory and visual cues controlled for
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
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Soler 2010
Methods Parallel randomised controlled trial
Participants Country of study: Spain
Setting: laboratory
Condition: post-spinal cord injury neuropathic pain
Prior management details: stable pharmacological treatment for at least 2 weeks prior to
start of treatment. Unresponsive to medication
n = 39
Age mean (SD): 45 (15.5)
Duration of symptoms: not reported
Gender distribution: 30 M, 9 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 minutes
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 10, x 1 daily (working days) for 2 weeks
Control type: 4 groups, tDCS + visual illusion, sham tDCS + visual illusion, tDCS +
control illusion, sham tDCS + control illusion
Outcomes Primary: pain VAS; 0 = no pain, 10 = unbearable pain; mean over previous 24 hours
When taken: end of treatment period, 12 and 24 days post-treatment
Secondary: BPI pain interference scale
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “We used a computer generated list as ran-
domisation strategy.”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 3 drop-outs, 1 in each group
Selective reporting (reporting bias) Low risk Comment: all main outcomes reported
Other bias Low risk Comment: no other biases detected
Adequate blinding of assessors? Unclear risk Comment: 2 mA intensity used - empirical evi-
dence that assessor blinding may be sub-optimal
at this intensity
Adequate blinding of participants? Unclear risk Comment: 2 mA may threaten blinding but as-
sessment of blinding seemed OK
Study Size High risk Comment: < 50 participants per treatment arm
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Soler 2010 (Continued)
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
Tan 2000
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: tertiary care teaching hospital
Condition: neuromuscular pain (excluding fibromyalgia)
Prior management details: unclear
n = 28
Age: 45 to 65, mean 55.6
Duration of symptoms: 4 to 45 years, mean 15
Gender distribution: 25 M, 3 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width not specified; intensity 10 to 600
µA; waveform shape not specified
Stimulation location: ear clip electrodes
Number of treatments: 12, frequency of treatment not specified
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: VAS 0 to 5 pain intensity
When taken: pre and post each treatment
Secondary: life interference scale, sickness impact profile - Roland Scale
When taken: not specified
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “each subjectwas randomly assigned to
receive either the active or the sham treatment
first”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: only 17 participants completed the
study and this drop-out (over 50%) is not
clearly accounted for in the analysis
Selective reporting (reporting bias) Low risk Comment: primary outcome data presented
clearly
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Tan 2000 (Continued)
Other bias Unclear risk Comment: participants also received local
stimulation to the painful area that may have
elicited a therapeutic effect
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Adequate blinding of participants? Low risk Quote: “sham treatment was made possible by
having the treatment delivered via a black box”
Comment: sham and active stimulators visu-
ally indistinguishable
Free from carry-over effects? Low risk Quote: “Note that there were no significant
differences in pain ratings pre-post changes be-
tween the active and sham groups”
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks follow-up
Tan 2006
Methods Parallel randomised controlled trial
Participants Country of study: USA
Setting: medical centre
Condition: post-SCI pain (not clearly neuropathic)
Prior management details: unclear
n = 40
Age: 38 to 82
Duration of symptoms: chronic > 6 months
Gender distribution: all male
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
to 500 µA; waveform shape not specified; duration 1 hour per session
Stimulation location: ear clip electrodes
Number of treatments: 21, x 1 daily for consecutive days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: Brief Pain Inventory (0 to 10 NRS), anchors “no pain” to “pain as bad as you
can imagine”
When taken: post-treatment period
Secondary: pain interference sub-scale of BPI
When taken: as for primary outcome
Notes Adverse events: not reported
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Tan 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The participants were then randomly as-
signed to either the active or sham CES treatment
groups”
Comment: method of randomisation not speci-
fied
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 2 (5%) patients withdrew from
the study.Unlikely to have strongly influenced the
findings
Selective reporting (reporting bias) Low risk Comment: primary outcomes presented clearly
and in full
Other bias Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “The investigators,research assistant (RA)
, and participants were blinded to treatment type
until the end of the initial phase.”
Adequate blinding of participants? Low risk Comment: see quote above
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Tan 2011
Methods Parallel randomised controlled trial
Participants Country of study: USA
Setting: 4 veterans affairs medical centres and 1 private rehabilitation clinic
Condition: post-spinal cord injury neuropathic pain
Prior management details: not reported
n = 105
Age mean (SD): active group 52.1 (10.5), sham group 52.5 (11.7)
Gender distribution: 90 M, 15 F
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
µA; waveform shape not specified; duration 1 hour per session
Stimulation location: earlobe clips
Number of treatments: 21, x 1 daily
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Tan 2011 (Continued)
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: Brief Pain Inventory pain intensity VAS 0 to 100, anchors not reported
When taken: at end of treatment period
Secondary: quality of life SF-12 physical and mental component sub-scales
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The equipment was set up for a dou-
ble-blind study by the manufacturer such that the
participants could not differentiate active from
sham CES devices. Research staff members who
interactedwith the participants (e.g. recruited and
trained participants, administered questionnaires,
followedupby telephone) did not knowwhich de-
vices were sham and which were active. Random-
ization was achieved by selecting a device from a
box initially containing equal numbers of active
and sham devices.”
Comment: whilst unconventional it appears to
avoid a systematic bias
Allocation concealment (selection bias) Low risk Comment: see quote/comment above
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: available case analysis with small loss
to follow-up
Selective reporting (reporting bias) Low risk Comment: key outcomes fully reported
Other bias Unclear risk Comment: baseline between-group imbalances
on BPI pain interference, SF-36 pain sub-scale
and coping strategies
Adequate blinding of assessors? Low risk Comment: stimulation sub-sensory and units in-
distinguishable
Adequate blinding of participants? Low risk Comment: Stimulation sub sensory and units in-
distinguishable
Study Size Unclear risk Comment: > 50 but < 200 participants per treat-
ment condition
Study duration High risk Comment: < 2 weeks follow-up
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Taylor 2013
Methods Parallel RCT
Participants Country of study: USA
Setting: community rheumatology practices
Condition: fibromyalgia
Prior management details: not reported but continued stable medication usage
n = 57 (46 after drop-out)
Age mean (SD): active group 51(10.6) sham group 51.5 (10.9), usual care group 48.6
(9.8)
Duration of symptoms: not reported
Gender distribution: 43 F, 3 M (data reported on completers)
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width not specified; intensity 100 µA;
waveform shape square wave biphasic, duration 1 hour per session
Stimulation location: earlobe clip electrodes
Number of treatments: x 1 daily for 8 weeks
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: pain VAS, anchors not reported
When taken: at the end of each week of treatment period
Secondary: Fibromyalgia Impact Questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: described as randomised but method of randomisa-
tion not reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: of 57, 11 did not complete - unclear if ITT analysis
employed.However, only 2 to 4 per group and balanced - mostly
due to assessment burden
Selective reporting (reporting bias) Low risk Comment: while no numeric data were provided on primary
outcomes in the study report, these data were provided upon
request to the authors
Other bias Low risk Comment: no other source of bias detected
Adequate blinding of assessors? Low risk Comment: participants self rated at home
Adequate blinding of participants? Low risk Comment: identical devices given to sham and active group with
sub-sensory stimulation parameters
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Taylor 2013 (Continued)
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Tzabazis 2013
Methods Unclear, likely parallel RCT (for 1 Hz only), 10 Hz data open-label therefore excluded
from this review
Participants Country of study: USA
Setting: not reported, likely laboratory
Condition: fibromyalgia
Prior management details: “moderate to severe despite current and stable treatment
regime”
n = unclear, abstract report (Schneider 2012) states 45, but full paper states 16
Age mean (SD): 53.2 (8.9)
Duration of symptoms, years mean (SD): not reported
Gender distribution: 14 female, 2 male
Interventions Stimulation type: rTMS 4-coil configuration
Stimulation parameters: frequency 1 Hz; no of trains not reported; duration of trains
not reported; ITI not reported, intensity 110% RMT, total no. pulses per session 1800,
stimulation duration 30 min
Stimulation location: targeted to the anterior cingulate cortex
Number of treatments: 20, x 1 daily (working days) for 4 weeks
Control type: sham coil
Outcomes Primary: Brief Pain Inventory average pain last 24 hours NRS, anchors not reported
When taken: end of treatment, 4 weeks post-treatment
Secondary: Fibromyalgia Impact Questionnaire
Notes COI: 3 authors have acted as paid consultants to the manufacturer of the stimulation
device, of which 2 hold stock in the company and 1 founded the company, is its chief
medical officer and has intellectual property rights
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: no description of the sequence
generation process used
Allocation concealment (selection bias) Unclear risk Comment: no description of allocation
concealment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no mention of the degree of
drop-out or how it was managed. However,
45 participants with fibromyalgia reported
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Tzabazis 2013 (Continued)
in the abstract of the same study (Schnei-
der 2012), but only 16 reported in the full
paper
Selective reporting (reporting bias) High risk Comment: no presentation of numeric
pain data with measures of variance
Other bias Unclear risk Comment: baseline and demographic data
not presented for clinical group
Adequate blinding of assessors? Unclear risk Comment: no description or mention of
blinding assessors for clinical part of study
Adequate blinding of participants? Unclear risk Comment: no description of blinding of
participants for clinical part of study. Sham
coil controls for auditory cues and is vi-
sually indistinguishable from active stim-
ulation but does not control for sensory
characteristics of active stimulationover the
scalp
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment:≥ 2weeks but < 8weeks follow-
up
Valle 2009
Methods Parallel randomised controlled trial, 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: refractory to medical intervention
n = 41
Age: mean 54.8 (SD 9.6) years
Duration of symptoms: condition 1: 7.54 (SD 3.93) years; condition 2: 8.39 (SD 2.06)
years; condition 3: 8.69 (SD 3.61) years
Gender distribution: 0 M; 41 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: condition 1: left dorsolateral prefrontal cortex; condition 2: left
motor cortex, condition 3; sham left motor cortex
Number of treatments: 10, x 1 daily on consecutive working days
Control type: sham tDCS (switched off after 30 seconds stimulation)
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Valle 2009 (Continued)
Outcomes Primary: pain VAS 0 to 10 cm, anchors not specified
When taken: immediately post-treatment, averaged over 3 days post-treatment, 30 and
60 days post-treatment
Secondary: quality of life; Fibromyalgia Impact Questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomizationwas performedus-
ing the order of entrance in the study and
a previous randomisation list generated by
a computer”
Allocation concealment (selection bias) Low risk Comment: the use of a pre-generated ran-
domisation list should have adequately en-
sured this
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no drop-out occurred
Selective reporting (reporting bias) High risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any post-treatment time point in
the study report
Other bias Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor
blinding of tDCS may be inadequate at 2
mA intensity (see Assessment of risk of bias
in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that partici-
pant blinding of tDCS may be inadequate
at 2 mA intensity (see Assessment of risk of
bias in included studies)
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Low risk Comment: ≥ 8 weeks follow-up
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Villamar 2013
Methods Randomised cross-over trial
Participants Country of study: USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: pain refractory to common analgesics and muscle relaxants
n = 18 randomised of which 17 allocated
Age mean (SD): 50.3 (8.5)
Duration of symptoms (years) mean (SD): 10.7 (6.8)
Gender distribution: 15 F, 3 M
Interventions Stimulation type: HD-tDCS
Stimulation parameters: intensity 2 mA, duration 20 minutes, anodal/cathodal/sham 4
x 1-ring configuration
Stimulation location: left motor cortex
Number of treatments: x 1 per condition
Control type: sham tDCS
Outcomes Primary: pain visual numerical scale; 0 = complete absence of pain, 10 = worst pain
imaginable
When taken: baseline, immediately post-stimulation, 30 minutes post-stimulation
Secondary: adapted quality if life scale for persons with chronic illness (7 points: 1 =
terrible, 7 = delighted)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the order of stimulation was counterbalanced
and randomly assigned for each individual”
Comment: method of randomisation not specified but
less likely to introduce bias in a cross-over design
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 loss to follow-up and multiple impu-
tation used
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported in full
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that participant blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
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Villamar 2013 (Continued)
Free from carry-over effects? Low risk Comment: 7 daywash-out periods observed.Data similar
at baseline
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks follow-up
Wrigley 2014
Methods Cross-over RCT
Participants Country of study: Australia
Setting:laboratory
Condition: chronic neuropathic pain post SCI
Prior management details; none
n = 10
Age mean (SD): 56.1 (14.9)
Duration of symptoms: 15.8 (11.3) years
Gender distribution: 8M 2F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 minutes
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 5, x 1 daily 5 days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst possible pain”
When taken: at end of treatment, 4 weeks post-treatment
Secondary: none relevant
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not specified but less im-
portant for cross-over design
Quote: “A randomized crossover design was used so that all sub-
jects participated in an active treatment (transcranial direct cur-
rent stimulation) and sham treatment period. Both the subject
and the response assessor were blinded to the randomization se-
quence.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported in full
114Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wrigley 2014 (Continued)
Other bias Low risk Comment: no other bias detected
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Free from carry-over effects? Low risk Comment: 4-week wash-out period observed and data appear
free of carry-over effects
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks follow-up
AE: adverse event
BIRS: Gracely Box Intensity Scale (BIRS)
BOCF: baseline observation carried forward
BPI: Brief Pain Inventory
CES: cranial electrotherapy stimulation
CNP: central neuropathic pain
COI: conflict of interest
CRPS: complex regional pain syndrome
DLPFC: dorsolateral pre-frontal cortex
F: female
FIQ: Fibromyalgia Impact Questionnaire
HD-tDCS: High definition tDCS
ITI: inter-train interval
ITT: intention-to-treat
L: left
LANSS: Leeds Assessment of Neuropathic Symptoms and Signs pain scale
M: male
MCS: motor cortex stimulation (MCS)
NIH: National Institutes of Health
NRS: numerical rating scale
PLP: phantom limb pain
R: right
RCT: randomised controlled trial
RMT: resting motor threshold
rTMS: repetitive transcranial magnetic stimulation
SCI: spinal cord injury
SD: standard deviation
TCES: transcranial electrical stimulation
tDCS: transcranial direct current stimulation
TENS: transcutaneous electrical nerve stimulation
TMS: transcranial magnetic stimulation
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VAS: visual analogue scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Avery 2007 The duration of painful symptoms is unclear. May not be exclusively chronic pain
Belci 2004 Pain is not measured as an outcome
Bolognini 2013 Inclusion of acute and chronic pain patients
Carraro 2010 Not a study of electrical brain stimulation
Choi 2012b Study of acute pain
Choi 2012a Study of acute pain
Evtiukhin 1998 A study of postoperative pain. No sham control employed
Frentzel 1989 Not a study of brain stimulation
Hargrove 2012a Uncontrolled long-term follow-up data from Hargrove 2012
Johnson 2006 Self reported pain is not measured
Katz 1991 Study not confined to chronic pain
Longobardi 1989 Not clearly studying chronic pain
Nelson 2010 Intervention not designed to alter cortical activity directly by electrical stimulation - a neuro feedback intervention
O’Connell 2013 Not a RCT or quasi-RCT - no randomisation specifically to treatment group or order
Pujol 1998 Participants are a mixture of acute and chronic pain patients
Sichinava 2012 No sham control employed for tDCS
Silva 2007 A single case report
Zaghi 2009 Single case report
NIBS: non-invasive brain stimulation
RCT: randomised controlled trial
tDCS: transcranial direct current stimulation
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Characteristics of studies awaiting assessment [ordered by study ID]
Acler 2012
Methods Parallel RCT
Participants Post-polio patients, n = 32
Interventions tDCS, bi-anodal, bilateral motor cortex, 1.5 mA, 20 minutes, daily for 5 days
Outcomes Pain, quality of life
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Albu 2011
Methods Sham controlled study, unclear whether randomised
Participants Post-spinal cord injury chronic neuropathic pain, n = 30
Interventions tDCS motor cortex, 2 mA, 10 sessions
Outcomes Pain intensity
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Ansari 2013
Methods Parallel RCT
Participants Fibromyalgia, n = 118
Interventions rTMS right DLPFC, low-frequency, 20 sessions
Outcomes Unclear whether self reported pain scores were collected
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Fricova 2009
Methods Sham controlled trial, unclear whether randomised
Participants Chronic neurogenic orofacial pain, n = 26
Interventions rTMS motor cortex, frequency unclear, appears to be a single session of stimulation per condition
Outcomes Pain VAS
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Fricova 2009 (Continued)
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Fricova 2011
Methods Sham controlled trial, unclear whether randomised, likely to be a cross-over design
Participants Chronic neurogenic orofacial pain, n = 26
Interventions rTMS motor cortex, frequency unclear, appears to be a single session of stimulation per condition
Outcomes Pain VAS
Notes Published as conference abstract only. Published as conference abstract only. Likely to be a duplicate report of Fricova
2009. Attempts to contact authors currently unsuccessful
Klirova 2010
Methods Parallel RCT
Participants Neuropathic orofacial pain, n = 29
Interventions rTMS, motor cortex, 10 Hz, 5 treatment sessions
Outcomes Pain VAS
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Klirova 2011
Methods Parallel RCT
Participants Neuropathic orofacial pain, medication resistant, n = 29
Interventions rTMS, motor cortex, 10 Hz, 5 treatment sessions
Outcomes Pain VAS
Notes Published as conference abstract only. Likely to be a duplicate report of Klirova 2010. Attempts to contact authors
currently unsuccessful
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Knotkova 2011
Methods Parallel RCT
Participants Complex regional pain syndrome type I, n = 25
Interventions tDCS, motor cortex, 2 mA, 20 minutes per session, daily for 5 days
Outcomes Pain, quality of life, physical activity
Notes Currently published as conference abstract only. Correspondence with authors - data unavailable as currently being
re-analysed
Pellaprat 2012
Methods Cross-over RCT
Participants Parkinson’s disease with related pain, n = 19
Interventions rTMS 20 Hz motor cortex, ? whether single session
Outcomes Pain VAS
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
Shklar 1997
Methods Unable to retrieve study report
Participants -
Interventions -
Outcomes -
Notes -
Vatashsky 1997
Methods Unable to retrieve study report
Participants -
Interventions -
Outcomes -
Notes -
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Ya ci 2013
Methods Parallel RCT
Participants Fibromyalgia, n = 25
Interventions rTMS motor cortex, 1 Hz, 90% RMT, 10 sessions daily
Outcomes Pain VAS, FIQ
Notes Published as conference abstract only. Attempts to contact authors currently unsuccessful
DLPFC: dorsolateral pre-frontal cortex
FIQ: Fibromyalgia Impact Questionnaire
RCT: randomised controlled trial
tDCS: transcranial direct current stimulation
VAS: visual analogue scale
Characteristics of ongoing studies [ordered by study ID]
ISRCTN89874874
Trial name or title Effectiveness of anodal transcranial direct current stimulation (tDCS) in patients with chronic low back pain:
a randomised controlled trial
Methods Parallel RCT
Participants Chronic low back pain, n = 135
Interventions tDCS 2 mA, 20 minutes, daily for 5 consecutive days
Outcomes Pain VAS, disability (Oswestry Disability Index), patient perceived satisfactory improvement, quality of life
(SF-36)
Starting date 20 February 2011
Contact information Kerstin Luedtke, Matinistr. 52, Hamburg, Germany, 20246
Notes Correspondence with authors - trial currently ongoing
NCT00697398
Trial name or title Repetitive Trans-Cranial Magnetic Stimulation of the Motor Cortex in Fibromylagia: A Study Evaluating the
Clinical Efficiency and the Metabolic Correlate in 18FDG-PET
Methods Parallel RCT
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NCT00697398 (Continued)
Participants Fibromyalgia
Interventions rTMS motor cortex, parameters not specified
Outcomes Analgesic efficiency at 36-month follow-up, quality of life
Starting date October 2008
Contact information Dr Eric Guedj, eric.guedj@ap-hm.fr
Notes Correspondence with authors: Study complete and currently under peer review for publication
NCT00815932
Trial name or title The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related
Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy
Methods Cross-over RCT
Participants Chronic neuropathic pain due to CRPS or diabetic neuropathy
Interventions tDCS or sham, 2 mA, 20 minutes, x 1 session, location not specified
Outcomes Pain intensity
Starting date February 2009
Contact information Dr Pesach Schvartzman, spesah@bgu.ac.il
Notes Contact in 2010 - study ongoing, recent attempts to contact for update unsuccessful
NCT00947622
Trial name or title Occipital Transcranial Direct Current Stimulation in Fibromyalgia
Methods Cross-over RCT
Participants Fibromyalgia
Interventions tDCS or sham, parameters not specified
Outcomes Pain VAS and FIQ
Starting date July 2009
Contact information Dr Mark Plazier, mark.plazier@uza.be
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NCT00947622 (Continued)
Notes Attempts to contact authors currently unsuccessful
NCT01112774
Trial name or title Application of transcranial direct current stimulation in patients with chronic pain after spinal cord injury
Methods Parallel RCT
Participants Chronic pain after spinal cord injury, proposed n = 60
Interventions tDCS 2 mA, 10 sessions
Outcomes Pain VAS, quality of life
Starting date April 2010
Contact information Dr Felipe Fregni, ffregni@neuromodulationlab.org, Kayleen Weaver, kmweaver@partners.org
Notes Contact with author - study at “to be analysed and reported” stage
NCT01220323
Trial name or title Transcranial direct current stimulation for chronic pain relief
Methods Cross-over RCT
Participants Chronic pain patients, proposed n = 100
Interventions tDCS, motor cortex, 2 mA, daily for 5 days
Outcomes Pain relief
Starting date November 2010
Contact information Dr Silvio Brill, Tel Aviv Sourasky Medical Centre
Notes Correspondence with authors: study ongoing
NCT01402960
Trial name or title Exploration of parameters of transcranial direct current stimulation in chronic pain
Methods Parallel RCT
Participants Chronic pain following traumatic spinal cord injury, n = 60
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NCT01402960 (Continued)
Interventions tDCS or sham, 2 mA, motor cortex, 20 minutes, x 1 daily for 5 days
Outcomes Pain
Starting date April 2010
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with author - study at “to be analysed and reported” stage
NCT01404052
Trial name or title Effects of transcranial direct current stimulation and transcranial ultrasound on osteoarthritis pain of the knee
Methods Parallel RCT
Participants Chronic knee osteoarthritis pain, n = 30
Interventions tDCS or sham, 20 minutes, 2 mA, motor cortex, 5 sessions
Outcomes Pain
Starting date January 2011
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with author - study at “to be analysed and reported” stage
NCT01575002
Trial name or title Effects of transcranial direct current stimulation in chronic corneal pain
Methods Cross-over RCT
Participants Chronic corneal pain
Interventions tDCS, active or sham, 1 session of each, parameters not reported
Outcomes Pain VAS
Starting date January 2012
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with author - study at “to be analysed and reported” stage
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NCT01599767
Trial name or title Spaulding-Harvard model system: Effects of transcranial direct current stimulation on chronic pain in spinal
cord injury
Methods Parallel RCT
Participants Moderate to severe sub-lesional pain post-spinal cord injury
Interventions Anodal tDCS 15 sessions x 1 daily, parameters not reported
Outcomes Pain
Starting date December 2011
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with author - study at “to be analysed and reported” stage
NCT01608321
Trial name or title rTMS for the treatment of chronic pain in GW1 veterans
Methods Parallel RCT
Participants Chronic pain related to Gulf War illness that meets diagnostic criteria for fibromyalgia, n = 206
Interventions rTMS 20 sessions, stimulation parameters unclear
Outcomes McGill pain questionnaire
Starting date August 2012
Contact information Dr Ansgar Furst, Dr John Ashford, ansgar.furst@va.gov, wes.ashford@va.gov
Notes Correspondence with authors: recruiting due to commence Spring 2013
NCT01746355
Trial name or title Assessment and treatment patients with atypical facial pain through repetitive transcranial magnetic stimula-
tion
Methods Parallel RCT
Participants Atypical facial pain, n = 40
Interventions rTMS or sham, parameters not reported, 5 sessions
Outcomes Pain VAS
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NCT01746355 (Continued)
Starting date March 2011
Contact information Ricardo Galhardoni
Notes Correspondence with authors: study near completion.
NCT01747070
Trial name or title Effect of cranial stimulation and acupuncture on pain, functional capability and cerebral function in os-
teoarthritis
Methods Parallel RCT
Participants Chronic osteoarthritis pain, n = 80
Interventions 4 groups, real tDCS + electroacupuncture sham; sham tDCS + electroacupuncture sham, sham tDCS +
electroacupuncture, real tDCS + electroacupuncture
tDCS 2 mA motor cortex. All single session.
Outcomes Daily pain intensity, WOMAC
Starting date January 2012
Contact information Dr Wolnei Caumo, caumo@cpovo.net
Notes Correspondence with authors: study ongoing
CRPS: complex regional pain syndrome
DLPFC: dorsolateral pre-frontal cortex
FIQ: Fibromyalgia Impact Questionnaire
RCT: randomised controlled trial
rTMS: repetitive transcranial magnetic stimulation
tDCS: transcranial direct current stimulation
VAS: visual analogue scale
WOMAC: Western Ontario and McMaster Universities Arthritis Index
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D A T A A N D A N A L Y S E S
Comparison 1. Repetitive transcranial magnetic stimulation (rTMS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 21 Std. Mean Difference (Fixed, 95% CI) -0.20 [-0.26, -0.13]
1.1 Low-frequency ≤ 1 Hz 6 Std. Mean Difference (Fixed, 95% CI) 0.15 [-0.01, 0.31]
1.2 High-frequency ≥ 5 Hz 20 Std. Mean Difference (Fixed, 95% CI) -0.27 [-0.35, -0.20]
2 Pain: short-term follow-up,
subgroup analysis:
multiple-dose vs single-dose
studies
21 Std. Mean Difference (Random, 95% CI) -0.19 [-0.33, -0.06]
2.1 Single-dose studies 12 Std. Mean Difference (Random, 95% CI) -0.23 [-0.37, -0.09]
2.2 Multiple-dose studies 9 Std. Mean Difference (Random, 95% CI) -0.12 [-0.47, 0.23]
3 Pain: short-term follow-up,
subgroup analysis, neuropathic
pain participants only
14 Std. Mean Difference (Fixed, 95% CI) -0.20 [-0.27, -0.12]
3.1 Low-frequency ≤ 1 Hz 5 Std. Mean Difference (Fixed, 95% CI) 0.15 [-0.02, 0.32]
3.2 High-frequency ≥ 5 Hz 14 Std. Mean Difference (Fixed, 95% CI) -0.27 [-0.35, -0.19]
4 Pain: short-term follow-up,
subgroup analysis,
non-neuropathic pain
participants only
6 Std. Mean Difference (Fixed, 95% CI) -0.19 [-0.44, 0.05]
4.1 Low-frequency ≤ 1 Hz 1 Std. Mean Difference (Fixed, 95% CI) 0.16 [-0.29, 0.61]
4.2 High-frequency ≥ 5 Hz 5 Std. Mean Difference (Fixed, 95% CI) -0.34 [-0.63, -0.05]
5 Pain: short-term follow-up,
subgroup analysis: motor cortex
studies only, low-frequency
studies excluded
17 Std. Mean Difference (Random, 95% CI) -0.32 [-0.46, -0.17]
5.1 Single-dose studies 12 Std. Mean Difference (Random, 95% CI) -0.39 [-0.51, -0.27]
5.2 Multiple-dose studies 5 Std. Mean Difference (Random, 95% CI) -0.07 [-0.41, 0.26]
6 Sensitivity analysis - imputed
correlation coefficient
increased. Pain: short-term
follow-up
23 Std. Mean Difference (Random, 95% CI) -0.21 [-0.34, -0.08]
6.1 Low-frequency ≤ 1 Hz 7 Std. Mean Difference (Random, 95% CI) 0.15 [0.01, 0.29]
6.2 High-frequency ≥ 5 Hz 22 Std. Mean Difference (Random, 95% CI) -0.30 [-0.44, -0.16]
7 Sensitivity analysis - imputed
correlation coefficient
decreased. Pain: short-term
follow-up
22 Std. Mean Difference (Random, 95% CI) -0.20 [-0.34, -0.06]
7.1 Low-frequency ≤ 1 Hz 6 Std. Mean Difference (Random, 95% CI) 0.17 [-0.03, 0.37]
7.2 High-frequency ≥ 5 Hz 21 Std. Mean Difference (Random, 95% CI) -0.28 [-0.42, -0.13]
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8 Sensitivity analysis - imputed
correlation increased. Pain:
short-term follow-up, subgroup
analysis: motor cortex studies
only, low-frequency studies
excluded
17 Std. Mean Difference (Random, 95% CI) -0.33 [-0.47, -0.20]
8.1 Single-dose studies 12 Std. Mean Difference (Random, 95% CI) -0.41 [-0.53, -0.29]
8.2 Multiple-dose studies 5 Std. Mean Difference (Random, 95% CI) -0.08 [-0.39, 0.23]
9 Sensitivity analysis - imputed
correlation decreased. Pain:
short-term follow-up, subgroup
analysis: motor cortex studies
only, low-frequency studies
excluded
17 Std. Mean Difference (Random, 95% CI) -0.31 [-0.46, -0.17]
9.1 Single-dose studies 12 Std. Mean Difference (Random, 95% CI) -0.38 [-0.49, -0.27]
9.2 Multiple-dose studies 5 Std. Mean Difference (Random, 95% CI) -0.11 [-0.48, 0.25]
10 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up
25 Std. Mean Difference (Fixed, 95% CI) -0.23 [-0.31, -0.16]
10.1 Low-frequency ≤ 1 Hz 9 Std. Mean Difference (Fixed, 95% CI) 0.09 [-0.05, 0.24]
10.2 High-frequency ≥ 5 Hz 23 Std. Mean Difference (Fixed, 95% CI) -0.34 [-0.42, -0.26]
11 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up,
subgroup analysis: motor cortex
studies only, low-frequency
studies excluded
21 Std. Mean Difference (Random, 95% CI) -0.39 [-0.56, -0.23]
11.1 Single-dose studies 14 Std. Mean Difference (Random, 95% CI) -0.36 [-0.48, -0.24]
11.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.50 [-0.99, -0.01]
12 Pain: short-term follow-up,
subgroup analysis: prefrontal
cortex studies only
4 Std. Mean Difference (Random, 95% CI) -0.47 [-1.48, 0.54]
12.1 Multiple-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.47 [-1.48, 0.54]
13 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up,
subgroup analysis: prefrontal
cortex studies only
5 Std. Mean Difference (Random, 95% CI) -0.48 [-1.32, 0.37]
13.1 Multiple-dose studies 5 Std. Mean Difference (Random, 95% CI) -0.48 [-1.32, 0.37]
14 Pain: medium-term follow-up 7 Std. Mean Difference (Random, 95% CI) -0.18 [-0.43, 0.06]
14.1 Low-frequency ≤ 1 Hz 1 Std. Mean Difference (Random, 95% CI) 0.36 [-0.41, 1.13]
14.2 High-frequency ≥ 5 Hz 6 Std. Mean Difference (Random, 95% CI) -0.23 [-0.48, 0.03]
15 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: medium-term follow-up
10 Std. Mean Difference (Random, 95% CI) -0.43 [-0.76, -0.10]
15.1 Low-frequency ≤ 1 Hz 2 Std. Mean Difference (Random, 95% CI) -0.08 [-1.26, 1.10]
15.2 High-frequency ≥ 5 Hz 9 Std. Mean Difference (Random, 95% CI) -0.48 [-0.83, -0.13]
16 Pain: long-term follow-up 3 Std. Mean Difference (Random, 95% CI) -0.12 [-0.46, 0.21]
17 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: long-term follow-up
4 Std. Mean Difference (Random, 95% CI) -0.46 [-1.10, 0.17]
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18 Disability/pain interference:
short-term follow-up
5 Std. Mean Difference (Random, 95% CI) -0.29 [-0.87, 0.29]
19 Disability/pain interference:
medium-term follow-up
4 Std. Mean Difference (Random, 95% CI) -0.37 [-1.07, 0.33]
20 Disability/pain interference:
long-term follow-up
3 Std. Mean Difference (Random, 95% CI) -0.23 [-0.62, 0.16]
21 Quality of life: short-term
follow-up (Fibromyalgia
Impact Questionnaire)
3 80 Mean Difference (IV, Random, 95% CI) -10.38 [-14.89, -5.
87]
22 Quality of life: medium-term
follow-up (Fibromyalgia
Impact Questionnaire)
3 80 Mean Difference (IV, Fixed, 95% CI) -11.49 [-17.04, -5.
95]
23 Quality of life: long-term
follow-up
1 Std. Mean Difference (Random, 95% CI) Totals not selected
Comparison 2. Cranial electrotherapy stimulation (CES)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 5 270 Std. Mean Difference (IV, Random, 95% CI) -0.24 [-0.48, 0.01]
2 Disability/function/pain
interference
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Quality of life 1 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
Comparison 3. Transcranial direct current stimulation (tDCS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 11 Std. Mean Difference (Random, 95% CI) -0.18 [-0.46, 0.09]
1.1 Single-dose studies 3 Std. Mean Difference (Random, 95% CI) -0.18 [-0.41, 0.05]
1.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.22 [-0.69, 0.25]
2 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only
11 Std. Mean Difference (Random, 95% CI) -0.23 [-0.48, 0.01]
2.1 Single-dose studies 3 Std. Mean Difference (Random, 95% CI) -0.18 [-0.41, 0.05]
2.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.35 [-0.79, 0.09]
3 Pain: short-term sensitivity
analysis: correlation increased
11 Std. Mean Difference (Random, 95% CI) -0.20 [-0.47, 0.06]
4 Pain: short-term sensitivity
analysis: correlation decreased
11 Std. Mean Difference (Random, 95% CI) -0.23 [-0.51, 0.06]
5 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only, sensitivity
analysis: correlation increased
11 Std. Mean Difference (Random, 95% CI) -0.23 [-0.48, 0.02]
5.1 Single-dose studies 3 Std. Mean Difference (Random, 95% CI) -0.18 [-0.41, 0.05]
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5.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.35 [-0.79, 0.10]
6 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only, sensitivity
analysis: correlation decreased
11 Std. Mean Difference (Random, 95% CI) -0.24 [-0.48, -0.00]
6.1 Single-dose studies 3 Std. Mean Difference (Random, 95% CI) -0.18 [-0.41, 0.05]
6.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.36 [-0.79, 0.07]
7 Pain: medium-term follow-up 5 Std. Mean Difference (Random, 95% CI) -0.20 [-0.63, 0.24]
8 Disability (pain interference):
short-term follow-up
1 Mean Difference (IV, Random, 95% CI) Subtotals only
9 Quality of life: short-term
follow-up
2 42 Std. Mean Difference (IV, Random, 95% CI) 0.88 [0.24, 1.53]
10 Quality of life: medium-term
follow-up
1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
11 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only
11 Std. Mean Difference (Random, 95% CI) -0.26 [-0.49, -0.03]
11.1 Single-dose studies 3 Std. Mean Difference (Random, 95% CI) -0.18 [-0.41, 0.05]
11.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.38 [-0.80, 0.03]
Comparison 4. Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2 Fibromyalgia Impact
Questionnaire total score
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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Analysis 1.1. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 1 Pain: short-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 1 Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 1.8 % -0.02 [ -0.52, 0.49 ]
Carretero 2009 0.15649 (0.230164) 2.3 % 0.16 [ -0.29, 0.61 ]
Lefaucheur 2001b 0.156 (0.162229) 4.6 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (1) 0.37847 (0.21421) 2.6 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 6.1 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.1 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 18.6 % 0.15 [ -0.01, 0.31 ]
Heterogeneity: Chi2 = 2.48, df = 5 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.84 (P = 0.065)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.259685) 1.8 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (2) -0.41092 (0.191008) 3.3 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (3) -0.287518 (0.187174) 3.5 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 10.8 % -0.38 [ -0.59, -0.18 ]
Avery 2013 0.57 (0.494898) 0.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
Defrin 2007 (4) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (5) 0.18872 (0.309645) 1.3 % 0.19 [ -0.42, 0.80 ]
Hirayama 2006 (6) 0.23554 (0.311152) 1.3 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (7) 0.19336 (0.309779) 1.3 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (8) -0.38726 (0.318223) 1.2 % -0.39 [ -1.01, 0.24 ]
Hosomi 2013 (9) -0.11985 (0.116422) 9.0 % -0.12 [ -0.35, 0.11 ]
Hosomi 2013 (10) -0.057109 (0.127547) 7.5 % -0.06 [ -0.31, 0.19 ]
Kang 2009 0.43402 (0.216454) 2.6 % 0.43 [ 0.01, 0.86 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Lefaucheur 2001a -0.9332 (0.219757) 2.5 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.2 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 14.6 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.3 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 5.9 % -0.33 [ -0.62, -0.05 ]
Mhalla 2011 -0.58 (0.32398) 1.2 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 0.8 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 2.6 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.1 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (11) -1.158204 (0.426308) 0.7 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (12) -1.110603 (0.419362) 0.7 % -1.11 [ -1.93, -0.29 ]
Short 2011 -0.55 (0.456633) 0.6 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 81.4 % -0.27 [ -0.35, -0.20 ]
Heterogeneity: Chi2 = 69.89, df = 25 (P<0.00001); I2 =64%
Test for overall effect: Z = 7.09 (P < 0.00001)
Total (95% CI) 100.0 % -0.20 [ -0.26, -0.13 ]
Heterogeneity: Chi2 = 94.64, df = 31 (P<0.00001); I2 =67%
Test for overall effect: Z = 5.61 (P < 0.00001)
Test for subgroup differences: Chi2 = 22.28, df = 1 (P = 0.00), I2 =96%
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) Pain score higher at baseline in active stim group
(5) SMA
(6) S1
(7) PMA
(8) M1
(9) M1 Group B (sham followed by real)
(10) M1 Group A (real followed by sham)
(11) 5Hz
(12) 10 Hz
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Analysis 1.2. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 2 Pain: short-
term follow-up, subgroup analysis: multiple-dose vs single-dose studies.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 2 Pain: short-term follow-up, subgroup analysis: multiple-dose vs single-dose studies
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.066506 (0.259685) 3.2 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2006 (2) -0.016296 (0.259415) 3.2 % -0.02 [ -0.52, 0.49 ]
Andr -Obadia 2008 (3) -0.287518 (0.187174) 4.0 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2008 (4) -0.41092 (0.191008) 3.9 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2011 -0.383319 (0.105999) 5.0 % -0.38 [ -0.59, -0.18 ]
Hirayama 2006 (5) -0.38726 (0.318223) 2.6 % -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (6) 0.23554 (0.311152) 2.7 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (7) 0.19336 (0.309779) 2.7 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (8) 0.18872 (0.309645) 2.7 % 0.19 [ -0.42, 0.80 ]
Lefaucheur 2001a -0.9332 (0.219757) 3.6 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b (9) -0.274478 (0.233036) 3.5 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2001b (10) 0.156 (0.230164) 3.5 % 0.16 [ -0.30, 0.61 ]
Lefaucheur 2004 -0.344828 (0.091197) 5.1 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 (11) 0.37847 (0.21421) 3.7 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2006 (12) -0.64827 (0.227633) 3.5 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 (13) -0.334132 (0.143948) 4.5 % -0.33 [ -0.62, -0.05 ]
Lefaucheur 2008 (14) 0.14778 (0.140854) 4.6 % 0.15 [ -0.13, 0.42 ]
Pleger 2004 -0.138771 (0.21807) 3.6 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.9 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (15) -1.158204 (0.426308) 1.8 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (16) -1.110603 (0.419362) 1.9 % -1.11 [ -1.93, -0.29 ]
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Saitoh 2007 (17) -0.169857 (0.332186) 2.5 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 75.4 % -0.23 [ -0.37, -0.09 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 53.49, df = 21 (P = 0.00012); I2 =61%
Test for overall effect: Z = 3.18 (P = 0.0015)
2 Multiple-dose studies
Avery 2013 0.57 (0.494898) 1.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.8 % -2.72 [ -4.17, -1.26 ]
Carretero 2009 0.6 (0.403061) 2.0 % 0.60 [ -0.19, 1.39 ]
Defrin 2007 1.12 (0.642857) 1.0 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (18) -0.019928 (0.116018) 4.8 % -0.02 [ -0.25, 0.21 ]
Hosomi 2013 (19) -0.057109 (0.127547) 4.7 % -0.06 [ -0.31, 0.19 ]
Kang 2009 0.43402 (0.216454) 3.6 % 0.43 [ 0.01, 0.86 ]
Mhalla 2011 -0.58 (0.32397959) 2.5 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 2.0 % -1.04 [ -1.81, -0.27 ]
Short 2011 -0.55 (0.456633) 1.7 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 24.6 % -0.12 [ -0.47, 0.23 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 35.62, df = 9 (P = 0.00005); I2 =75%
Test for overall effect: Z = 0.67 (P = 0.51)
Total (95% CI) 100.0 % -0.19 [ -0.33, -0.06 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 95.71, df = 31 (P<0.00001); I2 =68%
Test for overall effect: Z = 2.78 (P = 0.0054)
Test for subgroup differences: Chi2 = 0.31, df = 1 (P = 0.58), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
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(1) 20Hz
(2) 1Hz
(3) 20 Hz medial-lateral coil orientation
(4) 20Hz antero-posterior coil orientation
(5) M1
(6) S1
(7) PMA
(8) SMA
(9) 10Hz
(10) 0.5 Hz
(11) 1Hz
(12) 10Hz
(13) 10 Hz
(14) 1Hz
(15) 5Hz
(16) 10Hz
(17) 1Hz
(18) M1 Group A real followed by sham
(19) M1 Sham followed by real
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Analysis 1.3. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 3 Pain: short-
term follow-up, subgroup analysis, neuropathic pain participants only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 3 Pain: short-term follow-up, subgroup analysis, neuropathic pain participants only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 2.0 % -0.02 [ -0.52, 0.49 ]
Lefaucheur 2001b 0.156 (0.162229) 5.2 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (1) 0.37847 (0.21421) 3.0 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 6.9 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.2 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 18.3 % 0.15 [ -0.02, 0.32 ]
Heterogeneity: Chi2 = 2.48, df = 4 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.71 (P = 0.087)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.259685) 2.0 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (2) -0.41092 (0.191008) 3.7 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (3) -0.287518 (0.187174) 3.9 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 12.1 % -0.38 [ -0.59, -0.18 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
Defrin 2007 (4) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (5) 0.19336 (0.309779) 1.4 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (6) 0.23554 (0.311152) 1.4 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (7) -0.38726 (0.318223) 1.3 % -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (8) 0.18872 (0.309645) 1.4 % 0.19 [ -0.42, 0.80 ]
Hosomi 2013 (9) -0.11985 (0.116422) 10.1 % -0.12 [ -0.35, 0.11 ]
Hosomi 2013 (10) -0.057109 (0.127547) 8.4 % -0.06 [ -0.31, 0.19 ]
Kang 2009 0.43402 (0.216454) 2.9 % 0.43 [ 0.01, 0.86 ]
Lefaucheur 2001a -0.9332 (0.219757) 2.8 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.5 % -0.27 [ -0.73, 0.18 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Lefaucheur 2004 -0.344828 (0.091197) 16.4 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.6 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 6.6 % -0.33 [ -0.62, -0.05 ]
Saitoh 2007 (11) -1.110603 (0.419362) 0.8 % -1.11 [ -1.93, -0.29 ]
Saitoh 2007 (12) -1.158204 (0.426308) 0.7 % -1.16 [ -1.99, -0.32 ]
Subtotal (95% CI) 81.7 % -0.27 [ -0.35, -0.19 ]
Heterogeneity: Chi2 = 61.15, df = 19 (P<0.00001); I2 =69%
Test for overall effect: Z = 6.71 (P < 0.00001)
Total (95% CI) 100.0 % -0.20 [ -0.27, -0.12 ]
Heterogeneity: Chi2 = 83.16, df = 24 (P<0.00001); I2 =71%
Test for overall effect: Z = 5.34 (P < 0.00001)
Test for subgroup differences: Chi2 = 19.53, df = 1 (P = 0.00), I2 =95%
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) Pain score higher at baseline in active stim group
(5) PMA
(6) S1
(7) M1
(8) SMA
(9) M1 Group B (sham followed by real)
(10) M1 Group A (real followed by sham)
(11) 10 Hz
(12) 5Hz
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Analysis 1.4. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 4 Pain: short-
term follow-up, subgroup analysis, non-neuropathic pain participants only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 4 Pain: short-term follow-up, subgroup analysis, non-neuropathic pain participants only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 0.15649 (0.230164) 29.1 % 0.16 [ -0.29, 0.61 ]
Subtotal (95% CI) 29.1 % 0.16 [ -0.29, 0.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 High-frequency≥ 5 Hz
Avery 2013 0.57 (0.494898) 6.3 % 0.57 [ -0.40, 1.54 ]
Mhalla 2011 -0.58 (0.32398) 14.7 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 10.0 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 32.5 % -0.14 [ -0.57, 0.29 ]
Short 2011 -0.55 (0.456633) 7.4 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 70.9 % -0.34 [ -0.63, -0.05 ]
Heterogeneity: Chi2 = 8.17, df = 4 (P = 0.09); I2 =51%
Test for overall effect: Z = 2.29 (P = 0.022)
Total (95% CI) 100.0 % -0.19 [ -0.44, 0.05 ]
Heterogeneity: Chi2 = 11.43, df = 5 (P = 0.04); I2 =56%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Chi2 = 3.26, df = 1 (P = 0.07), I2 =69%
-4 -2 0 2 4
Favours active Favours sham
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Analysis 1.5. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 5 Pain: short-
term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 5 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.259685) 4.3 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (1) -0.41092 (0.191008) 5.8 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (2) -0.287518 (0.187174) 5.9 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 7.9 % -0.38 [ -0.59, -0.18 ]
Hirayama 2006 -0.38726 (0.318223) 3.4 % -0.39 [ -1.01, 0.24 ]
Lefaucheur 2001a -0.9332 (0.219757) 5.1 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 4.9 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 8.2 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 5.0 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 6.9 % -0.33 [ -0.62, -0.05 ]
Pleger 2004 -0.138771 (0.21807) 5.2 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 5.6 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 -1.158204 (0.426308) 2.3 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 -1.110603 (0.419362) 2.3 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 72.7 % -0.39 [ -0.51, -0.27 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 18.83, df = 13 (P = 0.13); I2 =31%
Test for overall effect: Z = 6.32 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.2 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.019928 (0.116018) 7.6 % -0.02 [ -0.25, 0.21 ]
Hosomi 2013 (4) -0.057109 (0.127547) 7.4 % -0.06 [ -0.31, 0.19 ]
Kang 2009 0.43402 (0.216454) 5.2 % 0.43 [ 0.01, 0.86 ]
Mhalla 2011 -0.58 (0.32397959) 3.3 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 2.6 % -1.04 [ -1.81, -0.27 ]
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 27.3 % -0.07 [ -0.41, 0.26 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 17.34, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 100.0 % -0.32 [ -0.46, -0.17 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 51.62, df = 19 (P = 0.00008); I2 =63%
Test for overall effect: Z = 4.29 (P = 0.000018)
Test for subgroup differences: Chi2 = 3.13, df = 1 (P = 0.08), I2 =68%
-2 -1 0 1 2
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) Group A real followed by sham
(4) Group B sham followed by real
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Analysis 1.6. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 6 Sensitivity
analysis - imputed correlation coefficient increased. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 6 Sensitivity analysis - imputed correlation coefficient increased. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.200013) 3.3 % -0.02 [ -0.41, 0.38 ]
Carretero 2009 0.6 (0.403061) 1.7 % 0.60 [ -0.19, 1.39 ]
Lee 2012 -0.59 (0.760204) 0.7 % -0.59 [ -2.08, 0.90 ]
Lefaucheur 2001b 0.15649 (0.17746) 3.5 % 0.16 [ -0.19, 0.50 ]
Lefaucheur 2006 (1) 0.37847 (0.165159) 3.7 % 0.38 [ 0.05, 0.70 ]
Lefaucheur 2008 0.14778 (0.097135) 4.3 % 0.15 [ -0.04, 0.34 ]
Saitoh 2007 -0.169857 (0.256121) 2.8 % -0.17 [ -0.67, 0.33 ]
Subtotal (95% CI) 20.0 % 0.15 [ 0.01, 0.29 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 6.36, df = 6 (P = 0.38); I2 =6%
Test for overall effect: Z = 2.13 (P = 0.033)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.200221) 3.3 % -0.07 [ -0.46, 0.33 ]
Andr -Obadia 2008 (2) -0.41092 (0.14727) 3.8 % -0.41 [ -0.70, -0.12 ]
Andr -Obadia 2008 (3) -0.287518 (0.144314) 3.9 % -0.29 [ -0.57, 0.00 ]
Andr -Obadia 2011 -0.383319 (0.081727) 4.4 % -0.38 [ -0.54, -0.22 ]
Avery 2013 0.57 (0.494898) 1.3 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.57314) 1.0 % -2.72 [ -3.84, -1.59 ]
Defrin 2007 1.12 (0.642857) 0.9 % 1.12 [ -0.14, 2.38 ]
Fregni 2005 0 (0) Not estimable
Hirayama 2006 (4) 0.18872 (0.238741) 2.9 % 0.19 [ -0.28, 0.66 ]
Hirayama 2006 (5) -0.38726 (0.245355) 2.9 % -0.39 [ -0.87, 0.09 ]
Hirayama 2006 (6) 0.23554 (0.239903) 2.9 % 0.24 [ -0.23, 0.71 ]
Hirayama 2006 (7) 0.19336 (0.238845) 2.9 % 0.19 [ -0.27, 0.66 ]
Hosomi 2013 (8) -0.11985 (0.089763) 4.4 % -0.12 [ -0.30, 0.06 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hosomi 2013 (9) -0.057109 (0.098341) 4.3 % -0.06 [ -0.25, 0.14 ]
Kang 2009 0.43402 (0.166889) 3.6 % 0.43 [ 0.11, 0.76 ]
Lee 2012 -0.4 (0.742347) 0.7 % -0.40 [ -1.85, 1.05 ]
Lefaucheur 2001a -0.9332 (0.169436) 3.6 % -0.93 [ -1.27, -0.60 ]
Lefaucheur 2001b -0.274478 (0.179675) 3.5 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 4.5 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 3.6 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 4.3 % -0.33 [ -0.53, -0.14 ]
Mhalla 2011 -0.58 (0.32398) 2.2 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 1.8 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.168136) 3.6 % -0.14 [ -0.47, 0.19 ]
Rollnik 2002 -0.150199 (0.153612) 3.8 % -0.15 [ -0.45, 0.15 ]
Saitoh 2007 (10) -1.158204 (0.323335) 2.2 % -1.16 [ -1.79, -0.52 ]
Saitoh 2007 (11) -1.110603 (0.32869) 2.2 % -1.11 [ -1.75, -0.47 ]
Short 2011 -0.55 (0.456633) 1.5 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 80.0 % -0.30 [ -0.44, -0.16 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 109.05, df = 26 (P<0.00001); I2 =76%
Test for overall effect: Z = 4.24 (P = 0.000022)
Total (95% CI) 100.0 % -0.21 [ -0.34, -0.08 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 149.37, df = 33 (P<0.00001); I2 =78%
Test for overall effect: Z = 3.24 (P = 0.0012)
Test for subgroup differences: Chi2 = 20.20, df = 1 (P = 0.00), I2 =95%
-4 -2 0 2 4
Favours active Favours sham
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(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) SMA
(5) M1
(6) S1
(7) PMA
(8) M1 Group B (sham followed by real)
(9) M1 Group A (real followed by sham)
(10) 10 Hz
(11) 5Hz
Analysis 1.7. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 7 Sensitivity
analysis - imputed correlation coefficient decreased. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 7 Sensitivity analysis - imputed correlation coefficient decreased. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.311698) 2.6 % -0.02 [ -0.63, 0.59 ]
Carretero 2009 0.6 (0.403061) 1.9 % 0.60 [ -0.19, 1.39 ]
Lefaucheur 2001b 0.15649 (0.276551) 2.9 % 0.16 [ -0.39, 0.70 ]
Lefaucheur 2006 0.37847 (0.257382) 3.1 % 0.38 [ -0.13, 0.88 ]
Lefaucheur 2008 0.14778 (0.151374) 4.3 % 0.15 [ -0.15, 0.44 ]
Saitoh 2007 -0.169857 (0.355683) 2.2 % -0.17 [ -0.87, 0.53 ]
Subtotal (95% CI) 17.1 % 0.17 [ -0.03, 0.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.09, df = 5 (P = 0.69); I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 1.67 (P = 0.095)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.312022) 2.6 % -0.07 [ -0.68, 0.55 ]
Andr -Obadia 2008 (1) -0.287518 (0.224898) 3.5 % -0.29 [ -0.73, 0.15 ]
Andr -Obadia 2008 (2) -0.41092 (0.229504) 3.4 % -0.41 [ -0.86, 0.04 ]
Andr -Obadia 2011 -0.383319 (0.127363) 4.6 % -0.38 [ -0.63, -0.13 ]
Avery 2013 0.57 (0.494898) 1.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.893174) 0.5 % -2.72 [ -4.47, -0.97 ]
Defrin 2007 1.12 (0.642857) 1.0 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (3) -0.38726 (0.245355) 3.2 % -0.39 [ -0.87, 0.09 ]
Hirayama 2006 (4) 0.18872 (0.238741) 3.3 % 0.19 [ -0.28, 0.66 ]
Hirayama 2006 (5) 0.23554 (0.239903) 3.3 % 0.24 [ -0.23, 0.71 ]
Hirayama 2006 (6) 0.19336 (0.238845) 3.3 % 0.19 [ -0.27, 0.66 ]
Hosomi 2013 (7) -0.11985 (0.139886) 4.4 % -0.12 [ -0.39, 0.15 ]
Hosomi 2013 (8) -0.057109 (0.153253) 4.3 % -0.06 [ -0.36, 0.24 ]
Kang 2009 0.43402 (0.166889) 4.1 % 0.43 [ 0.11, 0.76 ]
Lee 2012 -0.4 (0.742347) 0.8 % -0.40 [ -1.85, 1.05 ]
Lefaucheur 2001a -0.9332 (0.169436) 4.1 % -0.93 [ -1.27, -0.60 ]
Lefaucheur 2001b -0.274478 (0.179675) 4.0 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 5.1 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 4.0 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 4.9 % -0.33 [ -0.53, -0.14 ]
Mhalla 2011 -0.58 (0.32398) 2.5 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 2.0 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 3.5 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.7 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (9) -1.110603 (0.419362) 1.8 % -1.11 [ -1.93, -0.29 ]
Saitoh 2007 (10) -1.158204 (0.426308) 1.8 % -1.16 [ -1.99, -0.32 ]
Short 2011 -0.55 (0.456633) 1.6 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 82.9 % -0.28 [ -0.42, -0.13 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 85.31, df = 26 (P<0.00001); I2 =70%
Test for overall effect: Z = 3.69 (P = 0.00022)
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 100.0 % -0.20 [ -0.34, -0.06 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 105.99, df = 32 (P<0.00001); I2 =70%
Test for overall effect: Z = 2.85 (P = 0.0044)
Test for subgroup differences: Chi2 = 12.45, df = 1 (P = 0.00), I2 =92%
-2 -1 0 1 2
Favours active Favours sham
(1) medial-lateral coil orientatioin
(2) antero-posterior coil orientation
(3) M1
(4) SMA
(5) S1
(6) PMA
(7) M1 Group B (sham followed by real)
(8) M1 Group A (real followed by sham)
(9) 10 Hz
(10) 5Hz
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Analysis 1.8. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 8 Sensitivity
analysis - imputed correlation increased. Pain: short-term follow-up, subgroup analysis: motor cortex studies
only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 8 Sensitivity analysis - imputed correlation increased. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.200221) 4.8 % -0.07 [ -0.46, 0.33 ]
Andr -Obadia 2008 (1) -0.287518 (0.144314) 5.9 % -0.29 [ -0.57, 0.00 ]
Andr -Obadia 2008 (2) -0.41092 (0.14727) 5.9 % -0.41 [ -0.70, -0.12 ]
Andr -Obadia 2011 -0.383319 (0.081727) 7.2 % -0.38 [ -0.54, -0.22 ]
Hirayama 2006 -0.38726 (0.245355) 4.0 % -0.39 [ -0.87, 0.09 ]
Lefaucheur 2001a -0.9332 (0.169436) 5.4 % -0.93 [ -1.27, -0.60 ]
Lefaucheur 2001b -0.274478 (0.179675) 5.2 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 7.4 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 5.3 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 6.9 % -0.33 [ -0.53, -0.14 ]
Pleger 2004 -0.138771 (0.168136) 5.4 % -0.14 [ -0.47, 0.19 ]
Rollnik 2002 -0.150199 (0.153612) 5.7 % -0.15 [ -0.45, 0.15 ]
Saitoh 2007 -1.158204 (0.32869) 2.8 % -1.16 [ -1.80, -0.51 ]
Saitoh 2007 -1.110603 (0.323335) 2.9 % -1.11 [ -1.74, -0.48 ]
Subtotal (95% CI) 74.6 % -0.41 [ -0.53, -0.29 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 31.72, df = 13 (P = 0.003); I2 =59%
Test for overall effect: Z = 6.53 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.0 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.057109 (0.098341) 6.9 % -0.06 [ -0.25, 0.14 ]
Hosomi 2013 (4) -0.11985 (0.089763) 7.0 % -0.12 [ -0.30, 0.06 ]
Kang 2009 0.43402 (0.166889) 5.4 % 0.43 [ 0.11, 0.76 ]
Mhalla 2011 -0.58 (0.32397959) 2.9 % -0.58 [ -1.21, 0.05 ]
-1 -0.5 0 0.5 1
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 -1.08 (0.393857) 2.2 % -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) 25.4 % -0.08 [ -0.39, 0.23 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 21.85, df = 5 (P = 0.00056); I2 =77%
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 100.0 % -0.33 [ -0.47, -0.20 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 75.48, df = 19 (P<0.00001); I2 =75%
Test for overall effect: Z = 4.85 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.62, df = 1 (P = 0.06), I2 =72%
-1 -0.5 0 0.5 1
Favours active Favours sham
(1) medial-lateral coil orientation
(2) antero-posterior coil orientation
(3) Group A (real followed by sham)
(4) Group B (sham followed by real)
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Analysis 1.9. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 9 Sensitivity
analysis - imputed correlation decreased. Pain: short-term follow-up, subgroup analysis: motor cortex studies
only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 9 Sensitivity analysis - imputed correlation decreased. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.312022) 3.8 % -0.07 [ -0.68, 0.55 ]
Andr -Obadia 2008 (1) -0.287518 (0.224898) 5.7 % -0.29 [ -0.73, 0.15 ]
Andr -Obadia 2008 (2) -0.41092 (0.229504) 5.6 % -0.41 [ -0.86, 0.04 ]
Andr -Obadia 2011 -0.383319 (0.127363) 9.0 % -0.38 [ -0.63, -0.13 ]
Hirayama 2006 -0.38726 (0.382358) 2.8 % -0.39 [ -1.14, 0.36 ]
Lefaucheur 2001a -0.9332 (0.264047) 4.7 % -0.93 [ -1.45, -0.42 ]
Lefaucheur 2001b -0.274478 (0.280003) 4.4 % -0.27 [ -0.82, 0.27 ]
Lefaucheur 2004 -0.344828 (0.109577) 9.7 % -0.34 [ -0.56, -0.13 ]
Lefaucheur 2006 -0.64827 (0.312022) 3.8 % -0.65 [ -1.26, -0.04 ]
Lefaucheur 2008 -0.334132 (0.1547) 8.0 % -0.33 [ -0.64, -0.03 ]
Pleger 2004 -0.138771 (0.262021) 4.8 % -0.14 [ -0.65, 0.37 ]
Rollnik 2002 -0.150199 (0.239386) 5.3 % -0.15 [ -0.62, 0.32 ]
Saitoh 2007 -1.110603 (0.503881) 1.8 % -1.11 [ -2.10, -0.12 ]
Saitoh 2007 -1.158204 (0.512227) 1.7 % -1.16 [ -2.16, -0.15 ]
Subtotal (95% CI) 71.1 % -0.38 [ -0.49, -0.27 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 12.83, df = 13 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 6.72 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.2 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.11985 (0.139886) 8.5 % -0.12 [ -0.39, 0.15 ]
Hosomi 2013 (4) -0.057109 (0.153253) 8.0 % -0.06 [ -0.36, 0.24 ]
Kang 2009 0.43402 (0.260078) 4.8 % 0.43 [ -0.08, 0.94 ]
Mhalla 2011 -0.58 (0.32397959) 3.6 % -0.58 [ -1.21, 0.05 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 -1.08 (0.392857) 2.7 % -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) 28.9 % -0.11 [ -0.48, 0.25 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 16.33, df = 5 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.61 (P = 0.54)
Total (95% CI) 100.0 % -0.31 [ -0.46, -0.17 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 36.36, df = 19 (P = 0.01); I2 =48%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Chi2 = 1.78, df = 1 (P = 0.18), I2 =44%
-4 -2 0 2 4
Favours active Favours sham
(1) medial-lateral coil orientation
(2) antero-posterior coil orientation
(3) Group A (sham followed by real)
(4) Group A (real followed by sham)
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Analysis 1.10. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 10 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 10 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 2.0 % -0.02 [ -0.52, 0.49 ]
Carretero 2009 0.15649 (0.230164) 2.5 % 0.16 [ -0.29, 0.61 ]
Fregni 2011 0 (0) Not estimable
Irlbacher 2006 -0.178283 (0.188266) 3.7 % -0.18 [ -0.55, 0.19 ]
Lee 2012 (1) -0.59 (0.760204) 0.2 % -0.59 [ -2.08, 0.90 ]
Lefaucheur 2001b 0.156 (0.162229) 5.0 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (2) 0.37847 (0.21421) 2.9 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 6.6 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.2 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 24.1 % 0.09 [ -0.05, 0.24 ]
Heterogeneity: Chi2 = 5.84, df = 7 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.22)
2 High-frequency≥ 5 Hz
Ahmed 2011 -3.58 (0.660714) 0.3 % -3.58 [ -4.87, -2.29 ]
Andr -Obadia 2006 -0.066506 (0.259685) 2.0 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (3) -0.41092 (0.191008) 3.6 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (4) -0.287518 (0.187174) 3.8 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 11.7 % -0.38 [ -0.59, -0.18 ]
Avery 2013 0.57 (0.494898) 0.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
Defrin 2007 (5) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (6) -0.38726 (0.318223) 1.3 % -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (7) 0.18872 (0.309645) 1.4 % 0.19 [ -0.42, 0.80 ]
Hirayama 2006 (8) 0.23554 (0.311152) 1.4 % 0.24 [ -0.37, 0.85 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Hirayama 2006 (9) 0.19336 (0.309779) 1.4 % 0.19 [ -0.41, 0.80 ]
Irlbacher 2006 -0.0702 (0.187018) 3.8 % -0.07 [ -0.44, 0.30 ]
Kang 2009 0.43402 (0.216454) 2.8 % 0.43 [ 0.01, 0.86 ]
Khedr 2005 -1.59 (0.334) 1.2 % -1.59 [ -2.24, -0.94 ]
Lee 2012 (10) 0.31 (0.739796) 0.2 % 0.31 [ -1.14, 1.76 ]
Lefaucheur 2001a -0.9332 (0.219757) 2.7 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.4 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 15.8 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.5 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 6.3 % -0.33 [ -0.62, -0.05 ]
Mhalla 2011 -0.58 (0.32398) 1.3 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 0.9 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 2.8 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.3 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (11) -1.110603 (0.419362) 0.7 % -1.11 [ -1.93, -0.29 ]
Saitoh 2007 (12) -1.158204 (0.426308) 0.7 % -1.16 [ -1.99, -0.32 ]
Short 2011 -0.55 (0.456633) 0.6 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 75.9 % -0.34 [ -0.42, -0.26 ]
Heterogeneity: Chi2 = 105.24, df = 27 (P<0.00001); I2 =74%
Test for overall effect: Z = 8.13 (P < 0.00001)
Total (95% CI) 100.0 % -0.23 [ -0.31, -0.16 ]
Heterogeneity: Chi2 = 136.73, df = 35 (P<0.00001); I2 =74%
Test for overall effect: Z = 6.47 (P < 0.00001)
Test for subgroup differences: Chi2 = 25.66, df = 1 (P = 0.00), I2 =96%
-4 -2 0 2 4
Favours active Favours sham
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(1) right DLPFC
(2) 1Hz
(3) antero-posterior coil orientation
(4) medial-lateral coil orientation
(5) Pain score higher at baseline in active stim group
(6) M1
(7) SMA
(8) S1
(9) PMA
(10) left M1
(11) 10 Hz
(12) 5Hz
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Analysis 1.11. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 11 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: motor cortex
studies only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 11 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies
excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.259685) 4.1 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (1) -0.41092 (0.191008) 4.9 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (2) -0.287518 (0.187174) 5.0 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.149906) 5.4 % -0.38 [ -0.68, -0.09 ]
Hirayama 2006 -0.38726 (0.318223) 3.4 % -0.39 [ -1.01, 0.24 ]
Irlbacher 2006 -0.0702 (0.187018) 5.0 % -0.07 [ -0.44, 0.30 ]
Lefaucheur 2001a -0.9332 (0.219757) 4.5 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 4.4 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 6.0 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 4.4 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 5.5 % -0.33 [ -0.62, -0.05 ]
Mhalla 2011 -0.21 (0.316327) 3.4 % -0.21 [ -0.83, 0.41 ]
Pleger 2004 -0.138771 (0.21807) 4.6 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 4.8 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 -1.158204 (0.426308) 2.5 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 -1.110603 (0.419362) 2.5 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 70.4 % -0.36 [ -0.48, -0.24 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 21.60, df = 15 (P = 0.12); I2 =31%
Test for overall effect: Z = 5.95 (P < 0.00001)
2 Multiple-dose studies
Ahmed 2011 -3.58 (0.660714) 1.3 % -3.58 [ -4.87, -2.29 ]
Defrin 2007 1.12 (0.642857) 1.4 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.11985 (0.116422) 5.8 % -0.12 [ -0.35, 0.11 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hosomi 2013 (4) -0.057109 (0.127547) 5.7 % -0.06 [ -0.31, 0.19 ]
Kang 2009 0.43402 (0.216454) 4.6 % 0.43 [ 0.01, 0.86 ]
Khedr 2005 -1.59 (0.334) 3.3 % -1.59 [ -2.24, -0.94 ]
Lee 2012 0.26 (0.635204) 1.4 % 0.26 [ -0.98, 1.50 ]
Mhalla 2011 -0.58 (0.32397959) 3.4 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 2.7 % -1.04 [ -1.81, -0.27 ]
Subtotal (95% CI) 29.6 % -0.50 [ -0.99, -0.01 ]
Heterogeneity: Tau2 = 0.41; Chi2 = 64.43, df = 8 (P<0.00001); I2 =88%
Test for overall effect: Z = 1.99 (P = 0.046)
Total (95% CI) 100.0 % -0.39 [ -0.56, -0.23 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 90.00, df = 24 (P<0.00001); I2 =73%
Test for overall effect: Z = 4.59 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.27, df = 1 (P = 0.60), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) Group A (sham followed by real)
(4) Group B (real followed by sham)
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Analysis 1.12. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 12 Pain: short-
term follow-up, subgroup analysis: prefrontal cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 12 Pain: short-term follow-up, subgroup analysis: prefrontal cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Multiple-dose studies
Avery 2013 (1) 0.57 (0.494898) 24.8 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 (2) -2.7017609 (0.743356) 19.3 % -2.70 [ -4.16, -1.24 ]
Carretero 2009 (3) 0.15649 (0.230164) 30.2 % 0.16 [ -0.29, 0.61 ]
Short 2011 (4) -0.55 (0.456633) 25.7 % -0.55 [ -1.44, 0.34 ]
Total (95% CI) 100.0 % -0.47 [ -1.48, 0.54 ]
Heterogeneity: Tau2 = 0.83; Chi2 = 16.28, df = 3 (P = 0.00099); I2 =82%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours active Favours sham
(1) 10Hz
(2) 10Hz
(3) 1 Hz
(4) 10Hz
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Analysis 1.13. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 13 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: prefrontal cortex
studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 13 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: prefrontal cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Multiple-dose studies
Avery 2013 (1) 0.57 (0.494898) 20.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 (2) -2.7017609 (0.743356) 15.3 % -2.70 [ -4.16, -1.24 ]
Carretero 2009 (3) 0.15649 (0.230164) 25.9 % 0.16 [ -0.29, 0.61 ]
Lee 2012 (4) -0.6 (0.655612) 17.0 % -0.60 [ -1.88, 0.68 ]
Short 2011 (5) -0.55 (0.456633) 21.3 % -0.55 [ -1.44, 0.34 ]
Total (95% CI) 100.0 % -0.48 [ -1.32, 0.37 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 16.87, df = 4 (P = 0.002); I2 =76%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours active Favours sham
(1) 10Hz
(2) 10Hz
(3) 1 Hz
(4) 1Hz
(5) 10Hz
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Analysis 1.14. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 14 Pain:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 14 Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 (1) 0.36 (0.3954) 7.4 % 0.36 [ -0.41, 1.13 ]
Subtotal (95% CI) 7.4 % 0.36 [ -0.41, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
2 High-frequency≥ 5 Hz
Avery 2013 (2) -0.11 (0.484694) 5.4 % -0.11 [ -1.06, 0.84 ]
Hosomi 2013 (3) 0.12839 (0.127967) 20.7 % 0.13 [ -0.12, 0.38 ]
Hosomi 2013 (4) -0.14898 (0.116648) 21.5 % -0.15 [ -0.38, 0.08 ]
Kang 2009 (5) -0.126074 (0.207526) 15.4 % -0.13 [ -0.53, 0.28 ]
Lefaucheur 2001a (6) -0.77794 (0.209117) 15.3 % -0.78 [ -1.19, -0.37 ]
Passard 2007 (7) -0.4 (0.367347) 8.2 % -0.40 [ -1.12, 0.32 ]
Short 2011 (8) -0.46 (0.454082) 6.0 % -0.46 [ -1.35, 0.43 ]
Subtotal (95% CI) 92.6 % -0.23 [ -0.48, 0.03 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 14.70, df = 6 (P = 0.02); I2 =59%
Test for overall effect: Z = 1.73 (P = 0.083)
Total (95% CI) 100.0 % -0.18 [ -0.43, 0.06 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 16.31, df = 7 (P = 0.02); I2 =57%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Chi2 = 1.98, df = 1 (P = 0.16), I2 =50%
-2 -1 0 1 2
Favours active Favours sham
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(1) DLPFC, 1 Hz 4 weeks post treatment
(2) DLPFC 10Hz 1 month follow up
(3) M1 10Hz, Group A real followed by sham, 17 days post treatment
(4) M1 10Hz, Group B sham followed by real, 17 days post treatment
(5) M1, 10Hz, 3 week follow up
(6) M1, 10HZ, 12 days post stimulation
(7) M1, 10Hz, 15 days post first stim (likely 2 weeks post intervention)
(8) DLPFC,10Hz, 2 weeks post treatment
Analysis 1.15. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 15 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 15 Sensitivity analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 (1) 0.36 (0.3954) 7.8 % 0.36 [ -0.41, 1.13 ]
Lee 2012 (2) -0.9 (0.795918) 3.4 % -0.90 [ -2.46, 0.66 ]
Subtotal (95% CI) 11.2 % -0.08 [ -1.26, 1.10 ]
Heterogeneity: Tau2 = 0.40; Chi2 = 2.01, df = 1 (P = 0.16); I2 =50%
Test for overall effect: Z = 0.13 (P = 0.89)
2 High-frequency≥ 5 Hz
Ahmed 2011 -2.61 (0.558673) 5.5 % -2.61 [ -3.70, -1.52 ]
Avery 2013 (3) -0.11 (0.484694) 6.4 % -0.11 [ -1.06, 0.84 ]
Hosomi 2013 (4) 0.12839 (0.127967) 12.8 % 0.13 [ -0.12, 0.38 ]
Hosomi 2013 (5) -0.14898 (0.116648) 13.0 % -0.15 [ -0.38, 0.08 ]
Kang 2009 (6) -0.126074 (0.207526) 11.4 % -0.13 [ -0.53, 0.28 ]
Khedr 2005 -1.16 (0.313776) 9.3 % -1.16 [ -1.77, -0.55 ]
Lee 2012 0.06 (0.729592) 3.8 % 0.06 [ -1.37, 1.49 ]
-2 -1 0 1 2
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Lefaucheur 2001a (7) -0.77794 (0.209117) 11.4 % -0.78 [ -1.19, -0.37 ]
Passard 2007 (8) -0.4 (0.367347) 8.3 % -0.40 [ -1.12, 0.32 ]
Short 2011 (9) -0.46 (0.454082) 6.9 % -0.46 [ -1.35, 0.43 ]
Subtotal (95% CI) 88.8 % -0.48 [ -0.83, -0.13 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 43.06, df = 9 (P<0.00001); I2 =79%
Test for overall effect: Z = 2.68 (P = 0.0074)
Total (95% CI) 100.0 % -0.43 [ -0.76, -0.10 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 45.98, df = 11 (P<0.00001); I2 =76%
Test for overall effect: Z = 2.56 (P = 0.011)
Test for subgroup differences: Chi2 = 0.41, df = 1 (P = 0.52), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
(1) DLPFC 4 weeks post treatment
(2) dlpfc 4 weeks post treatment
(3) 10Hz DLPFC 1 month follow up
(4) M1 Group A real followed by sham, around 17 days post treatment
(5) M1 Group B sham followed by real, around 17 days post treatment
(6) M1 3 week follow up
(7) M1 12 days post
(8) M1 15 days post first stim (likely 2 weeks post internvetion)
(9) DLPFC 2 weeks post treatment
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Analysis 1.16. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 16 Pain: long-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 16 Pain: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) -0.27 (0.484694) 12.5 % -0.27 [ -1.22, 0.68 ]
Kang 2009 (2) -0.100705 (0.207229) 68.3 % -0.10 [ -0.51, 0.31 ]
Passard 2007 (3) -0.11 (0.390306) 19.2 % -0.11 [ -0.87, 0.65 ]
Total (95% CI) 100.0 % -0.12 [ -0.46, 0.21 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.10, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) 3 month follow up
(2) 7 week follow up
(3) 60 day follow up
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Analysis 1.17. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 17 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 17 Sensitivity analysis - inclusion of high risk of bias studies. Pain: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahmed 2011 (1) -1.62 (0.464286) 21.5 % -1.62 [ -2.53, -0.71 ]
Avery 2013 (2) -0.27 (0.484694) 20.7 % -0.27 [ -1.22, 0.68 ]
Kang 2009 (3) -0.100705 (0.207229) 33.1 % -0.10 [ -0.51, 0.31 ]
Passard 2007 (4) -0.11 (0.390306) 24.7 % -0.11 [ -0.87, 0.65 ]
Total (95% CI) 100.0 % -0.46 [ -1.10, 0.17 ]
Heterogeneity: Tau2 = 0.28; Chi2 = 9.25, df = 3 (P = 0.03); I2 =68%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) 20Hz, M1, 2 month follow up
(2) 10Hz DLPFC 3 month follow up
(3) 10Hz, M1, 7 week follow up
(4) 10Hz, M1, 60 day follow up
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Analysis 1.18. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 18
Disability/pain interference: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 18 Disability/pain interference: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) 0.38 (0.489796) 16.3 % 0.38 [ -0.58, 1.34 ]
Kang 2009 (2) 0.29605 (0.211186) 25.4 % 0.30 [ -0.12, 0.71 ]
Mhalla 2011 (3) -0.98 (0.336735) 21.2 % -0.98 [ -1.64, -0.32 ]
Passard 2007 (4) -0.55 (0.372449) 20.0 % -0.55 [ -1.28, 0.18 ]
Short 2011 (5) -0.64 (0.461735) 17.1 % -0.64 [ -1.54, 0.26 ]
Total (95% CI) 100.0 % -0.29 [ -0.87, 0.29 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 13.99, df = 4 (P = 0.01); I2 =71%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference end of treatment period
(2) BPI total (excl. walking subscale) end of 5 day stim period
(3) BPI interference end of 9 week treatment period (only monthly maintenance stim to go)
(4) BPI general activity subscale. 1 day post stim period
(5) BPI functional impairment end of 2 week treatment period
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Analysis 1.19. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 19
Disability/pain interference: medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 19 Disability/pain interference: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) 0.01 (0.482143) 20.6 % 0.01 [ -0.93, 0.95 ]
Kang 2009 (2) 0.233504 (0.209504) 29.8 % 0.23 [ -0.18, 0.64 ]
Mhalla 2011 (3) -1.16 (0.344388) 25.3 % -1.16 [ -1.83, -0.49 ]
Passard 2007 (4) -0.6 (0.375) 24.3 % -0.60 [ -1.33, 0.13 ]
Total (95% CI) 100.0 % -0.37 [ -1.07, 0.33 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 13.38, df = 3 (P = 0.004); I2 =78%
Test for overall effect: Z = 1.03 (P = 0.30)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference 1 month follow up
(2) BPI total (excl. walking subscale) 1 week post stim period
(3) BPI interference 1 month post treatment
(4) BPI general activity subscale. 16 days post stim period
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Analysis 1.20. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 20
Disability/pain interference: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 20 Disability/pain interference: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) -0.67 (0.5) 14.4 % -0.67 [ -1.65, 0.31 ]
Kang 2009 (2) -0.01742 (0.206721) 61.2 % -0.02 [ -0.42, 0.39 ]
Passard 2007 (3) -0.51 (0.372449) 24.4 % -0.51 [ -1.24, 0.22 ]
Total (95% CI) 100.0 % -0.23 [ -0.62, 0.16 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 2.36, df = 2 (P = 0.31); I2 =15%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference 3 month follow up
(2) BPI total (excl. walking subscale) 7 weeks post stim period
(3) BPI general activity subscale. 46 days post stim period
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Analysis 1.21. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 21 Quality of
life: short-term follow-up (Fibromyalgia Impact Questionnaire).
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 21 Quality of life: short-term follow-up (Fibromyalgia Impact Questionnaire)
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mhalla 2011 (1) 16 55 (16.6) 14 65.7 (11) 20.5 % -10.70 [ -20.67, -0.73 ]
Passard 2007 (2) 15 47.4 (8.1) 15 57.8 (6.8) 71.1 % -10.40 [ -15.75, -5.05 ]
Short 2011 (3) 10 42.07 (18.13) 10 51.5 (17.32) 8.4 % -9.43 [ -24.97, 6.11 ]
Total (95% CI) 41 39 100.0 % -10.38 [ -14.89, -5.87 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 4.51 (P < 0.00001)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours active Favours sham
(1) M1, 10Hz
(2) M1, 10Hz
(3) DLPFC, 10Hz
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Analysis 1.22. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 22 Quality of
life: medium-term follow-up (Fibromyalgia Impact Questionnaire).
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 22 Quality of life: medium-term follow-up (Fibromyalgia Impact Questionnaire)
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Mhalla 2011 (1) 16 56 (17.7) 14 63.3 (15) 22.5 % -7.30 [ -19.00, 4.40 ]
Passard 2007 (2) 15 48.7 (10.4) 15 62.2 (8.9) 64.1 % -13.50 [ -20.43, -6.57 ]
Short 2011 (3) 10 38.99 (19.44) 10 47.93 (14.7) 13.5 % -8.94 [ -24.05, 6.17 ]
Total (95% CI) 41 39 100.0 % -11.49 [ -17.04, -5.95 ]
Heterogeneity: Chi2 = 0.93, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 4.06 (P = 0.000049)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
(1) M1, 10Hz
(2) M1, 10Hz
(3) DLPFC, 10Hz
Analysis 1.23. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 23 Quality of
life: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 23 Quality of life: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 (1) -0.61 (0.375) -0.61 [ -1.34, 0.12 ]
-1 -0.5 0 0.5 1
Favours active Favours sham
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(1) 46 days post stimulation. Fibromyalgia impact questionnaire (total score)
Analysis 2.1. Comparison 2 Cranial electrotherapy stimulation (CES), Outcome 1 Pain: short-term follow-
up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 Cranial electrotherapy stimulation (CES)
Outcome: 1 Pain: short-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gabis 2003 10 2.83 (2.07) 10 2.65 (2.49) 7.6 % 0.08 [ -0.80, 0.95 ]
Gabis 2009 (1) 17 3.82 (2.86) 16 5.25 (2.29) 12.0 % -0.54 [ -1.23, 0.16 ]
Gabis 2009 (2) 19 3.26 (2.79) 23 4.65 (2.62) 15.3 % -0.51 [ -1.12, 0.11 ]
Tan 2006 18 5.73 (2.56) 20 6 (2.41) 14.3 % -0.11 [ -0.74, 0.53 ]
Tan 2011 45 5 (1.92) 55 5 (1.93) 37.5 % 0.0 [ -0.39, 0.39 ]
Taylor 2013 (3) 19 5.12 (1.69) 18 6.36 (2.11) 13.3 % -0.64 [ -1.30, 0.03 ]
Total (95% CI) 128 142 100.0 % -0.24 [ -0.48, 0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 4.87, df = 5 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.91 (P = 0.056)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) back pain
(2) neck pain
(3) Effect predominantly due to increase in pain in sham group
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Analysis 2.2. Comparison 2 Cranial electrotherapy stimulation (CES), Outcome 2 Disability/function/pain
interference.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 Cranial electrotherapy stimulation (CES)
Outcome: 2 Disability/function/pain interference
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Tan 2011 (1) 45 39.5 (24.3) 55 32.2 (23.8) 7.30 [ -2.19, 16.79 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours active Favours sham
(1) Baseline imbalances on this outcome
Analysis 2.3. Comparison 2 Cranial electrotherapy stimulation (CES), Outcome 3 Quality of life.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 Cranial electrotherapy stimulation (CES)
Outcome: 3 Quality of life
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Taylor 2013 (1) 18 45.05 (16.27) 18 70.1 (22.34) -1.25 [ -1.98, -0.53 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) Fibromyalgia Impact Questionnaire
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Analysis 3.1. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 1 Pain: short-term
follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 1 Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 9.3 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 14.2 % -0.15 [ -0.47, 0.18 ]
Villamar 2013 (1) -0.393703 (0.29557) 9.9 % -0.39 [ -0.97, 0.19 ]
Villamar 2013 (2) 0.11545 (0.285689) 10.2 % 0.12 [ -0.44, 0.68 ]
Subtotal (95% CI) 43.6 % -0.18 [ -0.41, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.20, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Multiple-dose studies
Antal 2010 -0.38 (0.673469) 3.5 % -0.38 [ -1.70, 0.94 ]
Fenton 2009 0.06593 (0.323217) 9.1 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 4.5 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (3) 1.11 (0.477041) 5.8 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (4) -0.73 (0.556122) 4.7 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 5.3 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.9 % 0.02 [ -0.79, 0.83 ]
Soler 2010 (5) -0.55 (0.45663) 6.2 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.278353) 10.4 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 56.4 % -0.22 [ -0.69, 0.25 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 21.07, df = 8 (P = 0.01); I2 =62%
Test for overall effect: Z = 0.90 (P = 0.37)
Total (95% CI) 100.0 % -0.18 [ -0.46, 0.09 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 23.52, df = 12 (P = 0.02); I2 =49%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.89), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) cathodal
(2) anodal
(3) DLPFC
(4) M1
(5) tDCS+ sham illusion vs sham tDCS + sham illusion
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Analysis 3.2. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 2 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 2 Pain: short-term follow-up, subgroup analysis: motor cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 9.9 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 18.5 % -0.15 [ -0.47, 0.18 ]
Villamar 2013 (1) -0.393703 (0.29557) 10.7 % -0.39 [ -0.97, 0.19 ]
Villamar 2013 (2) 0.11545 (0.285689) 11.2 % 0.12 [ -0.44, 0.68 ]
Subtotal (95% CI) 50.3 % -0.18 [ -0.41, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.20, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Multiple-dose studies
Antal 2010 -0.38 (0.673469) 3.0 % -0.38 [ -1.70, 0.94 ]
Fenton 2009 0.06593 (0.323217) 9.6 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 4.0 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 4.2 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 4.9 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.7 % 0.02 [ -0.79, 0.83 ]
Soler 2010 -0.55 (0.45663) 5.8 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.278353) 11.5 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 49.7 % -0.35 [ -0.79, 0.09 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 14.16, df = 7 (P = 0.05); I2 =51%
Test for overall effect: Z = 1.57 (P = 0.12)
Total (95% CI) 100.0 % -0.23 [ -0.48, 0.01 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 16.38, df = 11 (P = 0.13); I2 =33%
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Chi2 = 0.46, df = 1 (P = 0.50), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
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(1) cathodal
(2) anodal
Analysis 3.3. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 3 Pain: short-term
sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 3 Pain: short-term sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Antal 2010 -0.38 (0.673469) 3.1 % -0.38 [ -1.70, 0.94 ]
Boggio 2009 -0.417904 (0.268318) 9.8 % -0.42 [ -0.94, 0.11 ]
Fenton 2009 0.06593 (0.275383) 9.6 % 0.07 [ -0.47, 0.61 ]
Fregni 2006a -1.32 (0.568878) 4.1 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) 1.11 (0.477041) 5.3 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (2) -0.73 (0.556122) 4.2 % -0.73 [ -1.82, 0.36 ]
Jensen 2013 -0.146424 (0.140815) 13.7 % -0.15 [ -0.42, 0.13 ]
Mori 2010 -1.19 (0.507653) 4.8 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.3 % 0.02 [ -0.79, 0.83 ]
Soler 2010 (3) -0.74 (0.479592) 5.2 % -0.74 [ -1.68, 0.20 ]
Soler 2010 (4) -0.55 (0.45663) 5.6 % -0.55 [ -1.44, 0.34 ]
Villamar 2013 (5) 0.11545 (0.298113) 8.9 % 0.12 [ -0.47, 0.70 ]
Villamar 2013 (6) -0.393703 (0.308424) 8.7 % -0.39 [ -1.00, 0.21 ]
Wrigley 2014 0.35377 (0.237244) 10.7 % 0.35 [ -0.11, 0.82 ]
Total (95% CI) 100.0 % -0.20 [ -0.47, 0.06 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 26.59, df = 13 (P = 0.01); I2 =51%
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
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(1) DLPFC
(2) M1
(3) tDCS+ illusion vs sham TDCS + illusion
(4) tDCS+ sham illusion vs sham TDCS + sham illusion
(5) anodal
(6) cathodal
Analysis 3.4. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 4 Pain: short-term
sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 4 Pain: short-term sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Antal 2010 -0.38 (0.673469) 3.7 % -0.38 [ -1.70, 0.94 ]
Boggio 2009 -0.417904 (0.355472) 8.6 % -0.42 [ -1.11, 0.28 ]
Fenton 2009 0.06593 (0.364833) 8.4 % 0.07 [ -0.65, 0.78 ]
Fregni 2006a -1.32 (0.568878) 4.8 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) 1.11 (0.477041) 6.1 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (2) -0.73 (0.556122) 4.9 % -0.73 [ -1.82, 0.36 ]
Jensen 2013 -0.146424 (0.186554) 13.7 % -0.15 [ -0.51, 0.22 ]
Mori 2010 -1.19 (0.507653) 5.6 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 7.2 % 0.02 [ -0.79, 0.83 ]
Soler 2010 (3) -0.55 (0.45663) 6.4 % -0.55 [ -1.44, 0.34 ]
Soler 2010 (4) -0.74 (0.479592) 6.0 % -0.74 [ -1.68, 0.20 ]
Villamar 2013 (5) -0.393703 (0.408606) 7.4 % -0.39 [ -1.19, 0.41 ]
Villamar 2013 (6) 0.11545 (0.394946) 7.7 % 0.12 [ -0.66, 0.89 ]
Wrigley 2014 0.35377 (0.314305) 9.7 % 0.35 [ -0.26, 0.97 ]
-2 -1 0 1 2
Favours active Favours sham
(Continued . . . )
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 100.0 % -0.23 [ -0.51, 0.06 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 23.26, df = 13 (P = 0.04); I2 =44%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) DLPFC
(2) M1
(3) tDCS+ sham illusion vs sham TDCS + sham illusion
(4) tDCS+ illusion vs sham TDCS + illusion
(5) cathodal
(6) anodal
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Analysis 3.5. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 5 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 5 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 9.7 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 17.2 % -0.15 [ -0.47, 0.18 ]
Villamar 2013 (1) 0.11545 (0.285689) 10.9 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 10.5 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 48.3 % -0.18 [ -0.41, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.20, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Multiple-dose studies
Antal 2010 -0.38 (0.673469) 3.1 % -0.38 [ -1.70, 0.94 ]
Fenton 2009 0.06593 (0.323217) 9.4 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 4.1 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 4.3 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 5.0 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.7 % 0.02 [ -0.79, 0.83 ]
Soler 2010 -0.55 (0.45663) 5.9 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.237244) 13.2 % 0.35 [ -0.11, 0.82 ]
Subtotal (95% CI) 51.7 % -0.35 [ -0.79, 0.10 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 15.52, df = 7 (P = 0.03); I2 =55%
Test for overall effect: Z = 1.53 (P = 0.13)
Total (95% CI) 100.0 % -0.23 [ -0.48, 0.02 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 17.75, df = 11 (P = 0.09); I2 =38%
Test for overall effect: Z = 1.81 (P = 0.070)
Test for subgroup differences: Chi2 = 0.42, df = 1 (P = 0.51), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
(1) anodal
(2) cathodal
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Analysis 3.6. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 6 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 6 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 10.0 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 19.6 % -0.15 [ -0.47, 0.18 ]
Villamar 2013 (1) -0.393703 (0.29557) 10.9 % -0.39 [ -0.97, 0.19 ]
Villamar 2013 (2) 0.11545 (0.285689) 11.4 % 0.12 [ -0.44, 0.68 ]
Subtotal (95% CI) 52.0 % -0.18 [ -0.41, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.20, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Multiple-dose studies
Antal 2010 -0.38 (0.673469) 2.9 % -0.38 [ -1.70, 0.94 ]
Fenton 2009 0.06593 (0.323217) 9.7 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 4.0 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 4.1 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 4.8 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.7 % 0.02 [ -0.79, 0.83 ]
Soler 2010 -0.55 (0.45663) 5.7 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.314305) 10.1 % 0.35 [ -0.26, 0.97 ]
Subtotal (95% CI) 48.0 % -0.36 [ -0.79, 0.07 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 13.24, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 1.62 (P = 0.11)
Total (95% CI) 100.0 % -0.24 [ -0.48, 0.00 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 15.54, df = 11 (P = 0.16); I2 =29%
Test for overall effect: Z = 1.98 (P = 0.048)
Test for subgroup differences: Chi2 = 0.49, df = 1 (P = 0.48), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
(1) cathodal
(2) anodal
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Analysis 3.7. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 7 Pain: medium-term
follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 7 Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Antal 2010 -0.87 (0.701531) 8.5 % -0.87 [ -2.24, 0.50 ]
Fenton 2009 0.23766 (0.327394) 26.7 % 0.24 [ -0.40, 0.88 ]
Mori 2010 -0.96 (0.492347) 15.3 % -0.96 [ -1.92, 0.00 ]
Soler 2010 (1) -0.32 (0.464286) 16.7 % -0.32 [ -1.23, 0.59 ]
Wrigley 2014 0.04612 (0.270273) 32.9 % 0.05 [ -0.48, 0.58 ]
Total (95% CI) 100.0 % -0.20 [ -0.63, 0.24 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 5.81, df = 4 (P = 0.21); I2 =31%
Test for overall effect: Z = 0.89 (P = 0.37)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) tDCS+sham illusion versus sham tDCS + sham illusion
175Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.8. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 8 Disability (pain
interference): short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 8 Disability (pain interference): short-term follow-up
Study or subgroup Active Sham
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Soler 2010 10 4 (3.4) 10 4.9 (2.8) -0.90 [ -3.63, 1.83 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours active Favours sham
Analysis 3.9. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 9 Quality of life:
short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 9 Quality of life: short-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mori 2010 (1) 10 74.1 (19.5) 9 51.9 (15.2) 41.7 % 1.20 [ 0.21, 2.20 ]
Riberto 2011 (2) 11 49.8 (11.6) 12 37.9 (21.7) 58.3 % 0.65 [ -0.19, 1.49 ]
Total (95% CI) 21 21 100.0 % 0.88 [ 0.24, 1.53 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.69, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 2.68 (P = 0.0073)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours sham Favours active
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(1) MS-QoL-54
(2) SF-36 total
Analysis 3.10. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 10 Quality of life:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 10 Quality of life: medium-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mori 2010 10 75 (23.3) 9 60 (17.7) 0.69 [ -0.25, 1.62 ]
-2 -1 0 1 2
Favours sham Favours active
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Analysis 3.11. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 11 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 11 Pain: short-term follow-up, subgroup analysis: motor cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 10.4 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 23.2 % -0.15 [ -0.47, 0.18 ]
Villamar 2013 (1) 0.11545 (0.285689) 12.0 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 11.4 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 57.0 % -0.18 [ -0.41, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.20, df = 3 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
2 Multiple-dose studies
Antal 2010 -0.38 (0.673469) 2.8 % -0.38 [ -1.70, 0.94 ]
Fenton 2009 0.06593 (0.323217) 10.0 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 3.8 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 4.0 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 4.7 % -1.19 [ -2.18, -0.20 ]
Riberto 2011 0.02 (0.4158) 6.6 % 0.02 [ -0.79, 0.83 ]
Soler 2010 -0.55 (0.45663) 5.6 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.460994) 5.5 % 0.35 [ -0.55, 1.26 ]
Subtotal (95% CI) 43.0 % -0.38 [ -0.80, 0.03 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 11.06, df = 7 (P = 0.14); I2 =37%
Test for overall effect: Z = 1.81 (P = 0.070)
Total (95% CI) 100.0 % -0.26 [ -0.49, -0.03 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 13.78, df = 11 (P = 0.25); I2 =20%
Test for overall effect: Z = 2.21 (P = 0.027)
Test for subgroup differences: Chi2 = 0.70, df = 1 (P = 0.40), I2 =0.0%
-2 -1 0 1 2
Favours active Favours sham
(1) anodal
(2) cathodal
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Analysis 4.1. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 1 Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 1 Pain: short-term follow-up
Study or subgroup Active Sham
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hargrove 2012 (1) 39 4.6 (2.27) 38 6.01 (2.53) -1.41 [ -2.48, -0.34 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours RINCE Favours sham
(1) Per protocol analysis
Analysis 4.2. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 2 Fibromyalgia Impact Questionnaire total score.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 2 Fibromyalgia Impact Questionnaire total score
Study or subgroup Active Sham
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hargrove 2012 39 45.96 (20.42) 38 52.46 (18.53) -6.50 [ -15.21, 2.21 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours active Favours sham
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A D D I T I O N A L T A B L E S
Table 1. rTMS studies - characteristics of stimulation
Study Location
of stimu-
lation
Coil ori-
entation
Frequency
(Hz)
Intensity
(% RMT)
Number
of trains
Duration
of trains
Inter-
train
intervals
(sec)
Number
of
pulses per
session
Treat-
ment ses-
sions per
group
Ahmed
2011
M1 stump
region
45° angle
from sagit-
tal line
20 80 10 10 sec 50 2000 5, x 1 daily
André-
Obadia
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
20, 1 90 20 Hz: 20
1Hz: 1
20 Hz: 4
sec
1 Hz: 26
min
20 Hz: 84 1600 1
André-
Obadia
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
Medial-
lateral
20 90 20 4 sec 84 1600 1
André-
Obadia
2011
M1 hand
area, not
clearly re-
ported but
likely con-
tralateral
to painful
side
Not speci-
fied
20 90 20 4 sec 84 1600 1
Avery
2013
Left
DLPFC
Not speci-
fied
10 120 75 4 26 3000 15
Short 2011 Left
DLPFC
Para-
sagittal
10 120 80 5 sec 10 sec 4000 10,
x 1 daily
(working
days) for 2
weeks
Borckardt
2009
Left PFC Not speci-
fied
10 100 40 10 sec 20 4000 3 over a 5-
day period
Carretero
2009
Right
DLPFC
Not speci-
fied
1 110 20 60 sec 45 1200 Up to 20
on consec-
u-
tive work-
ing days
Defrin
2007
M1
midline
Not speci-
fied
5 115 500 10 sec 30 ? 500* 10, x 1
daily
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Table 1. rTMS studies - characteristics of stimulation (Continued)
Fregni
2005
Left and
right SII
Not speci-
fied
1 90 Not speci-
fied
Not speci-
fied
Not speci-
fied
1600 1
Fregni
2011
Right SII Not speci-
fied
1 70% maxi-
mum stim-
ulator out-
put inten-
sity (not
RMT)
1 Not speci-
fied
Not speci-
fied
1600 10, x 1
daily (week
days only)
Hirayama
2006
M1,
S1, PMA,
SMA
Not speci-
fied
5 90 10 10 sec 50 500 1
Hosomi
2013
M1 corre-
sponding
to painful
region
Not speci-
fied
5 90 10 10 sec 50 500 10, x 1
daily (week
days only)
Irlbacher
2006
M1 con-
tralateral
to painful
side
Not speci-
fied
5, 1 95 Not speci-
fied
Not speci-
fied
Not speci-
fied
500 1
Kang 2009 Right M1 45º pos-
tero-lateral
10 80 20 5 sec 55 1000 5, x 1 daily
Khedr
2005
M1 con-
tralateral
to painful
side
Not speci-
fied
20 80 10 10 sec 50 2000 5, x 1 daily
Lee 2012 Right
DLPFC
(low-
frequency)
Left
M1 (high-
frequency)
Not speci-
fied
10, 1 10 Hz: 80
1 Hz: 110
10 Hz:25
1 Hz: 2
10 Hz: 8
sec
1 Hz: 800
sec
10 Hz: 10
1 Hz: 60
10 Hz:
2000
1Hz: 1600
10, x 1
daily (week
days only)
Lefaucheur
2001a
M1 con-
tralateral
to painful
side
Not speci-
fied
10 80 20 5 sec 55 1000 1
Lefaucheur
2001b
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 0.5 80 10 Hz: 20
0.5 Hz: 1
10 Hz: 5
sec
0.5 Hz: 20
min
10 Hz: 55 10 Hz:
1000
0.5 Hz:
600
1
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Table 1. rTMS studies - characteristics of stimulation (Continued)
Lefaucheur
2004
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 20 5 sec 55 1000 1
Lefaucheur
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
min
10 Hz: 54 10 Hz:
1200
1Hz: 1200
1
Lefaucheur
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
min
10 Hz: 54 10 Hz:
1200
1Hz: 1200
1
Mhalla
2011
Left M1 Posteroan-
terior
10 80 15 10 sec 50 1500 14,
5 x 1 daily
(working
days), then
3
x 1 weekly,
then 3 x 1
fort-
nightly,
then 3 x 1
monthly
Onesti
2013
M1 deep
central sul-
cus
H-coil 20 100 30 2.5 sec 30 1500 5, x 1 daily
on consec-
utive days
Passard
2007
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 25 8 sec 52 2000 10,
x 1 daily
(working
days)
Picarelli
2010
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 100 25 10 sec 60 2500 10,
x 1 daily
(working
days)
Pleger
2004
M1 hand
area
Not speci-
fied
10 110 10 1.2 sec 10 120 1
Rollnik
2002
M1
midline
Not speci-
fied
20 80 20 2 sec Not speci-
fied
800 1
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Table 1. rTMS studies - characteristics of stimulation (Continued)
Saitoh
2007
M1 over
motor rep-
resentation
of painful
area
Not speci-
fied
10, 5, 1 90 10 Hz; 5
5 Hz: 10
1 Hz: 1
10 Hz: 10
sec
5 Hz: 10
sec
1 Hz: 500
sec
10 Hz: 50
5 Hz: 50
500 1
Tzabazis
2013
Targeted
to ACC
4-coil con-
figuration
1 Hz (10
Hz data ex-
cluded
as not ran-
domised)
110 Not
reported
Not
reported
Not
reported
1800 20,
x 1 daily
(working
days)
ACC: anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; M1: primary motor cortex; PFC: prefrontal cortex; PMA:
pre-motor area; RMT: resting motor threshold; dS1: primary somatosensory cortex; SII: secondary somatosensory cortex; SMA:
supplementary motor area
Table 2. CES studies - characteristics of stimulation
Study Electrode
placement
Frequency
(Hz)
Pulse width
(msec)
Waveform
shape
Intensity Duration
(min)
Treat-
ment sessions
per group
Capel 2003 Ear clip elec-
trodes
10 2 Not specified 12 µA 53 x 2 daily for 4
days
Cork 2004 Ear clip elec-
trodes
0.5 Not specified Modified
square wave
biphasic
100 µA 60 ? daily for 3
weeks
Gabis 2003 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Gabis 2009 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Katsnelson
2004
Mas-
toid processes
and forehead
Not specified Not specified 2 conditions:
symmetric,
asymmetric
11 to 15 mA 40 x 1 daily for 5
days
Lichtbroun
2001
Ear clip elec-
trodes
0.5 Not specified Biphasic
square wave
100 µA 60 x 1 daily for 30
days
Rintala 2010 Ear clip elec-
trodes
Not specified Not specified Not specified 100 µA 40 x 1 daily for 6
weeks
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Table 2. CES studies - characteristics of stimulation (Continued)
Tan 2000 Ear clip elec-
trodes
0.5 Not specified Not specified 10 to 600 µA 20 12 (timing not
specified)
Tan 2006 Ear clip elec-
trodes
Not specified Not specified Not specified 100 to500µA 60 x 1 daily for 21
days
Tan 2011 Ear clip elec-
trodes
Not specified Not specified Not specified 100 µA 60 x 1 daily for 21
days
Taylor 2013 Ear clip elec-
trodes
0.5 Not specified Modified
square-wave
biphasic
100 µA 60 x 1 daily for 8
weeks
Table 3. tDCS studies - characteristics of stimulation
Study Location of
stimulation
Electrode pad
size
Intensity (mA) Anodal or
cathodal?
Stimulus dura-
tion (min)
Treatment ses-
sions per group
Antal 2010 M1 left hand
area
35 cm2 1 mA Anodal 20 5, x 1 daily
Boggio 2009 M1 contralateral
to painful side
35 cm2 2 mA Anodal 30 1
Fenton 2009 M1 dominant
hemisphere
35 cm2 1 mA Anodal 20 2
Fregni 2006a M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Fregni 2006b M1 and DLPFC
contralateral to
painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Jensen 2013 M1 left 35cm2 2 mA Anodal 20 1
Mendonca 2011 Group 1: anodal
left M1
Group 2: catho-
dal left M1
Group 3: anodal
supraorbital
Group 4: catho-
dal supraorbital
Group 5: sham
35 cm2 2 mA Anodal or catho-
dal
20 1
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Table 3. tDCS studies - characteristics of stimulation (Continued)
Mori 2010 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Portilla 2013 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 x 1 per condition
Riberto 2011 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 10, x 1 weekly
Soler 2010 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 10, x 1 daily
(week days only)
Valle 2009 M1 and DLPFC
contralateral to
painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Villamar 2013 M1 left HD-tDCS 4 x 1-
ring montage
2 mA Anodal or catho-
dal
20 x 1 per condition
Wrigley 2014 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
DLPFC: dorsolateral prefrontal cortex; M1: primary motor cortex
HD-tDCS: High definition tDCS
Table 4. GRADE judgements for core comparisons
Comparison Result Limitations
of studies
Inconsis-
tency
Indirectness Imprecision Publication
bias
GRADE
judgement
rTMS
Pain: short-term
Low-fre-
quency rTMS
all
Ineffective
SMD 0.15 (-
0.01 to 0.31)
Down one
< 75% at low
risk of bias
None
(I2 = 0%, P =
0.78)
None Down one, n =
81
No direct evi-
dence
Low
High-fre-
quency TMS
all
Effective
SMD -0.27 (-
0.35 to -0.20)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 64%, P <
0.01)
None None, n = 447 No direct evi-
dence
Low
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Table 4. GRADE judgements for core comparisons (Continued)
Single-
dose, high-fre-
quency rTMS
applied to
the motor cor-
tex on chronic
pain
Effective
SMD -0.39 (-
0.51 to -0.27)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 31%, P =
0.13)
None Down one, n =
233
No direct evi-
dence
Low
Multiple-
dose, high-fre-
quency rTMS
applied to
the motor cor-
tex on chronic
pain
Ineffective
SMD -0.07 (-
0.41 to 0.26)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 71%, P <
0.01)
None Down one, n =
157
No direct evi-
dence
Very low
rTMS pre-
frontal cortex
Ineffective
SMD -0.47 (-
1.48 to 0.54)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 82%, P <
0.01)
None Down one, n =
68
No direct evi-
dence
Very low
Pain: medium-term
rTMS all Ineffective
SMD -0.15 (-
0.41 to 0.11)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 60%, P =
0.01)
None Down one, n =
184
No direct evi-
dence
Very low
Pain: long-term
rTMS all Ineffective
SMD -0.12, (-
0.46 to 0.21)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 0%, P =
0.95)
None Down one, n =
59
No direct evi-
dence
Low
CES
Pain: short-term
CES all Ineffective
SMD -0.24 (-
0.48 to 0.01)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 0%, P =
0.43)
None Down one, n =
270
No direct evi-
dence
Low
tDCS
Pain: short-term
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Table 4. GRADE judgements for core comparisons (Continued)
tDCS all Ineffective
SMD -0.18 (-
0.46 to 0.09)
Down one
< 75% studies
at low risk of
bias
Down one (I2
= 49%, P = 0.
02)
None Down one, n =
183
No direct evi-
dence
Very low
tDCS motor
cortex
Ineffective
SMD -0.23 (-
0.48 to 0.01)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 33%, P =
0.13)
None Down one, n =
182
No direct evi-
dence
Low
tDCS motor
cortex multi-
ple-dose stud-
ies
Ineffective
SMD -0.35 (-
0.79 to 0.09)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 51%, P =
0.05)
None Down one, n =
129
No direct evi-
dence
Very low
Pain: medium-term
tDCS all Ineffective
SMD -0.32 (-
0.76 to 0.11)
Down one
< 75% studies
at low risk of
bias
None (I2 =
40%, P = 0.
14)
None Down one n =
87
No direct evi-
dence
Low
RINCE
Pain: short-
term
Effective
SMD -1.41 (-
2.48 to -0.34)
P = 0.01
Down one -
study at un-
clear risk of
bias
n/a - single
study only
None Down two, as
only a single
study available
No direct evi-
dence - only a
single study
Very low
CES: cranial electrotherapy stimulation
RINCE: reduced impedance non-invasive cortical electrostimulation
rTMS: repetitive transcranial magnetic stimulation
SMD: standardised mean difference
tDCS: transcranial direct current stimulation
TMS: transcranial magnetic stimulation
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A P P E N D I C E S
Appendix 1. Main database search strategies for current update
CENTRAL (years 2009 to 2013 searched)
#1 MeSH descriptor: [Pain] explode all trees
#2 (chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint” or “temperomandib* joint” or “tempromandib* joint” or central or (post next stroke) or complex or regional
or “spinal cord”) near/4 pain*:ti,ab,kw (Word variations have been searched)
#3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* near/2 neuralg*) or (herp* near/2 neuralg*)
or (diabet* near/2 neuropath*) or (reflex near/4 dystroph*) or (sudeck* near/2 atroph*) or causalg* or whip-lash or whip*lash or
polymyalg* or (failed back near/4 surg*) or (failed back near/4 syndrome*)):ti,ab,kw (Word variations have been searched)
#4 #1 or #2 or #3
#5 MeSH descriptor: [Transcranial Magnetic Stimulation] this term only
#6 MeSH descriptor: [Electronarcosis] explode all trees
#7 (brain* or cortex or cortical or transcranial* or cranial or magneti*) near/4 stimulat*:ti,ab,kw (Word variations have been
searched)
#8 (transcrani* or crani* or brain*) near/4 (electrostim* or electro-stim* or electrotherap* or electro-therap*):ti,ab,kw (Word
variations have been searched)
#9 (non-invasive or non*invasive) near/4 stimulat*:ti,ab,kw (Word variations have been searched)
#10 “theta burst stimulat*” or iTBS or cTBS:ti,ab,kw (Word variations have been searched)
#11 “transcranial magnetic stimulation” or rTMS or “transcranial direct current stimulat*” or tDCS or “cranial electrostimulation”
or “cranial electrotherap*”:ti,ab,kw (Word variations have been searched)
#12 (electrosleep* or electronarco*):ti,ab,kw (Word variations have been searched)
#13 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12
#14 #4 and #13 from 2009 to 2013
MEDLINE and MEDLINE IN PROCESS (OVID)
1 exp Pain/ (283010)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (74023)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (28679)
4 or/1-3 (325946)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (6328)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (25872)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (147)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (822)
9 (theta burst stimulat* or iTBS or cTBS).tw. (575)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (7423)
11 (electrosleep or electronarco*).tw. (357)
12 or/5-11 (28316)
13 randomized controlled trial.pt. (337806)
14 controlled clinical trial.pt. (84996)
15 randomized.ab. (241501)
16 placebo.ab. (134421)
17 drug therapy.fs. (1571905)
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18 randomly.ab. (173459)
19 trial.ab. (248492)
20 groups.ab. (1134392)
21 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (2928552)
22 exp animals/ not humans.sh. (3751730)
23 21 not 22 (2487755)
24 4 and 12 and 23 (295)
25 (200911* or 200912* or 2010* or 2011* or 2012* or 2013*).ed. (2428299)
26 24 and 25 (112)
EMBASE (OVID)
1 exp Pain/ (729490)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (112128)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (41462)
4 or/1-3 (759765)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (11875)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (35587)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (194)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (1314)
9 (theta burst stimulat* or iTBS or cTBS).tw. (770)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (10413)
11 (electrosleep or electronarco*).tw. (375)
12 or/5-11 (39959)
13 4 and 12 (3078)
14 random$.tw. (793677)
15 factorial$.tw. (20700)
16 crossover$.tw. (46383)
17 cross over$.tw. (21096)
18 cross-over$.tw. (21096)
19 placebo$.tw. (189884)
20 (doubl$ adj blind$).tw. (140353)
21 (singl$ adj blind$).tw. (13272)
22 assign$.tw. (220119)
23 allocat$.tw. (74677)
24 volunteer$.tw. (170305)
25 Crossover Procedure/ (36109)
26 double-blind procedure.tw. (224)
27 Randomized Controlled Trial/ (338884)
28 Single Blind Procedure/ (16955)
29 or/14-28 (1300700)
30 (animal/ or nonhuman/) not human/ (4566449)
31 29 not 30 (1146950)
32 13 and 31 (574)
33 (200911* or 200912* or 2010* or 2011* or 2012* or 2013*).dd. (4384183)
34 32 and 33 (303)
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PsycINFO (OVID)
1 exp Pain/ (33859)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (17914)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (3654)
4 or/1-3 (39372)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (3412)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (9508)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (55)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (401)
9 (theta burst stimulat* or iTBS or cTBS).tw. (441)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (4745)
11 (electrosleep or electronarco*).tw. (6)
12 or/5-11 (9914)
13 4 and 12 (481)
14 clinical trials/ (6486)
15 (randomis* or randomiz*).tw. (39676)
16 (random$ adj3 (allocat$ or assign$)).tw. (22629)
17 ((clinic$ or control$) adj trial$).tw. (33763)
18 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw. (15332)
19 (crossover$ or “cross over$”).tw. (5478)
20 random sampling/ (445)
21 Experiment Controls/ (435)
22 Placebo/ (2892)
23 placebo$.tw. (23869)
24 exp program evaluation/ (12521)
25 treatment effectiveness evaluation/ (11860)
26 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw. (45199)
27 or/14-26 (142131)
28 13 and 27 (95)
29 limit 28 to yr=“2009 -Current” (60)
CINAHL (EBSCO)
S26 S25 Limiters - Published Date from: 20091101-20130231
S25 S15 AND S24
S24 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23
S23 (allocat* random*)
S22 (MH “Quantitative Studies”)
S21 (MH “Placebos”)
S20 placebo*
S19 (random* allocat*)
S18 (MH “Random Assignment”)
S17 (Randomi?ed control* trial*)
S16 (singl* blind* ) or (doubl* blind* ) or (tripl* blind* ) or (trebl* blind* ) or (trebl* mask* ) or (tripl* mask* ) or (doubl* mask*
) or (singl* mask* )
S15 S4 AND S14
S14 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI ( (electrosleep OR electronarco*) ) OR AB ( (electrosleep OR electronarco*) )
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S12 TI ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct current stimulation” OR tDCS OR “cranial
electrostimulation” OR “cranial electrotherapy”) ) OR AB ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct
current stimulation” OR tDCS OR “cranial electrostimulation” OR “cranial electrotherapy”) )
S11 TI ( (“theta burst stimulat*” OR iTBS OR cTBS) ) OR AB ( (“theta burst stimulat*” OR iTBS OR cTBS) )
S10 TI ( ((“non-invasive brain” OR “non*invasive brain”) AND stimulat*) ) OR AB ( ((“non-invasive brain” OR “non*invasive
brain”) AND stimulat*) )
S9 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR
AB ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S8 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR
AB ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S7 TI ( ((brain* OR cortex OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) ) OR AB ( ((brain* OR
cortex OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) )
S6 (MH “Electric Stimulation”)
S5 (MH “Electronarcosis”)
S4 S1 OR S2 OR S3
S3 TI ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR “trigemin* neuralg*” OR “herp* neuralg*” OR
“diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR whip-lash OR whip*lash OR polymyalg* OR
“failed back surg*” OR “failed back syndrome*”) ) OR AB ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR
“trigemin* neuralg*” OR “herp* neuralg*” OR “diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR
whip-lash OR whip*lash OR polymyalg* OR “failed back surg*” OR “failed back syndrome*”) )
S2 TI ( ((chronic* OR back OR musculoskel* OR intractabl* OR neuropath* OR phantom limb OR fantom limb OR neck
OR myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*” OR “tempromandib* joint*” OR central OR post*stroke
OR complex OR regional OR spinal cord) AND pain*). ) OR AB ( ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck OR myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*”
OR “tempromandib* joint*” OR central OR post*stroke OR complex OR regional OR spinal cord) AND pain*))
S1 (MH “Pain+”)
LILACS (7 February 2013)
1. (chronic$ or back or musculoskel$ or intractabl$ or neuropath$ or phantom limb or fantom limb or neck or myofasc$ or
temporomandib$ or temperomandib$ or tempromandib$ or central or (post stroke) or complex or regional or spinal cord sciatica or
back-ache or back ache or lumbago or fibromyalg$ or trigemin$ neuralg$ or herp$ neuralg$ or diabet$ neuropath$ or reflex dystroph$
or sudeck$ atrophy$ or causalg$ or whip-lash or whip$lash or polymyalg$ or failed back) 69863
2. (brain$ or cortex or cortical or transcrani$ or cranial or magneti$ stimulat$ or electrostim$ or electro-stim$ or electrotherapy$ or
electro-therap$ or non-invasive or non invasive or stimul$ or theta burst stimulat$ or iTBS or cTBS or transcranial magnetic stimulat$
or rTMS or transcranial direct current stimulat$ or tDCS or cranial electrostimulation or cranial electrotherapy$ or electrosleep$ or
electronarco$) 24787
3. 1&2 5559
4. (randomized controlled trial or controlled clinical trial or placebo or sham or randomly or trial or groups) 31227
5. 3&4 545
6. REMOVE ANY PRE 2009 (removed 292) 253
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Appendix 2. Trials register search results for current update
Register Date of search Search terms Number of records Number of relevant records
NRR archive 7 February 2013 (chronic* or back or mus-
culoskel* or intractabl*
or neuropath* or phan-
tom limb or fantom limb
or neck or myofasc* or
temp*romandib joint or
central or post*stroke or
complex or regional or
spinal cord or sciatica or
back-ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or diabet*
neuropath* or reflex dys-
troph* or sudeck* atroph*
or causalg* or whip-lash or
whip*lash or polymyalg*
or failed back surg*
or failed back syndrome)
AND (brain* or cortex or
cortical or transcranial* or
cranial or magneti* or di-
rect current or DC or elec-
tric or crani* or electros-
tim* or electrotherap* or
electro-therap* or non-in-
vasive or non*invasive or
theta burst stimulat* or
iTBS or Ctbs or transcra-
nial magnetic stimulation
or rTMSor transcranial di-
rect current stimulation or
tDCS or cranial electros-
timulation or cranial elec-
trotherapy or electrosleep
or electronarco*) al fields
AND (2009 OR 2010 OR
2011 OR 2012 OR 2013)
date started
2 0
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION: chronic*
OR back OR muscu-
loskel* OR intractabl* OR
89 10
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(Continued)
neuropath* OR phantom
limb OR fantom limb OR
neck OR myofasc* OR
temp?romandib joint OR
central OR post*stroke
OR complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVEN-
TION: brain* OR cortex
OR cortical OR transcra-
nial* OR cranial OR mag-
neti* OR direct current
OR DC OR electric OR
crani* OR electrostim*
OR electrotherap* OR
electro-therap* OR non-
invasive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
01/01/2009 to 07/02/
2013
adult
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION: chronic*
OR back OR muscu-
loskel* OR intractabl* OR
neuropath* OR phantom
limb OR fantom limb OR
neck OR myofasc* OR
temp?romandib joint OR
central OR post*stroke
OR complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVENTION: tran-
scranial magnetic stimu-
lation OR rTMS OR
transcranial direct current
20
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(Continued)
stimulation OR tDCS OR
cranial electrostimulation
OR cranial electrotherapy
OR electrosleep OR elec-
tronarco*
OUTCOME: pain
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed back
syndrome
INTERVEN-
TION: brain* OR cortex
OR cortical OR transcra-
nial* OR cranial OR mag-
neti* OR direct current
OR DC OR electric OR
crani* OR electrostim*
OR electrotherap* OR
electro-therap* OR non-
invasive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
2
Clinical trials.gov 7 February 2013
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
0
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(Continued)
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed back
syndrome
INTERVENTION: tran-
scranial magnetic stimu-
lation OR rTMS OR
transcranial direct current
stimulation OR tDCS OR
cranial electrostimulation
OR cranial electrotherapy
OR electrosleep OR elec-
tronarco*
OUTCOME: pain
HSRProj 11 February 2013 ((chronic* or back or mus-
culoskel* or intractabl* or
neuropath* or phantom
limb or fantom limb or
neck or myofasc* or temp?
romandib joint or central
or post*stroke or complex
or regional or spinal cord
or sciatica or back-ache
or back*ache or lumbago
or fibromyalg* or trigem*
neuralg* or herp* neuralg*
or diabet* neuropath* or
reflex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash or
polymyalg* or failed back
surg* or failed back syn-
drome) AND (brain* or
cortex or cortical or tran-
scranial* or cranial or
magneti* or direct cur-
rent or DC or electric
or crani* or electrostim*
or electrotherap* or elec-
tro-therap* or non-inva-
sive or non*invasive or
theta burst stimulat* or
iTBS or Ctbs or transcra-
152 0
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(Continued)
nial magnetic stimulation
or rTMSor transcranial di-
rect current stimulation or
tDCS or cranial electros-
timulation or cranial elec-
trotherapy or electrosleep
or electronarco*))
Current controlled trials
(excl clinicatrials.gov)
11 February 2013 (sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg*OR failed back
surg* OR failed back syn-
drome) AND(cranial elec-
trotherapyORelectrosleep
OR electronarco*)
0 1
Current controlled trials
(excl clinicatrials.gov)
11 February 2013 (sudeck*
atroph* OR causalg* OR
whip-lash OR whip*lash
OR polymyalg* OR failed
back surg* OR failed back
syndrome) AND (Ctbs
OR transcranial magnetic
stimulationOR rTMSOR
transcranial direct current
stimulation OR tDCS OR
cranial electrostimulation)
0
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 TRANSCRANIAL and
PAIN
1
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 CRANIAL AND PAIN 4
Current controlled trials
(excl clinicatrials.gov)
25/2/13 STIMULATION AND
PAIN
75
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 (Cortex or cortical) and
pain
8
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 Brain and pain 33
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 (Electro or electrical) and
pain
46
Total current controlled
trials
25 February 2013 167
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(Continued)
Total relevant trial records, all databases 11
Appendix 3. Search results summary table for current update: July 2013 search
Database searched Date searched Number of results
CENTRAL Issue 6 of 12, 2013 (The
Cochrane Library)
24 July 2013 2
MEDLINE (OVID) June 2013 to 19/7/
2013
MEDLINE In Process (OVID) - current
week
24 July 2013
24 July 2013
5
19
EMBASE (OVID) June 2013 to 2013
week 29
24 July 2013 8
PsycINFO (OVID) June 2013 to July week
3 2013
24 July 2013 1
CINAHL (EBSCO) June 2013 to July
2013
24 July 2013 4
Total 39
After de-duplication 35
After title abstract screening 0
After expert checking 2
Appendix 4. Full list of searches and results for 2009 version of review
1. Cochrane PaPaS Group Specialised Register, saved search: 177 results
“electric* stimulat* therap*” or “brain* stimulat*” or “cort* stimulat*” or “transcranial* stimulat*” or “cranial stimulat*” or “magneti*
stimulat*” or “direct current stimulat*” or “electric* stimulat*” or electrostim* or electrotherapy* or electro-therap* or “theta burst
stimulat*” or “transcran* magnet* stimulat*” or iTBS or cTBS or rTMS or “transcran* direct current stimulat*” or tDCS or electrosleep
or electronarco*
2. CENTRAL in The Cochrane Library
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#1 MeSH descriptor Pain explode all trees 25049
#2 (chronic* or back or musculoskel* or intractabl* or
neuropath* or phantom limb or fantom limb or neck or
myofasc* or “temporomandib* joint” or “temperomandib*
joint” or “tempromandib* joint” or central or (post NEXT
stroke) or complex or regional or “spinal cord”) near/4
pain*:ti,ab,kw
7785
#3 (sciatica or back-ache or back*ache or lumbago or
fibromyalg* or (trigemin* near/2 neuralg*) or (herp* near/2
neuralg*) or (diabet* near/2 neuropath*) or (reflex near/4
dystroph*) or (sudeck* near/2 atroph*) or causalg* or whip-
lash or whip*lash or polymyalg* or (failed back near/4
surg*) or (failed back near/4 syndrome*)):ti,ab,kw
3040
#4 (#1 OR #2 OR #3) 30353
#5 MeSH descriptor Transcranial Magnetic Stimulation
explode all trees
328
#6 MeSH descriptor Electronarcosis explode all trees 34
#7 (brain* or cortex or cortical or transcranial* or cranial or
magneti*) near/4 stimulat*:ti,ab,kw
1388
#8 (transcrani* or crani* or brain*) near/4 (electrostim* or
electro-stim* or electrotherap* or electro-therap*):ti,ab,kw
45
#9 (non-invasive or non*invasive) near/4 stimulat*:ti,ab,kw 55
#10 “theta burst stimulat*” or iTBS or cTBS:ti,ab,kw 9
#11 “transcranial magnetic stimulation” or rTMS or
“transcranial direct current stimulat*” or tDCS or “cranial
electrostimulation” or “cranial electrotherap*”:ti,ab,kw
747
#12 (electrosleep* or electronarco*):ti,ab,kw 45
#13 (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR
#12)
1505
#14 (#4 AND #13) 106
3a. MEDLINE
Database: Ovid MEDLINE(R) <1950 to November Week 3 2009>
1 exp Pain/ (252061)
198Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (61945)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (25802)
4 1 or 3 or 2 (288507)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (4240)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (21248)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (116)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (526)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (359)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5306)
11 (electrosleep or electronarco*).ab,ti. (357)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (23212)
13 4 and 12 (1069)
14 randomised controlled trial.pt. (291031)
15 controlled clinical trial.pt. (82962)
16 randomized.ab. (196258)
17 (placebo or sham).ab,ti. (164609)
18 drug therapy.fs. (1385685)
19 randomly.ab. (141449)
20 trial.ab. (203139)
21 groups.ab. (961704)
22 or/14-21 (2562312)
23 exp animals/ not humans.sh. (3518581)
24 22 not 23 (2157467)
25 24 and 13 (219)
3b. Database: Ovid MEDLINE(R) In-process & Other non-indexed citations
<25 November 2009>
1 exp Pain/ (6)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (4772)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (1251)
4 1 or 3 or 2 (5661)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (0)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (1057)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (5)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (42)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (38)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (375)
11 (electrosleep or electronarco*).ab,ti. (0)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (1113)
13 4 and 12 (39)
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4. Database: EMBASE
<1980 to 2009 Week 47>
1 exp Pain/ (394924)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (57196)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (21356)
4 1 or 3 or 2 (410258)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (5841)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (18227)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (74)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (498)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (330)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5259)
11 (electrosleep or electronarco*).ab,ti. (20)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (19954)
13 4 and 12 (1331)
14 random*.ti,ab. (415216)
15 factorial*.ti,ab. (8708)
16 (crossover* or cross over* or cross-over*).ti,ab. (40788)
17 placebo*.ti,ab. (114266)
18 (doubl* adj blind*).ti,ab. (87525)
19 (singl* adj blind*).ti,ab. (7775)
20 assign*.ti,ab. (113729)
21 allocat*.ti,ab. (36179)
22 volunteer*.ti,ab. (102464)
23 CROSSOVER PROCEDURE.sh. (21985)
24 DOUBLE-BLIND PROCEDURE.sh. (74829)
25 RANDOMIZED CONTROLLED TRIAL.sh. (176320)
26 SINGLE BLIND PROCEDURE.sh. (8721)
27 or/14-26 (691134)
28 ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/ (3551150)
29 HUMAN/ (6702208)
30 28 and 29 (569432)
31 28 not 30 (2981718)
32 27 not 31 (601828)
33 32 and 13 (234)
5. Database: PsycINFO
<1806 to November Week 4 2009>
1 exp Pain/ (26560)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or temp?
romandib* joint or central or post*stroke or complex or regional or spinal cord) adj4 pain*).ab,ti. (14094)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (2649)
4 1 or 3 or 2 (30822)
5 Transcranial Magnetic Stimulation/ or Electrosleep treatment/ (1830)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (7832)
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7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (47)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (144)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (259)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (2652)
11 (electrosleep or electronarco*).ab,ti. (140)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (8307)
13 4 and 12 (277)
14 (random* or placebo* or sham or trial or groups).ti,ab. (391590)
15 13 and 14 (64)
6. CINAHL
<Search run 11 January 2010>
1 exp PAIN/ 64959
2 ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck
OR myofasc* OR ”temporomandib* joint*“ OR ”tempero-
mandib* joint*“ OR ”tempromandib* joint*“ OR central OR
post*stroke OR complex OR regional OR spinal cord) AND
pain*).ti,ab
25127
3 (sciatica OR back-ache OR back*ache OR lumbago OR fi-
bromyalg* OR ”trigemin* neuralg*“ OR ”herp* neuralg*“ OR
”diabet* neuropath*“ OR ”reflex dystroph*“ OR ”sudeck*
atroph*“ OR causalg* OR whip-lash OR whip*lash OR
polymyalg* OR ”failed back surg*“ OR ”failed back syn-
drome*“).ti,ab
4111
4 1 OR 2 OR 3 75018
5 ELECTRONARCOSIS/ 1
6 ELECTRIC STIMULATION/ 3829
7 ((brain* OR cortex OR cortical OR transcranial* OR cranial
OR ”magneti*) AND stimulat*).ti,ab
545
8 ((transcrani* OR crani* OR brain*) AND (electrostim* OR
electro-stim* OR electrotherap* OR electro-therap*)).ti,ab
26
9 ((“non-invasive brain” OR “non*invasive brain”) AND stimu-
lat*).ti,ab
12
10 (“theta burst stimulat*” OR iTBS OR cTBS).ti,ab 16
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(Continued)
11 (“transcranial magnetic stimulation” OR rTMS OR “transcra-
nial direct current stimulation” OR tDCS OR “cranial elec-
trostimulation” OR “cranial electrotherapy”).ti,ab
437
12 (electrosleep OR electronarco*).ti,ab 1
13 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 4387
14 4 AND 13 836
15 exp CLINICAL TRIALS/ 79642
16 (clinical AND trial*).af 148411
17 ((singl* OR doubl* OR trebl* OR tripl*) AND (blind* OR
mask*)).ti,ab
11736
18 (Randomi?ed AND control* AND trial*).af 65515
19 RANDOM ASSIGNMENT/ 22506
20 (Random* AND allocat*).ti,ab 3666
21 placebo*.af 34556
22 PLACEBOS/ 5386
23 QUANTITATIVE STUDIES/ 5131
24 15 OR 16 OR17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 176918
25 14 AND 24 226
7. SCOPUS
We did not search this database as it includes all of MEDLINE, all of EMBASE and some of CINAHL, which have been searched
separately.
8. Search strategy for LILACS
http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/
1. Pain$ or dolor$ or intractabl$ or neuropath$ or phantom or fantom or myofasc$ or temp$romandibular or sciatic$ or back-ache or
backache or ache or lumbago or fibromyalg$ or neuralg$ or dystroph$ or atroph$ or causalgi$ or whip-lash or whiplash or polymyalg$
[Words]
2. ((Estimulaci$ or stimulat$) and (cerebra$ or brain$ or cortex or cortical or crania$ or transcranial$ or magneti$)) or electrostim$ or
electrotherapy$ or electro-therap$ or “theta burst stimul$” or iTBS or Ctbs or “transcrani$ magnet$ stimulat$” or rTMS or “transcrani$
direct current stimulat$” or tDCS or “cranial electrostimulat$” or “cranial electrotherapy$ or electrosleep or electronarco$ [Words]
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3. ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation
OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR
(Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw
investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw
blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw
randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT
(Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR
Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) ANDNOT (Ct animal ANDNOT (Ct human and Ct animal)))
[Words]
4. 1 and 2 and 3 (68)
Appendix 5. Trials register search results for 2009 version of review
Database Date of search Search strategy No. hits Agreed potential stud-
ies
National Research Reg-
ister (NRR) Archive
(NIHR)
23 October 2009 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
366 2
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(Continued)
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*) IN “TITLE”
Field
Clinicaltrials.gov 23 October 2009
Search 1
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
62
Clinicaltrials.gov 23 October 2009
Search 2
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
8 (all also picked up in
search 1)
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(Continued)
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
Clinicaltrials.gov 23 October 2009
Search 3
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
0
Clinicaltrials.gov 23 October 2009
Search 4
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
0
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(Continued)
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
TOTAL UNIQUE RE-
SULTS FOR CLINI-
CAL TRIALS.GOV
62 7
HSRProj (Health Ser-
vices Research Projects
in Progress)
23 October 2009 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
77 0
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(Continued)
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*)
Current Controlled Tri-
als
23 October 2009
Search 1
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(cranial electrother-
apy OR electrosleep OR
electronarco*)
0
Current Controlled Tri-
als
23 October 2009
Search 2
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stimu-
lationOR tDCSORcra-
nial electrostimulation)
0
Current Controlled Tri-
als
23 October 2009
Search 3
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(crani* OR electrostim*
OR
electrotherap* OR elec-
4
207Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
Current Controlled Tri-
als
23 October 2009
Search 4
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC)
13
Current Controlled Tri-
als
23 October 2009
Search 5
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial electrostimula-
tion
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
0
Current Controlled Tri-
als
23 October 2009
Search 6
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stim-
ulation OR tDCS )
9
Current Controlled Tri-
als
3 November 2009
Search 7
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
36
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(Continued)
reflex dystroph*) AND
(crani* OR electrostim*
OR electrotherap* OR
electro-therap*)
Current Controlled Tri-
als
23 October 2009
Search 8
(back-
ache OR back*ache OR
lumbago OR
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph*) AND (non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
53
Current Controlled Tri-
als
3 November 2009
Search 9
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial OR magneti*
OR direct current OR
DC)
52
Current Controlled Tri-
als
3 November 2009
Search 10
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(brain* OR cortex OR
cortical OR transcra-
nial*)
63
Current Controlled Tri-
als
3 November 2009
Search 11
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND(cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 12
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND (transcranial
direct current stimula-
tion OR tDCS)
11
Current Controlled Tri-
als
3 November 2009
Search 13
(central OR post*stroke
OR com-
plex OR regional OR
spinal cord OR sciatica)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
48
Current Controlled Tri-
als
3 November 2009
Search 14
(central OR post*stroke
OR complex OR re-
gional OR spinal cord
OR sciatica) AND (elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimu-
lat*)
199
Current Controlled Tri-
als
3 November 2009
Search 15
(central OR
post*stroke OR complex
OR regional OR spinal
cord OR sciatica) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC OR crani* OR elec-
trostim*)
1905
Current Controlled Tri-
als
3 November 2009
Search 16
(temp?romandib joint)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent ORDCOR electric
OR crani* OR electros-
tim* OR electrotherap*
OR electro-therap*)
0
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 17
(temp?romandib joint)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
0
Current Controlled Tri-
als
3 November 2009
Search 18
(temp?romandib joint)
AND (non-invasive OR
non*invasive OR theta
burst stimulat*)
0
Current Controlled Tri-
als
3 November 2009
Search 19
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (transcranial di-
rect current stimulation
OR tDCS OR cranial
electrostimulation
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
16
Current Controlled Tri-
als
3 November 2009
Search 20
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (Ctbs OR tran-
scranial magnetic stimu-
lation OR Rtms)
55
Current Controlled Tri-
als
3 November 2009
Search 21
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (crani* OR elec-
trostim* OR
electrotherap* OR elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
557
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 22
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent OR DC)
2385
Current Controlled Tri-
als
3 November 2009
Search 23
(temp*romandibular
joint) AND (brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap*)
8
Current Controlled Tri-
als
3 November 2009
Search 24
(temp*romandibular
joint) AND (elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimu-
lat* OR iTBS OR Ctbs
OR transcranial mag-
netic stimulation)
1
Current Controlled Tri-
als
3 November 2009
Search 25
(temp*romandibular
joint) AND (rTMS OR
transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
TOTAL
RESULTS FOR CUR-
RENT CON-
TROLLED TRIALS
5415 14
TOTAL
RESULTS FROM ALL
DATABASES
23
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(Continued)
DUPLICATES BE-
TWEEN DATABASES
7
FINAL TOTAL FROM
TRIALS REGISTERS
SEARCHES
16
Appendix 6. GRADE judgement summary table
Comparison Result Limitations
of studies
Inconsis-
tency
Indirectness Imprecision Publication
bias
GRADE
judgement
rTMS
Pain: short-term
Low-fre-
quency rTMS
all
Ineffective
SMD 0.15 (-
0.01 to 0.31)
Down one
< 75% at low
risk of bias
None
(I2 = 0%, P =
0.78)
None Down one, n =
81
No direct evi-
dence
Low
High-fre-
quency TMS
all
Effective
SMD -0.27 (-
0.35 to -0.20)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 64%, P <
0.01)
None None, n = 447 No direct evi-
dence
Low
Single-
dose, high-fre-
quency rTMS
applied to
the motor cor-
tex on chronic
pain
Effective
SMD -0.39 (-
0.27 to -0.51)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 31%, P =
0.13)
None Down one, n =
233
No direct evi-
dence
Low
Multiple-
dose, high-fre-
quency rTMS
applied to
the motor cor-
tex on chronic
pain
Ineffective
SMD -0.07 (-
0.41 to 0.26)
Down one
< 75% studies
at low risk of
bias
Down one (I2
= 71%, P < 0.
01)
None Down one, n =
157
No direct evi-
dence
Very low
rTMS pre-
frontal cortex
Ineffective
SMD -0.47 (-
1.48 to 0.54)
Down one
< 75% studies
at low risk of
bias
Down one (I2
= 82%, P < 0.
01)
None Down one, n =
68
No direct evi-
dence
Very low
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Pain: medium-term
rTMS all Ineffective
SMD -0.15 (-
0.41 to 0.11)
Down one
< 75% studies
at low risk of
bias
Down one (I2
= 57%, P = 0.
02)
None Down one, N
= 184
No direct evi-
dence
Very low
Pain: long-term
rTMS all Ineffective
SMD -0.12 (-
0.46 to 0.21)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 0%, P =
0.95)
None Down one, n =
59
No direct evi-
dence
Low
CES
Pain: short-term
CES all Ineffective
SMD -0.24 (-
0.48 to 0.01)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 0%, P =
0.43)
None Down one, n =
270
No direct evi-
dence
Low
tDCS
Pain: short-term
tDCS all Ineffective
SMD -0.18 (-
0.46 to 0.09)
Down one
< 75% studies
at low risk of
bias
Down one (I2
= 45%, P = 0.
05)
None Down one, n =
183
No direct evi-
dence
Very low
tDCS motor
cortex
Ineffective
SMD -0.23 (-
0.48 to 0.01)
Down one
< 75% studies
at low risk of
bias
None
(I2 = 33%, P =
0.13)
None Down one, n =
172
No direct evi-
dence
Low
tDCS motor
cortex, multi-
ple-dose stud-
ies
Ineffective
SMD -0.35 (-
0.79 to 0.09)
Down one
< 75% studies
at low risk of
bias
Down one
(I2 = 51%, P =
0.05)
None Down one, n =
119
No direct evi-
dence
Very low
Pain: medium-term
tDCS all Ineffective
SMD -0.42 (-
0.63 to 0.24)
Down one
< 75% studies
at low risk of
bias
None (I2 =
31%, P = 0.
21)
None Down one, n =
77
No direct evi-
dence
Low
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WH A T ’ S N E W
Last assessed as up-to-date: 24 July 2013.
Date Event Description
25 July 2013 New citation required and conclusions have changed We have performed a full update of the searches (Jan-
uary 2013) and a supplemental update of the main
databases (July 2013). This involved the inclusion of 21
new trials with 747 participants. We have updated all
analyses and made GRADE quality assessments for all
core comparisons. The addition of these data has sub-
stantially altered our conclusions regarding transcranial
direct current stimulation (tDCS), as our analysis no
longer suggests that tDCS is effective compared with
sham. While the broad conclusions for repetitive tran-
scranial magnetic stimulation (rTMS) and cranial elec-
trotherapy stimulation (CES) have not changed sub-
stantially, the addition of this new evidence and the ap-
plication of the GRADE system has modified some of
our interpretation. Previous readers should re-read this
update
11 February 2013 New search has been performed For this update we have altered the ’Risk of bias’ as-
sessment to reflect new evidence regarding the adequacy
of blinding of studies of tDCS and we have included
the following new ’Risk of bias’ criteria: sample size and
study duration. Details of this can be found in the sec-
tions: Assessment of risk of bias in included studies and
Description of the intervention. We have also applied
the GRADE approach to assessing the quality of evi-
dence
H I S T O R Y
Protocol first published: Issue 1, 2010
Review first published: Issue 9, 2010
Date Event Description
13 September 2010 Amended We amended the ’Risk of bias’ tables so that the criterion “allocation concealment” is not assessed
for studies with cross-over designs and the criterion “free from carry-over effects?” is not assessed
for studies with parallel designs. These changes are now reflected in Figure 1, where those criteria
now appear as empty boxes for the appropriate studies. This is in line with the original review
protocol and the changes are necessary due to a copy-editing error rather than any change to the
review methods.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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C O N T R I B U T I O N S O F A U T H O R S
NOC: Conceived and designed the review protocol, co-implemented the search strategy alongside the Cochrane PaPaS Group Trials
Search Co-ordinator, applied eligibility criteria, assessed studies, extracted and analysed data, and led the write-up of the review.
BM: Closely informed the protocol design and acted as the second review author, applied eligibility criteria, assessed studies, extracted
data and assisted with the write-up of the review.
LM: Provided statistical advice and support throughout the review and contributed to the design of the protocol.
LDS: Was involved in the conception and design of the review and acted as a third review author for conflicts in applying eligibility
criteria and assessing included studies.
SS: Informed the design of the protocol and has supported the implementation and reporting of the review throughout.
All authors read and commented upon the systematic review and commented on and approved the final manuscript.
D E C L A R A T I O N S O F I N T E R E S T
None known.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The database Scopus was not searched as the other searches had covered the full scope of this database.
As described in detail in Unit of analysis issues, on advice from a Cochrane statistician we meta-analysed parallel and cross-over studies
using the generic inverse variance method rather than combining them without this statistical adjustment as was specified in the
protocol. Subsequently the planned sensitivity analysis investigating the influence of study design was not deemed necessary.
The following decision was taken on encountering multiple outcomes within the same time period: for short-term outcomes where
more than one data point was available, we used the first post-stimulation measure; where multiple treatments were given, we took the
first outcome at the end of the treatment period. For medium-term outcomes where more than one data point was available we used
the measure that was closest to the mid-point of this time period. We decided to pool data from studies with a low or unclear risk of
bias as we felt that the analysis specified in the protocol (including only those studies with an overall low risk of bias) was too stringent
and would not allow any statistical assessment of the data.
We did not use overall risk of bias in sensitivity analyses as we found that it lacked sensitivity. Instead we considered individual criteria
in the ’Risk of bias’ assessment for sensitivity analyses. However, we excluded studies with a ’high’ risk of bias for any criterion from
the meta-analysis.
For this update we have altered the ’Risk of bias’ assessment to reflect new evidence regarding the adequacy of blinding of studies of
tDCS. Details of this can be found in Assessment of risk of bias in included studies and Description of the intervention.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pain Management; Brain [∗physiology]; Chronic Disease; Electric Stimulation Therapy [adverse effects; ∗methods]; Magnetic Field
Therapy [adverse effects; ∗methods]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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